drug_internal_id,drug_id,drug_name,warning_type,warning_class,warning_description,efo_id,efo_term,warning_year,warning_country
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,,severe adverse reactions,EFO:0009658,adverse effect,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,drug misuse,Off-Label Abuse; Hematologic Toxicity,MONDO:0002491,substance abuse,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,hematological toxicity,aplastic anaemia and agranulocytosis,HP:0012234,Agranulocytosis,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,hematological toxicity,Off-Label Abuse; Hematologic Toxicity,EFO:0011051,hematological toxicity,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,hematological toxicity,aplastic anaemia and agranulocytosis,HP:0001915,Aplastic anemia,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
12417,CHEMBL101,PHENYLBUTAZONE,Withdrawn,,toxicity,,,1984.0,Malaysia; United Arab Emirates; Ethiopia; Jordan; Germany; Chile; Bangladesh; Ghana; Sri Lanka; Bahrain; Armenia
116349,CHEMBL1014,CANDESARTAN CILEXETIL,Black Box Warning,teratogenicity,,,,,United States
116349,CHEMBL1014,CANDESARTAN CILEXETIL,Black Box Warning,cardiotoxicity,,,,,United States
116949,CHEMBL1017,TELMISARTAN,Black Box Warning,teratogenicity,,,,,United States
116949,CHEMBL1017,TELMISARTAN,Black Box Warning,cardiotoxicity,,,,,United States
117108,CHEMBL1018,DIENESTROL,Withdrawn,carcinogenicity,Suspected carcinogenicity in newborns following prenatal exposure,EFO:0011046,carcinogenicity,1979.0,Italy
119498,CHEMBL1023,BEXAROTENE,Black Box Warning,teratogenicity,,,,,United States
119640,CHEMBL1024,IFOSFAMIDE,Black Box Warning,neurotoxicity,,,,,United States
119640,CHEMBL1024,IFOSFAMIDE,Black Box Warning,nephrotoxicity,,,,,United States
119640,CHEMBL1024,IFOSFAMIDE,Black Box Warning,hematological toxicity,,,,,United States
12825,CHEMBL103,PROGESTERONE,Black Box Warning,cardiotoxicity,,,,,United States
12825,CHEMBL103,PROGESTERONE,Black Box Warning,vascular toxicity,,,,,United States
12825,CHEMBL103,PROGESTERONE,Black Box Warning,neurotoxicity,,,,,United States
12825,CHEMBL103,PROGESTERONE,Black Box Warning,respiratory toxicity,,,,,United States
12825,CHEMBL103,PROGESTERONE,Black Box Warning,carcinogenicity,,,,,United States
123693,CHEMBL1034,DICLOFENAC SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
123693,CHEMBL1034,DICLOFENAC SODIUM,Black Box Warning,neurotoxicity,,,,,United States
123693,CHEMBL1034,DICLOFENAC SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
123693,CHEMBL1034,DICLOFENAC SODIUM,Black Box Warning,musculoskeletal toxicity,,,,,United States
13590,CHEMBL105,MITOMYCIN,Black Box Warning,hematological toxicity,,,,,United States
13590,CHEMBL105,MITOMYCIN,Black Box Warning,nephrotoxicity,,,,,United States
176495,CHEMBL106258,AMINOREX,Withdrawn,respiratory toxicity,Pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1967.0,Germany
139045,CHEMBL1069,VALSARTAN,Black Box Warning,teratogenicity,,,,,United States
139045,CHEMBL1069,VALSARTAN,Black Box Warning,cardiotoxicity,,,,,United States
139210,CHEMBL1070,NABUMETONE,Black Box Warning,gastrointestinal toxicity,,,,,United States
139210,CHEMBL1070,NABUMETONE,Black Box Warning,neurotoxicity,,,,,United States
139210,CHEMBL1070,NABUMETONE,Black Box Warning,cardiotoxicity,,,,,United States
139225,CHEMBL1071,OXAPROZIN,Black Box Warning,cardiotoxicity,,,,,United States
139225,CHEMBL1071,OXAPROZIN,Black Box Warning,neurotoxicity,,,,,United States
139225,CHEMBL1071,OXAPROZIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
139281,CHEMBL1072,BUMETANIDE,Black Box Warning,nephrotoxicity,,,,,United States
139281,CHEMBL1072,BUMETANIDE,Black Box Warning,,,,,,United States
15086,CHEMBL108,CARBAMAZEPINE,Black Box Warning,hematological toxicity,,,,,United States
15086,CHEMBL108,CARBAMAZEPINE,Black Box Warning,dermatological toxicity,,,,,United States
15086,CHEMBL108,CARBAMAZEPINE,Black Box Warning,gastrointestinal toxicity,,,,,United States
631502,CHEMBL1082607,SALMETEROL XINAFOATE,Black Box Warning,respiratory toxicity,,,,,United States
630396,CHEMBL1083385,CLOPIDOGREL BISULFATE,Black Box Warning,,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,nephrotoxicity,,,,,United States
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,Black Box Warning,dermatological toxicity,,,,,United States
621308,CHEMBL1089221,BENDAZAC,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1993.0,Spain
621308,CHEMBL1089221,BENDAZAC,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1993.0,Spain
15217,CHEMBL109,VALPROIC ACID,Black Box Warning,hepatotoxicity,,,,,United States
15217,CHEMBL109,VALPROIC ACID,Black Box Warning,teratogenicity,,,,,United States
15217,CHEMBL109,VALPROIC ACID,Black Box Warning,gastrointestinal toxicity,,,,,United States
150451,CHEMBL1094,FELBAMATE,Black Box Warning,hematological toxicity,,,,,United States
150451,CHEMBL1094,FELBAMATE,Black Box Warning,hepatotoxicity,,,,,United States
624161,CHEMBL1096882,FLUDARABINE PHOSPHATE,Black Box Warning,neurotoxicity,,,,,United States
624161,CHEMBL1096882,FLUDARABINE PHOSPHATE,Black Box Warning,hematological toxicity,,,,,United States
624467,CHEMBL1098319,2-MERCAPTOETHANESULFONIC ACID,Withdrawn,immune system toxicity,"hypersensitivity reactions of different degrees, including slight skin eruptions up to more serious anaphylactic reactions, in patients with autoimmune conditions.",MONDO:0100053,anaphylaxis,1991.0,Germany
624467,CHEMBL1098319,2-MERCAPTOETHANESULFONIC ACID,Withdrawn,immune system toxicity,"hypersensitivity reactions of different degrees, including slight skin eruptions up to more serious anaphylactic reactions, in patients with autoimmune conditions.",EFO:1002004,drug hypersensitivity syndrome,1991.0,Germany
624467,CHEMBL1098319,2-MERCAPTOETHANESULFONIC ACID,Withdrawn,immune system toxicity,"hypersensitivity reactions of different degrees, including slight skin eruptions up to more serious anaphylactic reactions, in patients with autoimmune conditions.",EFO:0020927,skin reaction,1991.0,Germany
624467,CHEMBL1098319,2-MERCAPTOETHANESULFONIC ACID,Withdrawn,immune system toxicity,"hypersensitivity reactions of different degrees, including slight skin eruptions up to more serious anaphylactic reactions, in patients with autoimmune conditions.",EFO:0009482,drug allergy,1991.0,Germany
182928,CHEMBL110691,CHLORMADINONE ACETATE,Withdrawn,carcinogenicity,Animal carcinogenicity (dogs),EFO:0011046,carcinogenicity,1970.0,United States; United Kingdom; Italy
182928,CHEMBL110691,CHLORMADINONE ACETATE,Withdrawn,carcinogenicity,Increased incidence of breast tumours in beagle dogs during the course of long-term toxicity tests,EFO:0011046,carcinogenicity,1970.0,United States; United Kingdom; Italy
152751,CHEMBL1108,DROPERIDOL,Black Box Warning,cardiotoxicity,,,,,United States
152751,CHEMBL1108,DROPERIDOL,Withdrawn,cardiotoxicity,Serious cardiac adverse effects,EFO:1001482,cardiotoxicity,2001.0,Indonesia
16088,CHEMBL111,RIMONABANT,Withdrawn,psychiatric toxicity,"psychiatric disorders, particularly depression",MONDO:0002009,major depressive disorder,2008.0,European Union
16088,CHEMBL111,RIMONABANT,Withdrawn,psychiatric toxicity,"psychiatric disorders, particularly depression",EFO:0011059,psychiatric toxicity,2008.0,European Union
154051,CHEMBL1111,AMBRISENTAN,Black Box Warning,teratogenicity,,,,,United States
155006,CHEMBL1112,ARIPIPRAZOLE,Black Box Warning,psychiatric toxicity,,,,,United States
155006,CHEMBL1112,ARIPIPRAZOLE,Black Box Warning,,,,,,United States
155045,CHEMBL1113,AMOXAPINE,Black Box Warning,psychiatric toxicity,,,,,United States
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
161281,CHEMBL1118,DESVENLAFAXINE,Black Box Warning,psychiatric toxicity,,,,,United States
16450,CHEMBL112,ACETAMINOPHEN,Black Box Warning,misuse,,,,,United States
16450,CHEMBL112,ACETAMINOPHEN,Black Box Warning,hepatotoxicity,,,,,United States
16450,CHEMBL112,ACETAMINOPHEN,Black Box Warning,nephrotoxicity,,,,,United States
16450,CHEMBL112,ACETAMINOPHEN,Black Box Warning,vascular toxicity,,,,,United States
165774,CHEMBL1123,DICYCLOMINE,Withdrawn,,Serious adverse reactions in infants under six months,EFO:0009658,adverse effect,,Norway
169652,CHEMBL1131,ACITRETIN,Black Box Warning,teratogenicity,,,,,United States
169652,CHEMBL1131,ACITRETIN,Black Box Warning,hepatotoxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,nephrotoxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,immune system toxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,respiratory toxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,hematological toxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,cardiotoxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
8633,CHEMBL11359,CISPLATIN,Black Box Warning,vascular toxicity,,,,,United States
171587,CHEMBL1136,TELITHROMYCIN,Black Box Warning,,,,,,United States
17169,CHEMBL114,SAQUINAVIR,Black Box Warning,,,,,,United States
178545,CHEMBL1141,POTASSIUM IODIDE,Black Box Warning,vascular toxicity,,,,,United States
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,Black Box Warning,,,,,,United States
187962,CHEMBL1162,NORETHINDRONE,Black Box Warning,,,,,,United States
647206,CHEMBL1164729,FEBUXOSTAT,Black Box Warning,cardiotoxicity,,,,,United States
644928,CHEMBL1165342,VINCAMINE,Withdrawn,cardiotoxicity,cardia arrhythmias; risk of blood dyscrasias,EFO:0004269,cardiac arrhythmia,1980.0,Germany; Hungary
644928,CHEMBL1165342,VINCAMINE,Withdrawn,hematological toxicity,Hematological,EFO:0005803,hematologic disease,1980.0,Germany; Hungary
644928,CHEMBL1165342,VINCAMINE,Withdrawn,hematological toxicity,cardia arrhythmias; risk of blood dyscrasias,EFO:0005803,hematologic disease,1980.0,Germany; Hungary
189203,CHEMBL1168,RAMIPRIL,Black Box Warning,teratogenicity,,,,,United States
193096,CHEMBL1177,PEMOLINE,Black Box Warning,,,,,,United States
193096,CHEMBL1177,PEMOLINE,Withdrawn,hepatotoxicity,Liver toxicity,EFO:0011052,hepatotoxicity,1997.0,United States; United Kingdom; Canada
193096,CHEMBL1177,PEMOLINE,Withdrawn,hepatotoxicity,Hepatic toxicity,EFO:0004228,drug-induced liver injury,1997.0,United States; United Kingdom; Canada
193096,CHEMBL1177,PEMOLINE,Withdrawn,hepatotoxicity,Liver toxicity,EFO:0004228,drug-induced liver injury,1997.0,United States; United Kingdom; Canada
193096,CHEMBL1177,PEMOLINE,Withdrawn,hepatotoxicity,Hepatic toxicity,EFO:0011052,hepatotoxicity,1997.0,United States; United Kingdom; Canada
193281,CHEMBL117785,TETRABENAZINE,Black Box Warning,psychiatric toxicity,,,,,United States
18694,CHEMBL118,CELECOXIB,Black Box Warning,gastrointestinal toxicity,,,,,United States
18694,CHEMBL118,CELECOXIB,Black Box Warning,neurotoxicity,,,,,United States
18694,CHEMBL118,CELECOXIB,Black Box Warning,cardiotoxicity,,,,,United States
657667,CHEMBL1183717,ALMITRINE,Withdrawn,neurotoxicity,Serious and long-lasting peripheral neuropathy (damage to the nerves in the hands and feet) and significant weight loss that further weakens patients,EFO:0003100,peripheral neuropathy,2013.0,European Union
657667,CHEMBL1183717,ALMITRINE,Withdrawn,,Serious and long-lasting peripheral neuropathy (damage to the nerves in the hands and feet) and significant weight loss that further weakens patients,HP:0001824,Weight loss,2013.0,European Union
204115,CHEMBL1191,SULFAMETHIZOLE,Withdrawn,,adverse reactions and low sales,EFO:0009658,adverse effect,1984.0,Sweden
668616,CHEMBL1194666,DIETHYLPROPION,Withdrawn,drug misuse,"risk of serious side effects, such as pulmonary arterial hypertension (high blood pressure in the arteries of the lungs) and dependency. The medicines were also being used in patients with a history of heart disease or psychiatric disorders, increasing their risk of heart and psychiatric problems. In addition, there was evidence of use during pregnancy, which could pose risks to the unborn baby",,,1981.0,European Union; Sweden; United Kingdom; France
668616,CHEMBL1194666,DIETHYLPROPION,Withdrawn,drug misuse,"Lack of evidence of their value in long-term management of obesity, they have the potential for abuse and despite warnings they are frequently used over unacceptably prolonged periods",MONDO:0002491,substance abuse,1981.0,European Union; Sweden; United Kingdom; France
668616,CHEMBL1194666,DIETHYLPROPION,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1981.0,European Union; Sweden; United Kingdom; France
668616,CHEMBL1194666,DIETHYLPROPION,Withdrawn,drug misuse,"risk of serious side effects, such as pulmonary arterial hypertension (high blood pressure in the arteries of the lungs) and dependency. The medicines were also being used in patients with a history of heart disease or psychiatric disorders, increasing their risk of heart and psychiatric problems. In addition, there was evidence of use during pregnancy, which could pose risks to the unborn baby",MONDO:0004938,substance dependence,1981.0,European Union; Sweden; United Kingdom; France
668616,CHEMBL1194666,DIETHYLPROPION,Withdrawn,respiratory toxicity,"risk of serious side effects, such as pulmonary arterial hypertension (high blood pressure in the arteries of the lungs) and dependency. The medicines were also being used in patients with a history of heart disease or psychiatric disorders, increasing their risk of heart and psychiatric problems. In addition, there was evidence of use during pregnancy, which could pose risks to the unborn baby",EFO:0001361,pulmonary arterial hypertension,1981.0,European Union; Sweden; United Kingdom; France
721,CHEMBL12,DIAZEPAM,Black Box Warning,,,,,,United States
721,CHEMBL12,DIAZEPAM,Black Box Warning,misuse,,,,,United States
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,Black Box Warning,psychiatric toxicity,,,,,United States
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,Black Box Warning,cardiotoxicity,,,,,United States
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
674279,CHEMBL1200328,DULOXETINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674279,CHEMBL1200328,DULOXETINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674283,CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674285,CHEMBL1200334,MORICIZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674286,CHEMBL1200335,TESTOSTERONE ENANTHATE,Black Box Warning,neurotoxicity,,,,,United States
674286,CHEMBL1200335,TESTOSTERONE ENANTHATE,Black Box Warning,cardiotoxicity,,,,,United States
674286,CHEMBL1200335,TESTOSTERONE ENANTHATE,Black Box Warning,vascular toxicity,,,,,United States
674294,CHEMBL1200343,PERINDOPRIL ERBUMINE,Black Box Warning,teratogenicity,,,,,United States
674297,CHEMBL1200346,GADODIAMIDE,Black Box Warning,misuse,,,,,United States
674297,CHEMBL1200346,GADODIAMIDE,Black Box Warning,dermatological toxicity,,,,,United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,"QTc interval prolongation on the electrocardiogram, which could put patients at risk of Torsade de Pointes",HP:0001657,Prolonged QT interval,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,"QTc interval prolongation on the electrocardiogram, which could put patients at risk of Torsade de Pointes",EFO:0005307,torsades de pointes,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,Severe cardiovascular event,EFO:1001482,cardiotoxicity,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,"Prolongation of the QT interval giving rise to ventricular arrhythmias known as torsades de pointes; Effect of the drug on cardiac repolarization, manifested as QT interval prolongation. Some patients may be at risk of the very rare but serious ventricular arrhythmia known as torsades de pointes.",EFO:0005307,torsades de pointes,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,"Effect of the drug on cardiac repolarization, manifested as QT interval prolongation. Some patients may be at risk of the very rare but serious ventricular arrhythmia known as torsades de pointes.",HP:0001657,Prolonged QT interval,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,Cardiac repolarization; QTc interval prolongation,HP:0001657,Prolonged QT interval,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,Withdrawn,cardiotoxicity,Cardiac repolarization; QTc interval prolongation,EFO:0020913,electrocardiogram repolarisation abnormality,1999.0,Singapore; Armenia; Germany; Peru; United Kingdom; United States
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,Black Box Warning,carcinogenicity,,,,,United States
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,Black Box Warning,hematological toxicity,,,,,United States
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,Black Box Warning,immune system toxicity,,,,,United States
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,Black Box Warning,teratogenicity,,,,,United States
674360,CHEMBL1200409,LIDOCAINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674361,CHEMBL1200410,PROCARBAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674362,CHEMBL1200411,ROPINIROLE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674370,CHEMBL1200419,MOLINDONE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674371,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
674371,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,Black Box Warning,,,,,,United States
674371,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674375,CHEMBL1200424,PENTETATE ZINC TRISODIUM,Black Box Warning,respiratory toxicity,,,,,United States
674375,CHEMBL1200424,PENTETATE ZINC TRISODIUM,Black Box Warning,,,,,,United States
674381,CHEMBL1200430,ESTRADIOL ACETATE,Black Box Warning,vascular toxicity,,,,,United States
674381,CHEMBL1200430,ESTRADIOL ACETATE,Black Box Warning,cardiotoxicity,,,,,United States
674381,CHEMBL1200430,ESTRADIOL ACETATE,Black Box Warning,neurotoxicity,,,,,United States
674381,CHEMBL1200430,ESTRADIOL ACETATE,Black Box Warning,carcinogenicity,,,,,United States
674382,CHEMBL1200431,GADOPENTETATE DIMEGLUMINE,Black Box Warning,dermatological toxicity,,,,,United States
674387,CHEMBL1200436,OXANDROLONE,Black Box Warning,hepatotoxicity,,,,,United States
674388,CHEMBL1200437,QUINIDINE GLUCONATE,Black Box Warning,cardiotoxicity,,,,,United States
674405,CHEMBL1200454,VALGANCICLOVIR HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
674405,CHEMBL1200454,VALGANCICLOVIR HYDROCHLORIDE,Black Box Warning,carcinogenicity,,,,,United States
674405,CHEMBL1200454,VALGANCICLOVIR HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
674406,CHEMBL1200455,IOHEXOL,Black Box Warning,misuse,,,,,United States
674408,CHEMBL1200457,GADOVERSETAMIDE,Black Box Warning,,,,,,United States
674412,CHEMBL1200461,MIDODRINE HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
674414,CHEMBL1200463,OXAPROZIN POTASSIUM,Black Box Warning,,,,,,United States
674423,CHEMBL1200472,QUAZEPAM,Black Box Warning,,,,,,United States
674426,CHEMBL1200475,DAUNORUBICIN CITRATE,Black Box Warning,,,,,,United States
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,Withdrawn,hepatotoxicity,Adverse hepatic events,HP:0001399,Hepatic failure,2003.0,Canada; Spain; Turkey
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,Withdrawn,hepatotoxicity,Adverse hepatic events,EFO:0011052,hepatotoxicity,2003.0,Canada; Spain; Turkey
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,Withdrawn,hepatotoxicity,Adverse hepatic events,EFO:0004228,drug-induced liver injury,2003.0,Canada; Spain; Turkey
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Liver toxicity; Serious liver injury leading to liver transplant; Death,EFO:0011052,hepatotoxicity,2006.0,United States; European Union
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Liver toxicity; Serious liver injury leading to liver transplant; Death,EFO:0004228,drug-induced liver injury,2006.0,United States; European Union
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,serious liver injury,EFO:0011052,hepatotoxicity,2006.0,United States; European Union
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,serious liver injury,EFO:0004228,drug-induced liver injury,2006.0,United States; European Union
674458,CHEMBL1200507,IODIXANOL,Black Box Warning,misuse,,,,,United States
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,Black Box Warning,,,,,,United States
674481,CHEMBL1200530,CEFOXITIN SODIUM,Black Box Warning,,,,,,United States
674482,CHEMBL1200531,ALFENTANIL HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674485,CHEMBL1200534,MOEXIPRIL HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
674500,CHEMBL1200549,RAPACURONIUM BROMIDE,Withdrawn,respiratory toxicity,occurrence of bronchospasm,EFO:1002018,bronchial disease,2001.0,United States
674500,CHEMBL1200549,RAPACURONIUM BROMIDE,Withdrawn,respiratory toxicity,Fatal bronchospasm,EFO:1002018,bronchial disease,2001.0,United States
674507,CHEMBL1200556,DESMOPRESSIN ACETATE,Black Box Warning,metabolic toxicity,,,,,United States
674507,CHEMBL1200556,DESMOPRESSIN ACETATE,Black Box Warning,,,,,,United States
674509,CHEMBL1200558,BACITRACIN,Black Box Warning,nephrotoxicity,,,,,United States
674514,CHEMBL1200563,CERIVASTATIN SODIUM,Withdrawn,musculoskeletal toxicity,increased risk of rhabdomyolysis,EFO:0003867,rhabdomyolysis,2001.0,Worldwide
674514,CHEMBL1200563,CERIVASTATIN SODIUM,Withdrawn,nephrotoxicity,Rhabdomyolysis _ kidney failure and muscle damage,EFO:1002048,kidney failure,2001.0,Worldwide
674522,CHEMBL1200571,GADOBENATE DIMEGLUMINE,Black Box Warning,dermatological toxicity,,,,,United States
674536,CHEMBL1200585,OXYMETHOLONE,Black Box Warning,hepatotoxicity,,,,,United States
674539,CHEMBL1200588,CLINDAMYCIN HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
674539,CHEMBL1200588,CLINDAMYCIN HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
674544,CHEMBL1200593,GADOTERIDOL,Black Box Warning,dermatological toxicity,,,,,United States
674546,CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE,Withdrawn,respiratory toxicity,cases of pulmonary hypertension led to its withdrawal in several countries,EFO:0001361,pulmonary arterial hypertension,1967.0,Germany; Venezuela
674546,CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Cardiovascular,EFO:0000319,cardiovascular disease,1967.0,Germany; Venezuela
674557,CHEMBL1200606,MEXILETINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674557,CHEMBL1200606,MEXILETINE HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
674557,CHEMBL1200606,MEXILETINE HYDROCHLORIDE,Black Box Warning,dermatological toxicity,,,,,United States
674560,CHEMBL1200609,PAROXETINE MESYLATE,Black Box Warning,psychiatric toxicity,,,,,United States
674564,CHEMBL1200613,TOLMETIN SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
674564,CHEMBL1200613,TOLMETIN SODIUM,Black Box Warning,neurotoxicity,,,,,United States
674564,CHEMBL1200613,TOLMETIN SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
674565,CHEMBL1200614,IOVERSOL,Black Box Warning,misuse,,,,,United States
674572,CHEMBL1200621,GEMIFLOXACIN MESYLATE,Black Box Warning,,,,,,United States
674579,CHEMBL1200628,VANCOMYCIN HYDROCHLORIDE,Black Box Warning,,,,,,United States
674580,CHEMBL1200629,VECURONIUM BROMIDE,Black Box Warning,,,,,,United States
674580,CHEMBL1200629,VECURONIUM BROMIDE,Black Box Warning,carcinogenicity,,,,,United States
674583,CHEMBL1200632,CLINDAMYCIN PALMITATE HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
674583,CHEMBL1200632,CLINDAMYCIN PALMITATE HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
674595,CHEMBL1200644,FONDAPARINUX SODIUM,Black Box Warning,vascular toxicity,,,,,United States
674610,CHEMBL1200659,ENALAPRIL MALEATE,Black Box Warning,teratogenicity,,,,,United States
674610,CHEMBL1200659,ENALAPRIL MALEATE,Black Box Warning,cardiotoxicity,,,,,United States
674626,CHEMBL1200675,TOREMIFENE CITRATE,Black Box Warning,cardiotoxicity,,,,,United States
674632,CHEMBL1200681,MONTELUKAST SODIUM,Black Box Warning,,,,,,United States
674632,CHEMBL1200681,MONTELUKAST SODIUM,Black Box Warning,psychiatric toxicity,,,,,United States
674632,CHEMBL1200681,MONTELUKAST SODIUM,Black Box Warning,neurotoxicity,,,,,United States
674632,CHEMBL1200681,MONTELUKAST SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
674633,CHEMBL1200682,SODIUM OXYBATE,Black Box Warning,respiratory toxicity,,,,,United States
674633,CHEMBL1200682,SODIUM OXYBATE,Black Box Warning,misuse,,,,,United States
674633,CHEMBL1200682,SODIUM OXYBATE,Black Box Warning,neurotoxicity,,,,,United States
674637,CHEMBL1200686,PIMECROLIMUS,Black Box Warning,carcinogenicity,,,,,United States
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,Black Box Warning,teratogenicity,,,,,United States
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,Black Box Warning,cardiotoxicity,,,,,United States
674646,CHEMBL1200695,PHENYLPROPANOLAMINE HYDROCHLORIDE,Withdrawn,neurotoxicity,Increased risk of hemorrhagic stroke,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
674654,CHEMBL1200703,CHLORDIAZEPOXIDE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674654,CHEMBL1200703,CHLORDIAZEPOXIDE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674661,CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,Hepatotoxicity; Steven-Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0004276,Stevens-Johnson syndrome,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,"Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome and Erythema multiforme majus",EFO:1000694,erythema multiforme,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,"Severe cutaneous reactions including life-threatening toxic epidermal necrolysis, Stevens-Johnson syndrome, and fixed drug eruptions",EFO:0004276,Stevens-Johnson syndrome,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,Hepatotoxicity; Steven-Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0004775,toxic epidermal necrolysis,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,Life-threatening toxic epidermal necrolysis and borderline major bullous forms,EFO:0004775,toxic epidermal necrolysis,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,"Severe cutaneous reactions including life-threatening toxic epidermal necrolysis, Stevens-Johnson syndrome, and fixed drug eruptions",EFO:0004775,toxic epidermal necrolysis,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,hepatotoxicity,Hepatotoxicity; Steven-Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0011052,hepatotoxicity,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,hepatotoxicity,Hepatotoxicity; Steven-Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0004228,drug-induced liver injury,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,"Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome and Erythema multiforme majus",EFO:0004276,Stevens-Johnson syndrome,1996.0,Worldwide
674665,CHEMBL1200714,CHLORMEZANONE,Withdrawn,dermatological toxicity,"Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome and Erythema multiforme majus",EFO:0004775,toxic epidermal necrolysis,1996.0,Worldwide
674678,CHEMBL1200727,RUBIDIUM CHLORIDE RB 82,Black Box Warning,,,,,,United States
674680,CHEMBL1200729,CHLORAMPHENICOL SODIUM SUCCINATE,Black Box Warning,hematological toxicity,,,,,United States
674686,CHEMBL1200735,MOXIFLOXACIN HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
674686,CHEMBL1200735,MOXIFLOXACIN HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
674686,CHEMBL1200735,MOXIFLOXACIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674715,CHEMBL1200764,METHACHOLINE CHLORIDE,Black Box Warning,,,,,,United States
674724,CHEMBL1200773,TOCAINIDE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,Black Box Warning,,,,,,United States
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Hepatic adverse reactions,EFO:0004228,drug-induced liver injury,1999.0,Philippines; United States; European Union
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1999.0,Philippines; United States; European Union
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1999.0,Philippines; United States; European Union
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,Withdrawn,hepatotoxicity,Hepatic adverse reactions,EFO:0011052,hepatotoxicity,1999.0,Philippines; United States; European Union
674732,CHEMBL1200781,CITALOPRAM HYDROBROMIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,"Serious cardiac arrhythmias (e.g. ventricular tachycardia, torsades de pointes, and ventricular fibrillation) and sudden cardiac deaths",EFO:0005307,torsades de pointes,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Rare but serious cardiac adverse effects; Adverse cardiac events published by the FDA.; Serious cardiovascular adverse effects,EFO:1001482,cardiotoxicity,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,"Serious cardiac arrhythmias (e.g. ventricular tachycardia, torsades de pointes, and ventricular fibrillation) and sudden cardiac deaths",EFO:0004287,ventricular fibrillation,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,,Documented reports on adverse events including deaths associated with its use; Rare but serious heart complications including arrhythmias and sudden death,PATO:0001422,dead,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Fatal arrhythmia,EFO:0004269,cardiac arrhythmia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Association with cardiac arrhythmias and a number of deaths,EFO:0004269,cardiac arrhythmia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,,Association with cardiac arrhythmias and a number of deaths,PATO:0001422,dead,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Serious cardiovascular adverse effects,EFO:1001482,cardiotoxicity,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Possibility of rare but serious heart complications including arrhythmias and sudden death; Rare but serious heart complications including arrhythmias and sudden death; Increased risk of cardiac arrhythmias in patients taking other medications or suffering from underlying conditions known to increase risk of cardiac arrhythmias,EFO:0004269,cardiac arrhythmia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,Reports about cardiac arrhythmias with highest strength cisapride,EFO:0004269,cardiac arrhythmia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,,Risk/benefit ratio is further reviewed,,,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,"Serious cardiac arrhythmias (e.g. ventricular tachycardia, torsades de pointes, and ventricular fibrillation) and sudden cardiac deaths",NCIT:C50911,Sudden Cardiac Death,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,"Serious cardiac arrhythmias (e.g. ventricular tachycardia, torsades de pointes, and ventricular fibrillation) and sudden cardiac deaths",EFO:0004269,cardiac arrhythmia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,Withdrawn,cardiotoxicity,"Serious cardiac arrhythmias (e.g. ventricular tachycardia, torsades de pointes, and ventricular fibrillation) and sudden cardiac deaths",EFO:0005306,ventricular tachycardia,2000.0,Armenia; Brunei; Mauritius; Bhutan; United Kingdom; Philippines; United States; Oman; Canada; Singapore; Germany; Bahrain; Turkey; Cuba; Japan
674745,CHEMBL1200794,OXYMORPHONE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
674745,CHEMBL1200794,OXYMORPHONE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674749,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674755,CHEMBL1200804,DICLOFENAC POTASSIUM,Black Box Warning,neurotoxicity,,,,,United States
674755,CHEMBL1200804,DICLOFENAC POTASSIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
674755,CHEMBL1200804,DICLOFENAC POTASSIUM,Black Box Warning,cardiotoxicity,,,,,United States
674757,CHEMBL1200806,NAPROXEN SODIUM,Black Box Warning,neurotoxicity,,,,,United States
674757,CHEMBL1200806,NAPROXEN SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
674757,CHEMBL1200806,NAPROXEN SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
674773,CHEMBL1200822,FLECAINIDE ACETATE,Black Box Warning,cardiotoxicity,,,,,United States
674776,CHEMBL1200825,METHADONE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674776,CHEMBL1200825,METHADONE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
674776,CHEMBL1200825,METHADONE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674777,CHEMBL1200826,LITHIUM CARBONATE,Black Box Warning,misuse,,,,,United States
674777,CHEMBL1200826,LITHIUM CARBONATE,Black Box Warning,infectious disease,,,,,United States
674781,CHEMBL1200830,FERROUS SULFATE,Black Box Warning,misuse,,,,,United States
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,Withdrawn,carcinogenicity,possible but unconfirmed risk of cancer,EFO:0011046,carcinogenicity,2024.0,European Union
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,Withdrawn,carcinogenicity,increased risk of cancer in offspring exposed to 17-OHPC in utero,EFO:0011046,carcinogenicity,2024.0,European Union
674801,CHEMBL1200850,GANCICLOVIR SODIUM,Black Box Warning,carcinogenicity,,,,,United States
674801,CHEMBL1200850,GANCICLOVIR SODIUM,Black Box Warning,hematological toxicity,,,,,United States
674801,CHEMBL1200850,GANCICLOVIR SODIUM,Black Box Warning,teratogenicity,,,,,United States
674805,CHEMBL1200854,FLUPHENAZINE DECANOATE,Black Box Warning,psychiatric toxicity,,,,,United States
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,Black Box Warning,immune system toxicity,,,,,United States
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
674830,CHEMBL1200879,WARFARIN SODIUM,Black Box Warning,vascular toxicity,,,,,United States
674830,CHEMBL1200879,WARFARIN SODIUM,Black Box Warning,carcinogenicity,,,,,United States
674836,CHEMBL1200885,ALOSETRON HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
674841,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674841,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
674841,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674841,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,Withdrawn,drug misuse,abuse-deterrent properties,MONDO:0002491,substance abuse,2013.0,United States
674846,CHEMBL1200895,PHENELZINE SULFATE,Black Box Warning,psychiatric toxicity,,,,,United States
674854,CHEMBL1200903,SECOBARBITAL SODIUM,Withdrawn,drug misuse,Self-poisoning,EFO:0008546,poisoning,1980.0,France; Norway
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Cardiac arrythmias,EFO:0004269,cardiac arrhythmia,2005.0,Worldwide
674891,CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
674891,CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674896,CHEMBL1200945,PENTETATE CALCIUM TRISODIUM,Black Box Warning,respiratory toxicity,,,,,United States
674896,CHEMBL1200945,PENTETATE CALCIUM TRISODIUM,Black Box Warning,,,,,,United States
674898,CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE,Withdrawn,occular toxicity,Uveitis,EFO:1001231,uveitis,1990.0,United Kingdom
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,Black Box Warning,psychiatric toxicity,,,,,United States
674903,CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
674906,CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,Black Box Warning,carcinogenicity,,,,,United States
674906,CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,Black Box Warning,immune system toxicity,,,,,United States
674906,CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
674906,CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
674915,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,Black Box Warning,vascular toxicity,,,,,United States
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,Black Box Warning,neurotoxicity,,,,,United States
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,Black Box Warning,cardiotoxicity,,,,,United States
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,Black Box Warning,carcinogenicity,,,,,United States
674927,CHEMBL1200976,IDARUBICIN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
674927,CHEMBL1200976,IDARUBICIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674931,CHEMBL1200980,ESTROPIPATE,Black Box Warning,cardiotoxicity,,,,,United States
674931,CHEMBL1200980,ESTROPIPATE,Black Box Warning,vascular toxicity,,,,,United States
674931,CHEMBL1200980,ESTROPIPATE,Black Box Warning,neurotoxicity,,,,,United States
674931,CHEMBL1200980,ESTROPIPATE,Black Box Warning,carcinogenicity,,,,,United States
674932,CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
674932,CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
674932,CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE,Black Box Warning,carcinogenicity,,,,,United States
674934,CHEMBL1200983,GALLIUM NITRATE,Black Box Warning,,,,,,United States
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,Black Box Warning,psychiatric toxicity,,,,,United States
674938,CHEMBL1200987,EPROSARTAN MESYLATE,Black Box Warning,,,,,,United States
209829,CHEMBL1201,THIOTHIXENE,Black Box Warning,psychiatric toxicity,,,,,United States
674952,CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
674962,CHEMBL1201011,QUINAPRIL HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
674971,CHEMBL1201020,DISOPYRAMIDE PHOSPHATE,Black Box Warning,cardiotoxicity,,,,,United States
674971,CHEMBL1201020,DISOPYRAMIDE PHOSPHATE,Black Box Warning,musculoskeletal toxicity,,,,,United States
674983,CHEMBL1201032,RIZATRIPTAN BENZOATE,Black Box Warning,,,,,,United States
675003,CHEMBL1201052,MESORIDAZINE BESYLATE,Black Box Warning,,,,,,United States
675012,CHEMBL1201061,LEVALBUTEROL HYDROCHLORIDE,Black Box Warning,,,,,,United States
675014,CHEMBL1201063,PROPAFENONE HYDROCHLORIDE,Black Box Warning,,,,,,United States
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
675063,CHEMBL1201112,NELARABINE,Black Box Warning,neurotoxicity,,,,,United States
675066,CHEMBL1201115,ESMOLOL HYDROCHLORIDE,Withdrawn,drug misuse,"Increased risk of medication errors resulting in serious adverse events, including deaths",EFO:0011049,drug misuse,2010.0,United States
675070,CHEMBL1201119,LIOTHYRONINE SODIUM,Black Box Warning,,,,,,United States
675071,CHEMBL1201120,REMIFENTANIL HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
675071,CHEMBL1201120,REMIFENTANIL HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,immune system toxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,gastrointestinal toxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,cardiotoxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,neurotoxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,vascular toxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,respiratory toxicity,,,,,United States
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,Black Box Warning,,,,,,United States
675076,CHEMBL1201125,IOTHALAMATE MEGLUMINE,Black Box Warning,,,,,,United States
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,Black Box Warning,metabolic toxicity,,,,,United States
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
675100,CHEMBL1201149,NALTREXONE HYDROCHLORIDE,Black Box Warning,,,,,,United States
675105,CHEMBL1201154,PROCHLORPERAZINE EDISYLATE,Black Box Warning,,,,,,United States
675106,CHEMBL1201155,LOXAPINE SUCCINATE,Black Box Warning,,,,,,United States
675107,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
675110,CHEMBL1201159,FENTANYL HYDROCHLORIDE,Black Box Warning,,,,,,United States
675114,CHEMBL1201163,SUFENTANIL CITRATE,Black Box Warning,misuse,,,,,United States
675114,CHEMBL1201163,SUFENTANIL CITRATE,Black Box Warning,respiratory toxicity,,,,,United States
675119,CHEMBL1201168,ISOCARBOXAZID,Black Box Warning,,,,,,United States
675119,CHEMBL1201168,ISOCARBOXAZID,Withdrawn,,reported toxicity and in view of the availability of other less toxic drugs.,,,1974.0,Cuba; Japan
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,Black Box Warning,misuse,,,,,United States
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,Black Box Warning,neurotoxicity,,,,,United States
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,Black Box Warning,psychiatric toxicity,,,,,United States
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,Black Box Warning,hepatotoxicity,,,,,United States
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,Black Box Warning,hematological toxicity,,,,,United States
675131,CHEMBL1201180,DICLOFENAC EPOLAMINE,Black Box Warning,gastrointestinal toxicity,,,,,United States
675131,CHEMBL1201180,DICLOFENAC EPOLAMINE,Black Box Warning,cardiotoxicity,,,,,United States
675131,CHEMBL1201180,DICLOFENAC EPOLAMINE,Black Box Warning,neurotoxicity,,,,,United States
675528,CHEMBL1201414,TINZAPARIN SODIUM,Black Box Warning,,,,,,United States
675456,CHEMBL1201438,ALDESLEUKIN,Black Box Warning,vascular toxicity,,,,,United States
675419,CHEMBL1201439,BASILIXIMAB,Black Box Warning,,,,,,United States
675416,CHEMBL1201458,ETHIODIZED OIL,Black Box Warning,misuse,,,,,United States
675574,CHEMBL1201460,DALTEPARIN SODIUM,Black Box Warning,vascular toxicity,,,,,United States
675552,CHEMBL1201466,"ESTROGENS, CONJUGATED SYNTHETIC A",Black Box Warning,,,,,,United States
675596,CHEMBL1201467,"SYNTHETIC CONJUGATED ESTROGENS, B",Black Box Warning,,,,,,United States
675571,CHEMBL1201468,"ESTROGENS, ESTERIFIED",Black Box Warning,,,,,,United States
675454,CHEMBL1201476,ENOXAPARIN SODIUM,Black Box Warning,vascular toxicity,,,,,United States
675511,CHEMBL1201485,SOYBEAN OIL,Black Box Warning,misuse,,,,,United States
675468,CHEMBL1201486,QUINIDINE POLYGALACTURONATE,Black Box Warning,,,,,,United States
675424,CHEMBL1201489,SERACTIDE ACETATE,Withdrawn,immune system toxicity,higher risk of immunogenicity,EFO:0011053,Immune system toxicity,2017.0,United States
675524,CHEMBL1201506,GEMTUZUMAB OZOGAMICIN,Black Box Warning,hepatotoxicity,,,,,United States
675524,CHEMBL1201506,GEMTUZUMAB OZOGAMICIN,Withdrawn,,greater number of deaths,PATO:0001422,dead,2010.0,United States
675604,CHEMBL1201507,GLATIRAMER ACETATE,Black Box Warning,immune system toxicity,,,,,United States
675476,CHEMBL1201535,PHENYLPROPANOLAMINE POLISTIREX,Withdrawn,neurotoxicity,Increased risk of hemorrhagic stroke,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
675367,CHEMBL1201550,DENILEUKIN DIFTITOX,Black Box Warning,,,,,,United States
675613,CHEMBL1201557,INTERFERON ALFACON-1,Black Box Warning,,,,,,United States
675368,CHEMBL1201558,INTERFERON ALFA-2B,Black Box Warning,,,,,,United States
675549,CHEMBL1201560,PEGINTERFERON ALFA-2A,Black Box Warning,,,,,,United States
675616,CHEMBL1201561,PEGINTERFERON ALFA-2B,Black Box Warning,,,,,,United States
675493,CHEMBL1201566,DARBEPOETIN ALFA,Black Box Warning,neurotoxicity,,,,,United States
675493,CHEMBL1201566,DARBEPOETIN ALFA,Black Box Warning,vascular toxicity,,,,,United States
675493,CHEMBL1201566,DARBEPOETIN ALFA,Black Box Warning,cardiotoxicity,,,,,United States
675493,CHEMBL1201566,DARBEPOETIN ALFA,Black Box Warning,carcinogenicity,,,,,United States
675387,CHEMBL1201569,RIMABOTULINUMTOXINB,Black Box Warning,,,,,,United States
675371,CHEMBL1201572,ETANERCEPT,Black Box Warning,carcinogenicity,,,,,United States
675371,CHEMBL1201572,ETANERCEPT,Black Box Warning,infectious disease,,,,,United States
675548,CHEMBL1201573,OPRELVEKIN,Black Box Warning,,,,,,United States
675360,CHEMBL1201574,ONABOTULINUMTOXINA,Black Box Warning,,,,,,United States
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",HP:0100806,Sepsis,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",MONDO:0019956,encephalitis,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,Progressive multifocal leukoencephalopathy,EFO:0007455,progressive multifocal leukoencephalopathy,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,,Serious side effects,EFO:0009658,adverse effect,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",HP:0001298,Encephalopathy,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",EFO:0007292,Guillain-Barre syndrome,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",EFO:0007371,Miller Fisher syndrome,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",MONDO:0021108,meningitis,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",OMIT:0010908,Opportunistic Infections,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675481,CHEMBL1201575,EFALIZUMAB,Withdrawn,neurotoxicity,"Progressive multifocal leukoencephalopathy. The drug is also suspected to be correlated with other serious adverse effects like Guillain-Barre- and Miller-Fisher-Syndrome, encephalitis, encephalopathy, meningitis, sepsis und opportunistic infections",EFO:0007455,progressive multifocal leukoencephalopathy,2009.0,Mexico; European Union; Ireland; Ukraine; United Kingdom; United States; Canada; Switzerland
675578,CHEMBL1201576,RITUXIMAB,Black Box Warning,infectious disease,,,,,United States
675579,CHEMBL1201577,CETUXIMAB,Black Box Warning,cardiotoxicity,,,,,United States
675482,CHEMBL1201580,ADALIMUMAB,Black Box Warning,infectious disease,,,,,United States
675482,CHEMBL1201580,ADALIMUMAB,Black Box Warning,carcinogenicity,,,,,United States
675617,CHEMBL1201581,INFLIXIMAB,Black Box Warning,carcinogenicity,,,,,United States
675617,CHEMBL1201581,INFLIXIMAB,Black Box Warning,infectious disease,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,teratogenicity,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,respiratory toxicity,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,cardiotoxicity,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,dermatological toxicity,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,infectious disease,,,,,United States
675581,CHEMBL1201585,TRASTUZUMAB,Black Box Warning,hepatotoxicity,,,,,United States
675582,CHEMBL1201587,ALEMTUZUMAB,Black Box Warning,hematological toxicity,,,,,United States
675582,CHEMBL1201587,ALEMTUZUMAB,Black Box Warning,neurotoxicity,,,,,United States
675582,CHEMBL1201587,ALEMTUZUMAB,Black Box Warning,immune system toxicity,,,,,United States
675582,CHEMBL1201587,ALEMTUZUMAB,Black Box Warning,carcinogenicity,,,,,United States
675582,CHEMBL1201587,ALEMTUZUMAB,Black Box Warning,infectious disease,,,,,United States
675485,CHEMBL1201589,OMALIZUMAB,Black Box Warning,immune system toxicity,,,,,United States
675485,CHEMBL1201589,OMALIZUMAB,Black Box Warning,neurotoxicity,,,,,United States
675485,CHEMBL1201589,OMALIZUMAB,Black Box Warning,dermatological toxicity,,,,,United States
675485,CHEMBL1201589,OMALIZUMAB,Black Box Warning,vascular toxicity,,,,,United States
675485,CHEMBL1201589,OMALIZUMAB,Black Box Warning,respiratory toxicity,,,,,United States
675388,CHEMBL1201594,RASBURICASE,Black Box Warning,,,,,,United States
675399,CHEMBL1201595,LARONIDASE,Black Box Warning,immune system toxicity,,,,,United States
675486,CHEMBL1201599,HUMAN IMMUNOGLOBULIN G,Black Box Warning,,,,,,United States
675486,CHEMBL1201599,HUMAN IMMUNOGLOBULIN G,Black Box Warning,nephrotoxicity,,,,,United States
675487,CHEMBL1201604,TOSITUMOMAB,Black Box Warning,,,,,,United States
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,Immune-mediated encephalitis and meningoencephalitis,EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,"Serious inflammatory brain disorders, including encephalitis and meningoencephalitis, in patients with multiple sclerosis.",EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,Immune-mediated encephalitis and meningoencephalitis,EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,Reports of serious inflammatory brain disorders,EFO:0020926,noninfective encephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders, including encephalitis and meningoencephalitis, in patients with multiple sclerosis.",EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0020930,immune-mediated adverse reaction,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders, including encephalitis and meningoencephalitis, in patients with multiple sclerosis.",EFO:0020926,noninfective encephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,Immune-mediated encephalitis and meningoencephalitis,EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,Immune-mediated encephalitis and meningoencephalitis,EFO:0020930,immune-mediated adverse reaction,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,"Serious inflammatory brain disorders, including encephalitis and meningoencephalitis, in patients with multiple sclerosis.",EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0007364,meningoencephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders worldwide, including encephalitis and meningoencephalitis. Serious and potentially fatal immune reactions affecting the brain, liver and other organs.",EFO:0020926,noninfective encephalitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,neurotoxicity,"Serious inflammatory brain disorders, including encephalitis and meningoencephalitis, in patients with multiple sclerosis.",EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675587,CHEMBL1201605,DACLIZUMAB,Withdrawn,immune system toxicity,Immune-mediated encephalitis and meningoencephalitis,EFO:0001423,encephalomyelitis,2018.0,United States; United Kingdom; European Union; Canada
675488,CHEMBL1201607,NATALIZUMAB,Black Box Warning,infectious disease,,,,,United States
675588,CHEMBL1201608,MUROMONAB-CD3,Black Box Warning,,,,,,United States
675554,CHEMBL1201619,APROTININ,Withdrawn,,Increased mortality,PATO:0001422,dead,2007.0,United States
675534,CHEMBL1201631,INSULIN HUMAN,Black Box Warning,,,,,,United States
675396,CHEMBL1201632,IMIGLUCERASE,Black Box Warning,immune system toxicity,,,,,United States
675621,CHEMBL1201649,"ESTROGENS, CONJUGATED",Black Box Warning,,,,,,United States
675563,CHEMBL1201651,PROTAMINE SULFATE,Black Box Warning,vascular toxicity,,,,,United States
675679,CHEMBL1201728,DESVENLAFAXINE SUCCINATE,Black Box Warning,psychiatric toxicity,,,,,United States
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,Black Box Warning,,,,,,United States
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
675686,CHEMBL1201735,BUPROPION HYDROBROMIDE,Black Box Warning,psychiatric toxicity,,,,,United States
675691,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,Black Box Warning,cardiotoxicity,,,,,United States
675691,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,Black Box Warning,musculoskeletal toxicity,,,,,United States
675699,CHEMBL1201748,CABAZITAXEL,Black Box Warning,,,,,,United States
675703,CHEMBL1201752,IXABEPILONE,Black Box Warning,,,,,,United States
675724,CHEMBL1201773,PRASUGREL HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
675728,CHEMBL1201777,TAPENTADOL HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
675728,CHEMBL1201777,TAPENTADOL HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
675773,CHEMBL1201822,GALSULFASE,Black Box Warning,immune system toxicity,,,,,United States
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,Black Box Warning,vascular toxicity,,,,,United States
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,Black Box Warning,respiratory toxicity,,,,,United States
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,Black Box Warning,cardiotoxicity,,,,,United States
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,Black Box Warning,dermatological toxicity,,,,,United States
675777,CHEMBL1201826,IDURSULFASE,Black Box Warning,immune system toxicity,,,,,United States
675777,CHEMBL1201826,IDURSULFASE,Black Box Warning,dermatological toxicity,,,,,United States
675777,CHEMBL1201826,IDURSULFASE,Black Box Warning,vascular toxicity,,,,,United States
675777,CHEMBL1201826,IDURSULFASE,Black Box Warning,respiratory toxicity,,,,,United States
675778,CHEMBL1201827,PANITUMUMAB,Black Box Warning,dermatological toxicity,,,,,United States
675779,CHEMBL1201828,ECULIZUMAB,Black Box Warning,infectious disease,,,,,United States
675779,CHEMBL1201828,ECULIZUMAB,Black Box Warning,neurotoxicity,,,,,United States
675782,CHEMBL1201831,CERTOLIZUMAB PEGOL,Black Box Warning,,,,,,United States
675784,CHEMBL1201833,GOLIMUMAB,Black Box Warning,carcinogenicity,,,,,United States
675784,CHEMBL1201833,GOLIMUMAB,Black Box Warning,infectious disease,,,,,United States
675787,CHEMBL1201836,OFATUMUMAB,Black Box Warning,infectious disease,,,,,United States
675788,CHEMBL1201837,ECALLANTIDE,Black Box Warning,immune system toxicity,,,,,United States
675813,CHEMBL1201864,DIENOGEST,Black Box Warning,,,,,,United States
675814,CHEMBL1201865,VELAGLUCERASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
675816,CHEMBL1201867,FERUMOXYTOL,Black Box Warning,,,,,,United States
210388,CHEMBL1202,CIPROFLOXACIN HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
210388,CHEMBL1202,CIPROFLOXACIN HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
210388,CHEMBL1202,CIPROFLOXACIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
678116,CHEMBL1204165,DILEVALOL HYDROCHLORIDE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1990.0,Worldwide
678116,CHEMBL1204165,DILEVALOL HYDROCHLORIDE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1990.0,Worldwide
678138,CHEMBL1204187,GEPIRONE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
20027,CHEMBL121,ROSIGLITAZONE,Withdrawn,cardiotoxicity,Increased cardiovascular risk outweighs its benefit; Cardiovascular risk; Elevated risk of cardiovascular events,EFO:1001482,cardiotoxicity,2010.0,Armenia; Guatemala; Egypt; New Zealand; Madagascar; European Union
20027,CHEMBL121,ROSIGLITAZONE,Withdrawn,cardiotoxicity,Elevated risk of cardiovascular events,EFO:1001482,cardiotoxicity,2010.0,Armenia; Guatemala; Egypt; New Zealand; Madagascar; European Union
685092,CHEMBL1213251,CLOBENZOREX,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1999.0,Portugal; Oman; France
685092,CHEMBL1213251,CLOBENZOREX,Withdrawn,,unfavourable benefit/risk balance,,,1999.0,Portugal; Oman; France
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,Serious abnormal heart rhythms,EFO:0004269,cardiac arrhythmia,2010.0,Canada; New Zealand; Vietnam
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,"Prolong the PR interval, widen the QRS complex, prolong the QT interval and therefore increase the risk of serious abnormal heart rhythms.",EFO:0004269,cardiac arrhythmia,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,"Prolong the PR interval, widen the QRS complex, prolong the QT interval and therefore increase the risk of serious abnormal heart rhythms.",EFO:0020929,electrocardiogram PR prolongation,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,,Risk of serious abnormal heart rhythms that have been linked to serious adverse effects including sudden death,NCIT:C107103,Sudden Death,2010.0,Canada; New Zealand; Vietnam
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,,Adverse drug reactions,EFO:0009658,adverse effect,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,"Prolong the PR interval, widen the QRS complex, prolong the QT interval and therefore increase the risk of serious abnormal heart rhythms.",HP:0006677,Prolonged QRS complex,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,"Prolong the PR interval, widen the QRS complex, prolong the QT interval and therefore increase the risk of serious abnormal heart rhythms.",HP:0001657,Prolonged QT interval,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,cardiotoxicity,Risk of serious abnormal heart rhythms that have been linked to serious adverse effects including sudden death,EFO:0004269,cardiac arrhythmia,2010.0,Canada; New Zealand; Vietnam
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Potentially fatal overdose,EFO:0020911,overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Potentially fatal overdose,EFO:0020923,accidental overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Risk of potentially fatal overdose,EFO:0020923,accidental overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Risk of potentially fatal overdose,EFO:0020911,overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Potentially fatal overdose,EFO:0020924,intentional overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,,"Deaths. More dangerous than other simple analgesics in overdose, particularly when combined with alcohol",PATO:0001422,dead,2010.0,Canada; New Zealand; Vietnam
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,"Deaths. More dangerous than other simple analgesics in overdose, particularly when combined with alcohol",EFO:0020911,overdose,2010.0,Canada; New Zealand; Vietnam
685193,CHEMBL1213351,PROPOXYPHENE,Withdrawn,drug misuse,Risk of potentially fatal overdose,EFO:0020924,intentional overdose,2009.0,European Union; New Zealand; Canada; Iraq; United States
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,Withdrawn,,Low efficacy/skin reactions,EFO:0020002,lack of efficacy,1984.0,Greece
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,Withdrawn,dermatological toxicity,Low efficacy/skin reactions,EFO:0020927,skin reaction,1984.0,Greece
21697,CHEMBL122,ROFECOXIB,Black Box Warning,,,,,,United States
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,Risk for heart attack and stroke,EFO:0000712,stroke,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,Risk for heart attack and stroke,EFO:0000612,myocardial infarction,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,Increased risk in cardiovascular events such as heart attack and strokes especially when used for long duration.,EFO:0000712,stroke,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,Increased risk of cardiovascular side effects,EFO:1001482,cardiotoxicity,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,Increased risk in cardiovascular events such as heart attack and strokes especially when used for long duration.,EFO:0000612,myocardial infarction,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,"Increased risk of serious cardiovascular events, such as heart attacks and strokes",EFO:0000712,stroke,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,neurotoxicity,Risk for heart attack and stroke,EFO:0000712,stroke,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,cardiotoxicity,"Increased risk of serious cardiovascular events, such as heart attacks and strokes",EFO:0000612,myocardial infarction,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,neurotoxicity,"Increased risk of serious cardiovascular events, such as heart attacks and strokes",EFO:0000712,stroke,2004.0,Worldwide
21697,CHEMBL122,ROFECOXIB,Withdrawn,neurotoxicity,Increased risk in cardiovascular events such as heart attack and strokes especially when used for long duration.,EFO:0000712,stroke,2004.0,Worldwide
222633,CHEMBL1220,TINIDAZOLE,Black Box Warning,carcinogenicity,,,,,United States
227917,CHEMBL1228,OXYPHENBUTAZONE ANHYDROUS,Withdrawn,hematological toxicity,serious blood dyscrasias,EFO:0005803,hematologic disease,1984.0,France; United States; United Kingdom; Germany; Sweden; Bangladesh; Ethiopia; Cyprus
227917,CHEMBL1228,OXYPHENBUTAZONE ANHYDROUS,Withdrawn,,severe adverse reactions.,EFO:0009658,adverse effect,1984.0,France; United States; United Kingdom; Germany; Sweden; Bangladesh; Ethiopia; Cyprus
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"increased risk of abuse and addiction in Norwegian patients, as well as a risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).",MONDO:0002491,substance abuse,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"Increased risk of abuse or addiction, intoxication, psychomotor impairment",EFO:0008546,poisoning,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,neurotoxicity,"Increased risk of abuse or addiction, intoxication, psychomotor impairment",EFO:0020909,impaired psychomotor skills,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,psychiatric toxicity,"Increased risk of abuse or addiction, intoxication, psychomotor impairment",EFO:0020909,impaired psychomotor skills,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"Increased risk of abuse or addiction, intoxication, psychomotor impairment",MONDO:0002491,substance abuse,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"increased risk of abuse and addiction in Norwegian patients, as well as a risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).",EFO:0008546,poisoning,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,neurotoxicity,"increased risk of abuse and addiction in Norwegian patients, as well as a risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).",EFO:0020909,impaired psychomotor skills,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"increased risk of abuse and addiction in Norwegian patients, as well as a risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).",MONDO:0004938,substance dependence,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,psychiatric toxicity,"increased risk of abuse and addiction in Norwegian patients, as well as a risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).",EFO:0020909,impaired psychomotor skills,2007.0,European Union
230249,CHEMBL1233,CARISOPRODOL,Withdrawn,drug misuse,"Increased risk of abuse or addiction, intoxication, psychomotor impairment",MONDO:0004938,substance dependence,2007.0,European Union
699373,CHEMBL1237022,TOCILIZUMAB,Black Box Warning,infectious disease,,,,,United States
699373,CHEMBL1237022,TOCILIZUMAB,Black Box Warning,carcinogenicity,,,,,United States
699374,CHEMBL1237023,DENOSUMAB,Black Box Warning,,,,,,United States
699376,CHEMBL1237025,PEGLOTICASE,Black Box Warning,immune system toxicity,,,,,United States
699406,CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
699406,CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
699416,CHEMBL1237065,TRAMADOL HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
699416,CHEMBL1237065,TRAMADOL HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
699455,CHEMBL1237104,PROPOXYPHENE HYDROCHLORIDE,Black Box Warning,,,,,,United States
699455,CHEMBL1237104,PROPOXYPHENE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Serious toxicity to the heart; increase the risk for serious abnormal heart rhythms.,EFO:0004269,cardiac arrhythmia,2009.0,European Union; New Zealand; Canada; Iraq; United States
699456,CHEMBL1237105,CARBOPROST TROMETHAMINE,Black Box Warning,,,,,,United States
699486,CHEMBL1237135,MAPROTILINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
231062,CHEMBL1242,PHENAZOPYRIDINE,Withdrawn,carcinogenicity,unacceptable benefit to risk ratio (carcinogenic potential),EFO:0011046,carcinogenicity,1984.0,Greece
25047,CHEMBL125,MILTEFOSINE,Black Box Warning,teratogenicity,,,,,United States
237298,CHEMBL1252,ABARELIX,Black Box Warning,,,,,,United States
704719,CHEMBL1255739,METHAPYRILENE HYDROCHLORIDE,Withdrawn,carcinogenicity,Animal carcinogenicity (rodents),EFO:0011046,carcinogenicity,1979.0,Germany; United States; United Kingdom; Italy; India; Philippines; Egypt; Dominican Republic; Chile; Canada; Australia
705687,CHEMBL1256696,CARBETAPENTANE CITRATE,Withdrawn,,FDAs determination that carbetapentane citrate has not been shown to be effective at the over-the-counter (OTC) doses stated in the exempting regulation.,EFO:0020002,lack of efficacy,2007.0,United States
705834,CHEMBL1256841,NIALAMIDE,Withdrawn,,Hepatotoxicity; Drug Interaction,EFO:0009878,drug interaction,1974.0,United States; United Kingdom; Japan; Cuba; India
705834,CHEMBL1256841,NIALAMIDE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0004228,drug-induced liver injury,1974.0,United States; United Kingdom; Japan; Cuba; India
705834,CHEMBL1256841,NIALAMIDE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0011052,hepatotoxicity,1974.0,United States; United Kingdom; Japan; Cuba; India
705834,CHEMBL1256841,NIALAMIDE,Withdrawn,,lack substantial evidence of efficacy and safety,EFO:0020002,lack of efficacy,1974.0,United States; United Kingdom; Japan; Cuba; India
705834,CHEMBL1256841,NIALAMIDE,Withdrawn,,reported toxicity and in view of the availability of other less toxic drugs,,,1974.0,United States; United Kingdom; Japan; Cuba; India
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hepatotoxicity,Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity,EFO:0004228,drug-induced liver injury,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hematological toxicity,"rare cases of haemolytic anaemia - sometimes fatal - thrombocytopenia, hepatotoxicity",HP:0001873,Thrombocytopenia,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hepatotoxicity,Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity,EFO:0011052,hepatotoxicity,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hepatotoxicity,"rare cases of haemolytic anaemia - sometimes fatal - thrombocytopenia, hepatotoxicity",EFO:0004228,drug-induced liver injury,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,immune system toxicity,Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity,EFO:1002003,hypersensitivity reaction disease,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hematological toxicity,Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity,EFO:0005558,hemolytic anemia,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hepatotoxicity,"rare cases of haemolytic anaemia - sometimes fatal - thrombocytopenia, hepatotoxicity",EFO:0011052,hepatotoxicity,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hematological toxicity,increased incidence of hemolytic anemia,EFO:0005558,hemolytic anemia,1986.0,Worldwide
705835,CHEMBL1256842,NOMIFENSINE MALEATE,Withdrawn,hematological toxicity,"rare cases of haemolytic anaemia - sometimes fatal - thrombocytopenia, hepatotoxicity",EFO:0005558,hemolytic anemia,1986.0,Worldwide
706035,CHEMBL1257040,TRIFLUOPERAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
708075,CHEMBL1259059,SOFOSBUVIR,Black Box Warning,,,,,,United States
10813,CHEMBL12713,SERTINDOLE,Withdrawn,cardiotoxicity,Arrhythmias and Sudden Cardiac Death (Arrhythmias and Sudden),EFO:0004269,cardiac arrhythmia,1998.0,Germany; European Union; Ireland; United Kingdom; Italy; Netherlands; Bulgaria
10813,CHEMBL12713,SERTINDOLE,Withdrawn,cardiotoxicity,Arrhythmias and Sudden Cardiac Death (Arrhythmias and Sudden),EFO:0004278,sudden cardiac arrest,1998.0,Germany; European Union; Ireland; United Kingdom; Italy; Netherlands; Bulgaria
10813,CHEMBL12713,SERTINDOLE,Withdrawn,,serious adverse reactions,EFO:0009658,adverse effect,1998.0,Germany; European Union; Ireland; United Kingdom; Italy; Netherlands; Bulgaria
249414,CHEMBL1274,NILUTAMIDE,Black Box Warning,respiratory toxicity,,,,,United States
249814,CHEMBL1275,PERGOLIDE MESYLATE,Withdrawn,cardiotoxicity,Valvulopathy,EFO:0009551,heart valve disease,2007.0,United States; Canada
249814,CHEMBL1275,PERGOLIDE MESYLATE,Withdrawn,cardiotoxicity,Risk for heart valve damage,EFO:0009551,heart valve disease,2007.0,United States; Canada
209964,CHEMBL127516,BUTAMBEN,Withdrawn,neurotoxicity,"associated with severe adverse reactions, such as severe tissue slough and transverse myelitis",MONDO:0021553,transverse myelitis,1964.0,United States
209964,CHEMBL127516,BUTAMBEN,Withdrawn,dermatological toxicity,"associated with severe adverse reactions, such as severe tissue slough and transverse myelitis",HP:0032156,Skin detachment,1964.0,United States
712273,CHEMBL1276308,MIFEPRISTONE,Black Box Warning,,,,,,United States
712273,CHEMBL1276308,MIFEPRISTONE,Black Box Warning,gastrointestinal toxicity,,,,,United States
712273,CHEMBL1276308,MIFEPRISTONE,Black Box Warning,infectious disease,,,,,United States
712273,CHEMBL1276308,MIFEPRISTONE,Black Box Warning,cardiotoxicity,,,,,United States
712273,CHEMBL1276308,MIFEPRISTONE,Black Box Warning,hematological toxicity,,,,,United States
250908,CHEMBL1282,IMIQUIMOD,Black Box Warning,,,,,,United States
27307,CHEMBL129,ZIDOVUDINE,Black Box Warning,hematological toxicity,,,,,United States
27307,CHEMBL129,ZIDOVUDINE,Black Box Warning,metabolic toxicity,,,,,United States
27307,CHEMBL129,ZIDOVUDINE,Black Box Warning,hepatotoxicity,,,,,United States
27307,CHEMBL129,ZIDOVUDINE,Black Box Warning,musculoskeletal toxicity,,,,,United States
27340,CHEMBL130,CHLORAMPHENICOL,Withdrawn,hematological toxicity,"Bone marrow depression (anemia, thrombocytopenia, and granulocytopenia temporally associated with treatment). Bone marrow toxicities may present as either reversible bone marrow depression, which was dose-related and responsive to drug withdrawal, or as aplastic anemia, which was not dose-related, irreversible, and associated with a high mortality",EFO:0007053,myelosuppression,2012.0,United States
738635,CHEMBL1314751,PROCHLORPERAZINE MALEATE,Black Box Warning,,,,,,United States
739751,CHEMBL1315867,TERBUTALINE SULFATE,Black Box Warning,cardiotoxicity,,,,,United States
739751,CHEMBL1315867,TERBUTALINE SULFATE,Black Box Warning,metabolic toxicity,,,,,United States
739751,CHEMBL1315867,TERBUTALINE SULFATE,Black Box Warning,vascular toxicity,,,,,United States
746768,CHEMBL1322884,PHENOTHRIN,Withdrawn,carcinogenicity,Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman
267825,CHEMBL1324,TOLCAPONE,Black Box Warning,hepatotoxicity,,,,,United States
267825,CHEMBL1324,TOLCAPONE,Withdrawn,hepatotoxicity,Hepatotoxicity,HP:0004787,Fulminant hepatitis,1998.0,European Union; Portugal; Ireland; Australia; Canada; United Kingdom
267825,CHEMBL1324,TOLCAPONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1998.0,European Union; Portugal; Ireland; Australia; Canada; United Kingdom
267825,CHEMBL1324,TOLCAPONE,Withdrawn,hepatotoxicity,hepatotoxic effects,EFO:0004228,drug-induced liver injury,1998.0,European Union; Portugal; Ireland; Australia; Canada; United Kingdom
267825,CHEMBL1324,TOLCAPONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1998.0,European Union; Portugal; Ireland; Australia; Canada; United Kingdom
267825,CHEMBL1324,TOLCAPONE,Withdrawn,hepatotoxicity,hepatotoxic effects,EFO:0011052,hepatotoxicity,1998.0,European Union; Portugal; Ireland; Australia; Canada; United Kingdom
11715,CHEMBL13280,FLUNITRAZEPAM,Withdrawn,drug misuse,Abuse,MONDO:0002491,substance abuse,1996.0,France
754676,CHEMBL1330792,ACETARSONE,Withdrawn,,Harmful,EFO:0009658,adverse effect,1982.0,Mauritius
757917,CHEMBL1334033,PERHEXILINE MALEATE,Withdrawn,hepatotoxicity,Neurologic and Hepatic Toxicities,EFO:0004228,drug-induced liver injury,1985.0,United Kingdom; Spain
757917,CHEMBL1334033,PERHEXILINE MALEATE,Withdrawn,hepatotoxicity,Neurologic and Hepatic Toxicities,EFO:0011052,hepatotoxicity,1985.0,United Kingdom; Spain
757917,CHEMBL1334033,PERHEXILINE MALEATE,Withdrawn,neurotoxicity,Neurologic and Hepatic Toxicities,EFO:0011057,neurotoxicity,1985.0,United Kingdom; Spain
11685,CHEMBL13376,CLOMETACIN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1987.0,France
11685,CHEMBL13376,CLOMETACIN,Withdrawn,hepatotoxicity,Hepatotoxicity,HP:0012115,Hepatitis,1987.0,France
11685,CHEMBL13376,CLOMETACIN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1987.0,France
11685,CHEMBL13376,CLOMETACIN,Withdrawn,hepatotoxicity,Hepatotoxicity,HP:0000952,Jaundice,1987.0,France
284208,CHEMBL1341,METHOXYFLURANE,Withdrawn,hepatotoxicity,"Serious, irreversible, and even fatal nephrotoxicity and hepatotoxicity",EFO:0011052,hepatotoxicity,2001.0,United States
284208,CHEMBL1341,METHOXYFLURANE,Withdrawn,hepatotoxicity,"Serious, irreversible, and even fatal nephrotoxicity and hepatotoxicity",EFO:0004228,drug-induced liver injury,2001.0,United States
284208,CHEMBL1341,METHOXYFLURANE,Withdrawn,nephrotoxicity,"Serious, irreversible, and even fatal nephrotoxicity and hepatotoxicity",HP:0000112,Nephropathy,2001.0,United States
27626,CHEMBL135,ESTRADIOL,Black Box Warning,neurotoxicity,,,,,United States
27626,CHEMBL135,ESTRADIOL,Black Box Warning,cardiotoxicity,,,,,United States
27626,CHEMBL135,ESTRADIOL,Black Box Warning,vascular toxicity,,,,,United States
27626,CHEMBL135,ESTRADIOL,Black Box Warning,carcinogenicity,,,,,United States
27626,CHEMBL135,ESTRADIOL,Black Box Warning,respiratory toxicity,,,,,United States
300022,CHEMBL1351,CARBOPLATIN,Black Box Warning,immune system toxicity,,,,,United States
300022,CHEMBL1351,CARBOPLATIN,Black Box Warning,hematological toxicity,,,,,United States
300022,CHEMBL1351,CARBOPLATIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
300022,CHEMBL1351,CARBOPLATIN,Black Box Warning,cardiotoxicity,,,,,United States
300022,CHEMBL1351,CARBOPLATIN,Black Box Warning,nephrotoxicity,,,,,United States
304381,CHEMBL1353,SODIUM BICARBONATE,Black Box Warning,misuse,,,,,United States
224263,CHEMBL135400,ZOPICLONE,Withdrawn,carcinogenicity,animal studies have disclosed thyroid disorders and neoplasms,EFO:0011046,carcinogenicity,1987.0,Norway
224263,CHEMBL135400,ZOPICLONE,Withdrawn,,animal studies have disclosed thyroid disorders and neoplasms,EFO:1000627,thyroid disease,1987.0,Norway
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,Withdrawn,neurotoxicity,Convulsions,HP:0001250,Seizure,1996.0,France
226851,CHEMBL136478,SODIUM NITROPRUSSIDE,Black Box Warning,,,,,,United States
226851,CHEMBL136478,SODIUM NITROPRUSSIDE,Black Box Warning,misuse,,,,,United States
226851,CHEMBL136478,SODIUM NITROPRUSSIDE,Black Box Warning,vascular toxicity,,,,,United States
308917,CHEMBL1366,AURANOFIN,Black Box Warning,hematological toxicity,,,,,United States
308917,CHEMBL1366,AURANOFIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
308917,CHEMBL1366,AURANOFIN,Black Box Warning,nephrotoxicity,,,,,United States
308917,CHEMBL1366,AURANOFIN,Black Box Warning,dermatological toxicity,,,,,United States
27912,CHEMBL137,METRONIDAZOLE,Black Box Warning,carcinogenicity,,,,,United States
27912,CHEMBL137,METRONIDAZOLE,Black Box Warning,infectious disease,,,,,United States
27912,CHEMBL137,METRONIDAZOLE,Black Box Warning,nephrotoxicity,,,,,United States
313314,CHEMBL1370,BUDESONIDE,Black Box Warning,infectious disease,,,,,United States
798263,CHEMBL1374379,BENZONATATE,Black Box Warning,immune system toxicity,,,,,United States
798263,CHEMBL1374379,BENZONATATE,Black Box Warning,respiratory toxicity,,,,,United States
798263,CHEMBL1374379,BENZONATATE,Black Box Warning,misuse,,,,,United States
798263,CHEMBL1374379,BENZONATATE,Black Box Warning,vascular toxicity,,,,,United States
799627,CHEMBL1375743,ZIPRASIDONE HYDROCHLORIDE,Black Box Warning,,,,,,United States
29890,CHEMBL139,DICLOFENAC,Black Box Warning,neurotoxicity,,,,,United States
29890,CHEMBL139,DICLOFENAC,Black Box Warning,gastrointestinal toxicity,,,,,United States
29890,CHEMBL139,DICLOFENAC,Black Box Warning,cardiotoxicity,,,,,United States
328201,CHEMBL1393,SPIRONOLACTONE,Black Box Warning,carcinogenicity,,,,,United States
822010,CHEMBL1398126,AMILORIDE HYDROCHLORIDE,Black Box Warning,metabolic toxicity,,,,,United States
822010,CHEMBL1398126,AMILORIDE HYDROCHLORIDE,Black Box Warning,,,,,,United States
233553,CHEMBL139877,SULFACARBAMIDE,Withdrawn,hepatotoxicity,"Dermatologic, Hematologic and Hepatic Reactions",EFO:0004228,drug-induced liver injury,1988.0,Germany
233553,CHEMBL139877,SULFACARBAMIDE,Withdrawn,hematological toxicity,"Dermatologic, Hematologic and Hepatic Reactions",EFO:0005803,hematologic disease,1988.0,Germany
233553,CHEMBL139877,SULFACARBAMIDE,Withdrawn,hepatotoxicity,"Dermatologic, Hematologic and Hepatic Reactions",EFO:0011052,hepatotoxicity,1988.0,Germany
233553,CHEMBL139877,SULFACARBAMIDE,Withdrawn,dermatological toxicity,"Dermatologic, Hematologic and Hepatic Reactions",EFO:0000701,skin disease,1988.0,Germany
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,EFO:0004228,drug-induced liver injury,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,cases of acute and chronic liver disease,EFO:0004228,drug-induced liver injury,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,HP:0012115,Hepatitis,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,HP:0000952,Jaundice,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,Hepatic toxicity,EFO:0004228,drug-induced liver injury,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,Hepatic toxicity,EFO:0011052,hepatotoxicity,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,EFO:0011052,hepatotoxicity,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
826568,CHEMBL1402684,OXYPHENISATIN ACETATE,Withdrawn,hepatotoxicity,cases of acute and chronic liver disease,EFO:0011052,hepatotoxicity,1970.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
13456,CHEMBL14060,PHENOL,Withdrawn,,benefits do not outweigh the risks,,,1983.0,Dominican Republic
345595,CHEMBL1409,FLUVOXAMINE MALEATE,Black Box Warning,psychiatric toxicity,,,,,United States
33986,CHEMBL141,LAMIVUDINE,Black Box Warning,hepatotoxicity,,,,,United States
33986,CHEMBL141,LAMIVUDINE,Black Box Warning,metabolic toxicity,,,,,United States
33986,CHEMBL141,LAMIVUDINE,Black Box Warning,,,,,,United States
835863,CHEMBL1411979,METHAPYRILENE,Withdrawn,carcinogenicity,suspected carcinogenicity,EFO:0011046,carcinogenicity,1979.0,Germany; United States; United Kingdom; Italy; India; Philippines; Egypt; Dominican Republic; Chile; Canada; Australia
835863,CHEMBL1411979,METHAPYRILENE,Withdrawn,,health risks associated with use,EFO:0009658,adverse effect,1979.0,Germany; United States; United Kingdom; Italy; India; Philippines; Egypt; Dominican Republic; Chile; Canada; Australia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,neurotoxicity,"severe neurotoxicity and hypersensitivity reactions. Moreover, the mononitrasation of piperazine in the stomach can produce the potential carcinogen N-mononitrosopiperazine",EFO:0011057,neurotoxicity,1983.0,Sweden; Armenia; Netherlands; Malaysia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,neurotoxicity,"Questionable safety with detection of neurotoxicity, hypersensitivity and nitrosamine-generating ability",EFO:0011057,neurotoxicity,1983.0,Sweden; Armenia; Netherlands; Malaysia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,carcinogenicity,carcinogenic and mutagenic potential,EFO:0011046,carcinogenicity,1983.0,Sweden; Armenia; Netherlands; Malaysia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,carcinogenicity,"Questionable safety with detection of neurotoxicity, hypersensitivity and nitrosamine-generating ability",EFO:0011046,carcinogenicity,1983.0,Sweden; Armenia; Netherlands; Malaysia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,immune system toxicity,"Questionable safety with detection of neurotoxicity, hypersensitivity and nitrosamine-generating ability",EFO:1002003,hypersensitivity reaction disease,1983.0,Sweden; Armenia; Netherlands; Malaysia
352917,CHEMBL1412,PIPERAZINE,Withdrawn,immune system toxicity,"severe neurotoxicity and hypersensitivity reactions. Moreover, the mononitrasation of piperazine in the stomach can produce the potential carcinogen N-mononitrosopiperazine",EFO:1002003,hypersensitivity reaction disease,1983.0,Sweden; Armenia; Netherlands; Malaysia
231925,CHEMBL141305,CYCLOFENIL,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1987.0,France
231925,CHEMBL141305,CYCLOFENIL,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1987.0,France
838204,CHEMBL1414320,SUXIBUZONE,Withdrawn,,unfavourable risk-benefit ratio and the lack of substantial evidence of efficacy,EFO:0020002,lack of efficacy,,Italy
838204,CHEMBL1414320,SUXIBUZONE,Withdrawn,,unfavourable risk-benefit ratio and the lack of substantial evidence of efficacy,EFO:0009658,adverse effect,,Italy
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
842060,CHEMBL1418176,METHANDROSTENOLONE,Withdrawn,drug misuse,Off-label abuse,MONDO:0002491,substance abuse,1982.0,France; United States; United Kingdom; Germany
358192,CHEMBL1419,SIBUTRAMINE,Withdrawn,neurotoxicity,Increased risk of heart attack and stroke,EFO:0000712,stroke,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
358192,CHEMBL1419,SIBUTRAMINE,Withdrawn,cardiotoxicity,Higher rate of cardiovascular events in obese and overweight patients using sibutramine than in patients managing their weight through exercise and diet alone,EFO:1001482,cardiotoxicity,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
358192,CHEMBL1419,SIBUTRAMINE,Withdrawn,cardiotoxicity,Increased risk of heart attack and stroke,EFO:0000612,myocardial infarction,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
358192,CHEMBL1419,SIBUTRAMINE,Withdrawn,cardiotoxicity,Increase of risk of cardivascular events in patients with history of cardiovascular disease; Based on data from the SCOUT trial (which showed a higher rate of cardiovascular events in obese and overweight patients using sibutramine than in patients managing their weight through exercise and diet alone).; Elevated risk of cardiotoxicity,EFO:1001482,cardiotoxicity,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
358192,CHEMBL1419,SIBUTRAMINE,Withdrawn,cardiotoxicity,Increased risk of heart attack and stroke,EFO:0000712,stroke,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
365248,CHEMBL1428,NIMODIPINE,Black Box Warning,misuse,,,,,United States
369179,CHEMBL1430,PENICILLAMINE,Black Box Warning,,,,,,United States
858397,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,Black Box Warning,,,,,,United States
13949,CHEMBL14376,ILOPERIDONE,Black Box Warning,psychiatric toxicity,,,,,United States
864943,CHEMBL1441059,ALBUTEROL SULFATE,Black Box Warning,,,,,,United States
378207,CHEMBL1447,LINCOMYCIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
378207,CHEMBL1447,LINCOMYCIN,Black Box Warning,infectious disease,,,,,United States
871360,CHEMBL1447476,BITHIONOLATE SODIUM,Withdrawn,dermatological toxicity,Dermatologic Toxicity,EFO:1000753,phototoxic dermatitis,1967.0,United States; Japan
871360,CHEMBL1447476,BITHIONOLATE SODIUM,Withdrawn,dermatological toxicity,potent photosensitizer with the potential to cause serious skin disorders,EFO:1000753,phototoxic dermatitis,1967.0,United States; Japan
871360,CHEMBL1447476,BITHIONOLATE SODIUM,Withdrawn,dermatological toxicity,potent photosensitizer with the potential to cause serious skin disorders,EFO:0020984,skin sensitization,1967.0,United States; Japan
871360,CHEMBL1447476,BITHIONOLATE SODIUM,Withdrawn,dermatological toxicity,potent photosensitizer with the potential to cause serious skin disorders,EFO:0000701,skin disease,1967.0,United States; Japan
871360,CHEMBL1447476,BITHIONOLATE SODIUM,Withdrawn,dermatological toxicity,Dermatologic Toxicity,EFO:0000701,skin disease,1967.0,United States; Japan
872071,CHEMBL1448187,FLUPHENAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
876580,CHEMBL1452696,FEPRAZONE,Withdrawn,dermatological toxicity,Cutaneous Reaction; Multi-Organ Toxicities,EFO:0020927,skin reaction,1984.0,Germany; Greece; United Kingdom; Egypt
876580,CHEMBL1452696,FEPRAZONE,Withdrawn,,Cutaneous Reaction; Multi-Organ Toxicities,EFO:1001373,Multiple Organ Failure,1984.0,Germany; Greece; United Kingdom; Egypt
876580,CHEMBL1452696,FEPRAZONE,Withdrawn,carcinogenicity,"reported adverse reactions, particularly involving the skin, and demonstration of a carcinogenic potential in rats",EFO:0011046,carcinogenicity,1984.0,Germany; Greece; United Kingdom; Egypt
876580,CHEMBL1452696,FEPRAZONE,Withdrawn,dermatological toxicity,"reported adverse reactions, particularly involving the skin, and demonstration of a carcinogenic potential in rats",EFO:0020927,skin reaction,1984.0,Germany; Greece; United Kingdom; Egypt
384948,CHEMBL1454,LEVAMISOLE,Withdrawn,neurotoxicity,Adverse effects that cause encephalitis and mortality,EFO:0001423,encephalomyelitis,2000.0,Vietnam; China
384948,CHEMBL1454,LEVAMISOLE,Withdrawn,neurotoxicity,leukoencephalopathy,NCIT:C27059,Leukoencephalopathy,2000.0,Vietnam; China
384948,CHEMBL1454,LEVAMISOLE,Withdrawn,,Adverse effects that cause encephalitis and mortality,PATO:0001422,dead,2000.0,Vietnam; China
384948,CHEMBL1454,LEVAMISOLE,Withdrawn,immune system toxicity,Adverse effects that cause encephalitis and mortality,EFO:0001423,encephalomyelitis,2000.0,Vietnam; China
878794,CHEMBL1454910,NITROXOLINE,Withdrawn,occular toxicity,cataracts have developed in rats in prolonged dosage studies,MONDO:0005129,cataract,1973.0,Ireland
386327,CHEMBL1455,ALTRETAMINE,Black Box Warning,,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,carcinogenicity,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,immune system toxicity,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,teratogenicity,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,infectious disease,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,gastrointestinal toxicity,,,,,United States
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,Black Box Warning,cardiotoxicity,,,,,United States
390877,CHEMBL1460,DIDANOSINE,Black Box Warning,immune system toxicity,,,,,United States
390877,CHEMBL1460,DIDANOSINE,Black Box Warning,metabolic toxicity,,,,,United States
390877,CHEMBL1460,DIDANOSINE,Black Box Warning,hepatotoxicity,,,,,United States
390877,CHEMBL1460,DIDANOSINE,Black Box Warning,gastrointestinal toxicity,,,,,United States
244737,CHEMBL146095,GLAFENINE,Withdrawn,immune system toxicity,"associated with severe allergic responses, including anaphylactoid reactions",EFO:0009482,drug allergy,1984.0,Worldwide
244737,CHEMBL146095,GLAFENINE,Withdrawn,immune system toxicity,"associated with severe allergic responses, including anaphylactoid reactions",MONDO:0100053,anaphylaxis,1984.0,Worldwide
244737,CHEMBL146095,GLAFENINE,Withdrawn,immune system toxicity,"associated with severe allergic responses, including anaphylactoid reactions",EFO:0020918,non-allergic anaphylaxis,1984.0,Worldwide
244737,CHEMBL146095,GLAFENINE,Withdrawn,immune system toxicity,"associated with severe allergic responses, including anaphylactoid reactions; reports of anaphylactic shock",EFO:1002003,hypersensitivity reaction disease,1984.0,Worldwide
393942,CHEMBL1463,FLUCYTOSINE,Black Box Warning,,,,,,United States
887229,CHEMBL1463345,CANRENONE,Withdrawn,carcinogenicity,Animal carcinogenicity,EFO:0011046,carcinogenicity,1986.0,Germany
395607,CHEMBL1467,ALLOPURINOL,Black Box Warning,,,,,,United States
898773,CHEMBL1474889,CLOBUTINOL,Withdrawn,cardiotoxicity,QT prolongation,HP:0001657,Prolonged QT interval,2007.0,Worldwide
898773,CHEMBL1474889,CLOBUTINOL,Withdrawn,cardiotoxicity,"adverse cardiac effects, QT-prolongation",HP:0001657,Prolonged QT interval,2007.0,Worldwide
898847,CHEMBL1474963,BENZARONE,Withdrawn,hepatotoxicity,Hepatitis,HP:0012115,Hepatitis,1992.0,Germany
898847,CHEMBL1474963,BENZARONE,Withdrawn,hepatotoxicity,Hepatitis,EFO:0004228,drug-induced liver injury,1992.0,Germany
898847,CHEMBL1474963,BENZARONE,Withdrawn,hepatotoxicity,Hepatitis,EFO:0011052,hepatotoxicity,1992.0,Germany
403465,CHEMBL1477,CERIVASTATIN,Withdrawn,musculoskeletal toxicity,"Increased reporting rate of rhabdomyolysis with Baycol relative to other statins, especially when gemfibrozil is co-prescribed",EFO:0003867,rhabdomyolysis,2001.0,Worldwide
403465,CHEMBL1477,CERIVASTATIN,Withdrawn,,"Increased reporting rate of rhabdomyolysis with Baycol relative to other statins, especially when gemfibrozil is co-prescribed",EFO:0009878,drug interaction,2001.0,Worldwide
403465,CHEMBL1477,CERIVASTATIN,Withdrawn,,"Severe muscle damage. Combination of cerivastatin and another cholesterol lowering drug, gemfibrozil, has caused severe damage to muscle in some patients. The damage can be in the form of rhabdomyolysis where there is breakdown of muscle cells and release of myoglobin which in turn can lead to kidney damage",EFO:0009878,drug interaction,2001.0,Worldwide
403465,CHEMBL1477,CERIVASTATIN,Withdrawn,nephrotoxicity,"Severe muscle damage. Combination of cerivastatin and another cholesterol lowering drug, gemfibrozil, has caused severe damage to muscle in some patients. The damage can be in the form of rhabdomyolysis where there is breakdown of muscle cells and release of myoglobin which in turn can lead to kidney damage",EFO:1002048,kidney failure,2001.0,Worldwide
403465,CHEMBL1477,CERIVASTATIN,Withdrawn,musculoskeletal toxicity,"Severe muscle damage. Combination of cerivastatin and another cholesterol lowering drug, gemfibrozil, has caused severe damage to muscle in some patients. The damage can be in the form of rhabdomyolysis where there is breakdown of muscle cells and release of myoglobin which in turn can lead to kidney damage",EFO:0003867,rhabdomyolysis,2001.0,Worldwide
405364,CHEMBL1479,DANAZOL,Black Box Warning,neurotoxicity,,,,,United States
405364,CHEMBL1479,DANAZOL,Black Box Warning,hepatotoxicity,,,,,United States
405364,CHEMBL1479,DANAZOL,Black Box Warning,teratogenicity,,,,,United States
405364,CHEMBL1479,DANAZOL,Black Box Warning,vascular toxicity,,,,,United States
405364,CHEMBL1479,DANAZOL,Black Box Warning,carcinogenicity,,,,,United States
417163,CHEMBL1486,TENOFOVIR DISOPROXIL FUMARATE,Black Box Warning,hepatotoxicity,,,,,United States
417163,CHEMBL1486,TENOFOVIR DISOPROXIL FUMARATE,Black Box Warning,immune system toxicity,,,,,United States
419410,CHEMBL1497,BETAMETHASONE VALERATE,Black Box Warning,,,,,,United States
250525,CHEMBL149972,PHENOBARBITAL SODIUM,Black Box Warning,,,,,,United States
924160,CHEMBL1500276,OXELADIN,Withdrawn,carcinogenicity,carcinogenicity,EFO:0011046,carcinogenicity,1994.0,France; Germany
419542,CHEMBL1501,FLUOCINONIDE,Black Box Warning,,,,,,United States
421038,CHEMBL1511,ESTRADIOL VALERATE,Black Box Warning,vascular toxicity,,,,,United States
421038,CHEMBL1511,ESTRADIOL VALERATE,Black Box Warning,cardiotoxicity,,,,,United States
421038,CHEMBL1511,ESTRADIOL VALERATE,Black Box Warning,neurotoxicity,,,,,United States
421038,CHEMBL1511,ESTRADIOL VALERATE,Black Box Warning,respiratory toxicity,,,,,United States
421038,CHEMBL1511,ESTRADIOL VALERATE,Black Box Warning,carcinogenicity,,,,,United States
421066,CHEMBL1513,IRBESARTAN,Black Box Warning,teratogenicity,,,,,United States
421066,CHEMBL1513,IRBESARTAN,Black Box Warning,cardiotoxicity,,,,,United States
421070,CHEMBL1514,LEVOMETHADYL ACETATE,Withdrawn,cardiotoxicity,adverse cardiac events,EFO:1001482,cardiotoxicity,2001.0,European Union
939495,CHEMBL1515611,BROMISOVALUM,Withdrawn,drug misuse,Dependence potential and the risk of subsequent chronic intoxication,MONDO:0002491,substance abuse,1987.0,Netherlands
939495,CHEMBL1515611,BROMISOVALUM,Withdrawn,drug misuse,Dependence potential and the risk of subsequent chronic intoxication,MONDO:0004938,substance dependence,1987.0,Netherlands
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,neurotoxicity,"Cardiovascular ischemic events occurring in Zelnorm-treated patients included myocardial infarction, stroke, and unstable angina pectoris",EFO:0000712,stroke,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Risk for heart attack, stroke, and unstable angina",EFO:0020925,angina unstable,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Risk for heart attack, stroke, and unstable angina",EFO:0000712,stroke,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Cardiovascular ischemic events occurring in Zelnorm-treated patients included myocardial infarction, stroke, and unstable angina pectoris",EFO:0000712,stroke,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,neurotoxicity,"Risk for heart attack, stroke, and unstable angina",EFO:0000712,stroke,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Cardiovascular ischemic events occurring in Zelnorm-treated patients included myocardial infarction, stroke, and unstable angina pectoris",EFO:0000612,myocardial infarction,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Risk for heart attack, stroke, and unstable angina",EFO:0000612,myocardial infarction,2007.0,United States; Australia; Canada
940358,CHEMBL1516474,TEGASEROD MALEATE,Withdrawn,cardiotoxicity,"Cardiovascular ischemic events occurring in Zelnorm-treated patients included myocardial infarction, stroke, and unstable angina pectoris",EFO:0020925,angina unstable,2007.0,United States; Australia; Canada
421208,CHEMBL1518,PROPYLTHIOURACIL,Black Box Warning,hepatotoxicity,,,,,United States
421317,CHEMBL1519,TRANDOLAPRIL,Black Box Warning,teratogenicity,,,,,United States
421332,CHEMBL1521,ZALEPLON,Black Box Warning,misuse,,,,,United States
421332,CHEMBL1521,ZALEPLON,Black Box Warning,,,,,,United States
421334,CHEMBL1522,ESZOPICLONE,Black Box Warning,misuse,,,,,United States
421334,CHEMBL1522,ESZOPICLONE,Black Box Warning,,,,,,United States
948157,CHEMBL1524273,PHTHALYLSULFATHIAZOLE,Withdrawn,drug misuse,"found to be of little or no therapeutic value, its side effects can be harmful, and it is subject to misuse",MONDO:0002491,substance abuse,1982.0,Bangladesh
421902,CHEMBL1525,PERMETHRIN,Withdrawn,carcinogenicity,Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman
255049,CHEMBL152684,BECLOBRATE,Withdrawn,hepatotoxicity,Fatal hepatitis,EFO:0004228,drug-induced liver injury,1990.0,Switzerland
255049,CHEMBL152684,BECLOBRATE,Withdrawn,hepatotoxicity,Fatal hepatitis,HP:0012115,Hepatitis,1990.0,Switzerland
952723,CHEMBL1528839,PHENFORMIN HYDROCHLORIDE,Withdrawn,metabolic toxicity,Severe Metabolic Acidosis,HP:0001942,Metabolic acidosis,1970.0,France; United States; Germany; Switzerland; Norway; Denmark; Canada; Turkey; Finland; Austria; Sweden; Cyprus; Ethiopia; Ireland; Yemen; United Kingdom; Saudia arabia
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,Black Box Warning,metabolic toxicity,,,,,United States
958409,CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE,Withdrawn,,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0009878,drug interaction,1998.0,Worldwide
958409,CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE,Withdrawn,,associated with potentially harmful interactions with other drugs. Mibefradil dihydrochloride reduced the activity of certain liver enzymes that are important in helping the body eliminate many other drugs. Inhibiting these enzymes can cause some of these drugs to accumulate to dangerous levels in the body,EFO:0009878,drug interaction,1998.0,Worldwide
958409,CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE,Withdrawn,cardiotoxicity,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0005307,torsades de pointes,1998.0,Worldwide
958409,CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE,Withdrawn,cardiotoxicity,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0004269,cardiac arrhythmia,1998.0,Worldwide
51056,CHEMBL154,NAPROXEN,Black Box Warning,cardiotoxicity,,,,,United States
51056,CHEMBL154,NAPROXEN,Black Box Warning,gastrointestinal toxicity,,,,,United States
51056,CHEMBL154,NAPROXEN,Black Box Warning,neurotoxicity,,,,,United States
431141,CHEMBL1542,AZATHIOPRINE,Black Box Warning,carcinogenicity,,,,,United States
431141,CHEMBL1542,AZATHIOPRINE,Black Box Warning,hematological toxicity,,,,,United States
431141,CHEMBL1542,AZATHIOPRINE,Black Box Warning,immune system toxicity,,,,,United States
431141,CHEMBL1542,AZATHIOPRINE,Black Box Warning,teratogenicity,,,,,United States
441571,CHEMBL1550,PHYTONADIONE,Black Box Warning,immune system toxicity,,,,,United States
441571,CHEMBL1550,PHYTONADIONE,Black Box Warning,vascular toxicity,,,,,United States
441571,CHEMBL1550,PHYTONADIONE,Black Box Warning,respiratory toxicity,,,,,United States
441571,CHEMBL1550,PHYTONADIONE,Black Box Warning,nephrotoxicity,,,,,United States
444750,CHEMBL1560,CAPTOPRIL,Black Box Warning,teratogenicity,,,,,United States
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,Black Box Warning,neurotoxicity,,,,,United States
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
450864,CHEMBL1567,SUNITINIB MALATE,Black Box Warning,hepatotoxicity,,,,,United States
450864,CHEMBL1567,SUNITINIB MALATE,Black Box Warning,hematological toxicity,,,,,United States
16521,CHEMBL15677,FENCLOFENAC,Withdrawn,dermatological toxicity,"associated with serious adverse effects, predominantly skin rashes",EFO:1000697,exanthem,1984.0,Worldwide
16521,CHEMBL15677,FENCLOFENAC,Withdrawn,carcinogenicity,Cutaneous Reactions; Animal Carcinogenicity,EFO:0011046,carcinogenicity,1984.0,Worldwide
16521,CHEMBL15677,FENCLOFENAC,Withdrawn,dermatological toxicity,Cutaneous Reactions; Animal Carcinogenicity,EFO:0006346,severe cutaneous adverse reaction,1984.0,Worldwide
991941,CHEMBL1568057,METAPROTERENOL SULFATE,Withdrawn,cardiotoxicity,"Significantly less efficacious than salbutamol and cardiac side effects, mainly palpitations and tachycardia because of its non-selectivity",HP:0001962,Palpitations,2009.0,United Kingdom
991941,CHEMBL1568057,METAPROTERENOL SULFATE,Withdrawn,cardiotoxicity,"significantly less efficacious than salbutamol...significantly increased incidence of cardiac side effects, mainly palpitations and tachycardia because of its non-selectivity.",HP:0001649,Tachycardia,2009.0,United Kingdom
255904,CHEMBL157101,KETOCONAZOLE,Black Box Warning,hepatotoxicity,,,,,United States
255904,CHEMBL157101,KETOCONAZOLE,Black Box Warning,cardiotoxicity,,,,,United States
255904,CHEMBL157101,KETOCONAZOLE,Withdrawn,hepatotoxicity,Liver toxicity is more frequent and severe than with other antifungal treatments; Elevated risk of early onset liver damage,EFO:0004228,drug-induced liver injury,2011.0,Guatemala; Madagascar
255904,CHEMBL157101,KETOCONAZOLE,Withdrawn,hepatotoxicity,Liver toxicity is more frequent and severe than with other antifungal treatments; Elevated risk of early onset liver damage,EFO:0011052,hepatotoxicity,2011.0,Guatemala; Madagascar
453532,CHEMBL1574,PHENTERMINE,Withdrawn,,risks outweigh the benefits,,,1981.0,Sweden; United Kingdom; Mauritius
453532,CHEMBL1574,PHENTERMINE,Withdrawn,drug misuse,"lack of evidence of their value in long-term management of obesity, they have the potential for abuse and despite warnings they are frequently used over unacceptably prolonged periods.",MONDO:0002491,substance abuse,1981.0,Sweden; United Kingdom; Mauritius
16510,CHEMBL15770,SULINDAC,Black Box Warning,gastrointestinal toxicity,,,,,United States
16510,CHEMBL15770,SULINDAC,Black Box Warning,cardiotoxicity,,,,,United States
16510,CHEMBL15770,SULINDAC,Black Box Warning,neurotoxicity,,,,,United States
453578,CHEMBL1580,PENTOSTATIN,Black Box Warning,,,,,,United States
16599,CHEMBL15870,INDOPROFEN,Withdrawn,gastrointestinal toxicity,Animal Carcinogenicity (rodent); Gastrointestinal Toxicity,EFO:0011050,gastrointestinal toxicity,1983.0,Worldwide
16599,CHEMBL15870,INDOPROFEN,Withdrawn,carcinogenicity,Animal Carcinogenicity (rodent); Gastrointestinal Toxicity,EFO:0011046,carcinogenicity,1983.0,Worldwide
16599,CHEMBL15870,INDOPROFEN,Withdrawn,carcinogenicity,serious adverse gastrointestinal reactions; tumours in a carcinogenicity study undertaken in rats,EFO:0011046,carcinogenicity,1983.0,Worldwide
16599,CHEMBL15870,INDOPROFEN,Withdrawn,gastrointestinal toxicity,serious adverse gastrointestinal reactions; tumours in a carcinogenicity study undertaken in rats,EFO:0000405,digestive system disease,1983.0,Worldwide
16654,CHEMBL15891,LINDANE,Black Box Warning,neurotoxicity,,,,,United States
16654,CHEMBL15891,LINDANE,Withdrawn,,potential to cause toxic effects,EFO:0009658,adverse effect,2001.0,Chile; Brazil
16654,CHEMBL15891,LINDANE,Withdrawn,,Toxic effects on environment and human health,,,2001.0,Chile; Brazil
1015985,CHEMBL1592101,BISMUTH SUBGALLATE,Withdrawn,neurotoxicity,possible association with encephalopathy,HP:0001298,Encephalopathy,1975.0,Egypt
265957,CHEMBL159226,MOXISYLYTE,Withdrawn,hepatotoxicity,dose-dependent hepatotoxicity,EFO:0004228,drug-induced liver injury,1993.0,France
265957,CHEMBL159226,MOXISYLYTE,Withdrawn,hepatotoxicity,dose-dependent hepatotoxicity,EFO:0011052,hepatotoxicity,1993.0,France
1017603,CHEMBL1593719,PHENICARBAZIDE,Withdrawn,,serious nature of the adverse effects,EFO:0009658,adverse effect,,Ireland
72873,CHEMBL160,CYCLOSPORINE,Black Box Warning,carcinogenicity,,,,,United States
72873,CHEMBL160,CYCLOSPORINE,Black Box Warning,immune system toxicity,,,,,United States
72873,CHEMBL160,CYCLOSPORINE,Black Box Warning,nephrotoxicity,,,,,United States
72873,CHEMBL160,CYCLOSPORINE,Black Box Warning,vascular toxicity,,,,,United States
72873,CHEMBL160,CYCLOSPORINE,Black Box Warning,infectious disease,,,,,United States
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,Black Box Warning,immune system toxicity,,,,,United States
16498,CHEMBL16073,PHENACETIN,Withdrawn,hematological toxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,MONDO:0001117,methemoglobinemia,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,nephrotoxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,HP:0000112,Nephropathy,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,nephrotoxicity,Nephropathy,EFO:0003086,kidney disease,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,carcinogenicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,EFO:0011046,carcinogenicity,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,carcinogenicity,renal damage and its carcinogenicity.,EFO:0011046,carcinogenicity,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,hepatotoxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,EFO:0011052,hepatotoxicity,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,hematological toxicity,high potential for harm to the kidneys and the possibility of hemolytic anemia and methemoglobinemia resulting from abuse,EFO:0005558,hemolytic anemia,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,hematological toxicity,high potential for harm to the kidneys and the possibility of hemolytic anemia and methemoglobinemia resulting from abuse,MONDO:0001117,methemoglobinemia,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,nephrotoxicity,risk of nephropathy from long-term use,EFO:0011056,nephrotoxicity,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,hematological toxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,EFO:0005558,hemolytic anemia,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,nephrotoxicity,high potential for harm to the kidneys and the possibility of hemolytic anemia and methemoglobinemia resulting from abuse,EFO:0011056,nephrotoxicity,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,hepatotoxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,EFO:0004228,drug-induced liver injury,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16498,CHEMBL16073,PHENACETIN,Withdrawn,nephrotoxicity,nephropathy; liver and kidney toxicity; carcinogenicity; haemolytic anaemia and methaemoglobinaemia,EFO:0003086,kidney disease,1965.0,Malaysia; Romania; Germany; Ireland; Panama; Italy; Finland; New Zealand; Ethiopia; Greece; Yemen; Chile; Hong Kong; Philippines; Israel; United Arab Emirates; Nigeria; Mauritius; Denmark; United States; Brazil; United Kingdom; Bangladesh; Oman; Netherlands; Cyprus; Thailand; Sweden; Norway; Suriname; India; Rwanda; Nepal; Austria; Bahrain; Japan; Turkey
16727,CHEMBL16080,TRICHLOROETHANE,Withdrawn,drug misuse,potentially toxic to the cardiovascular system and was associated with deaths from misuse or abuse,MONDO:0002491,substance abuse,1977.0,United States
16727,CHEMBL16080,TRICHLOROETHANE,Withdrawn,cardiotoxicity,potentially toxic to the cardiovascular system and was associated with deaths from misuse or abuse,EFO:1001482,cardiotoxicity,1977.0,United States
458912,CHEMBL1611,PHENYTOIN SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
458912,CHEMBL1611,PHENYTOIN SODIUM,Black Box Warning,vascular toxicity,,,,,United States
458912,CHEMBL1611,PHENYTOIN SODIUM,Black Box Warning,misuse,,,,,United States
458912,CHEMBL1611,PHENYTOIN SODIUM,Black Box Warning,hematological toxicity,,,,,United States
1038352,CHEMBL1615369,DABIGATRAN ETEXILATE MESYLATE,Black Box Warning,neurotoxicity,,,,,United States
1038352,CHEMBL1615369,DABIGATRAN ETEXILATE MESYLATE,Black Box Warning,vascular toxicity,,,,,United States
1038355,CHEMBL1615372,LURASIDONE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
1038390,CHEMBL1615439,PHENDIMETRAZINE,Withdrawn,,unfavourable benefit/risk balance,,,2000.0,Oman
467361,CHEMBL1619,CLADRIBINE,Black Box Warning,teratogenicity,,,,,United States
467361,CHEMBL1619,CLADRIBINE,Black Box Warning,neurotoxicity,,,,,United States
468656,CHEMBL1621,PALIPERIDONE,Black Box Warning,,,,,,United States
1051125,CHEMBL1628234,DOXEPIN HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
88100,CHEMBL163,RITONAVIR,Black Box Warning,,,,,,United States
485738,CHEMBL1643,RIBAVIRIN,Black Box Warning,hematological toxicity,,,,,United States
485738,CHEMBL1643,RIBAVIRIN,Black Box Warning,teratogenicity,,,,,United States
485738,CHEMBL1643,RIBAVIRIN,Black Box Warning,respiratory toxicity,,,,,United States
485738,CHEMBL1643,RIBAVIRIN,Black Box Warning,carcinogenicity,,,,,United States
485738,CHEMBL1643,RIBAVIRIN,Black Box Warning,dermatological toxicity,,,,,United States
1058777,CHEMBL1644029,POTASSIUM NITRATE,Withdrawn,carcinogenicity,potential carcinogenic risk,EFO:0011046,carcinogenicity,1981.0,France
18271,CHEMBL16476,PRONETALOL,Withdrawn,carcinogenicity,Animal carcinogenicity (rodent),EFO:0011046,carcinogenicity,1965.0,United Kingdom
498105,CHEMBL1663,PERFLUTREN,Black Box Warning,cardiotoxicity,,,,,United States
504310,CHEMBL1670,MITOTANE,Black Box Warning,,,,,,United States
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
543658,CHEMBL1692,IMIPRAMINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
543703,CHEMBL1693,DIETHYLPROPION HYDROCHLORIDE,Withdrawn,,Risks outweigh the benefits,,,1981.0,European Union; Sweden; United Kingdom; France
544432,CHEMBL1694,BENAZEPRIL HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
544432,CHEMBL1694,BENAZEPRIL HYDROCHLORIDE,Black Box Warning,,,,,,United States
545075,CHEMBL1696,DESIPRAMINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
1078456,CHEMBL1697686,CLOFOREX,Withdrawn,respiratory toxicity,Concern that its use was associated with cases of pulmonary hypertension led to its withdrawal in several countries,EFO:0001361,pulmonary arterial hypertension,1969.0,Germany; Sweden
1078456,CHEMBL1697686,CLOFOREX,Withdrawn,cardiotoxicity,Cardiovascular,EFO:1001482,cardiotoxicity,1969.0,Germany; Sweden
1078515,CHEMBL1697751,ISAXONINE PHOSPHATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1983.0,France
1078515,CHEMBL1697751,ISAXONINE PHOSPHATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1983.0,France
1078515,CHEMBL1697751,ISAXONINE PHOSPHATE,Withdrawn,hepatotoxicity,Hepatotoxicity,HP:0012115,Hepatitis,1983.0,France
1078524,CHEMBL1697760,MUZOLIMINE,Withdrawn,neurotoxicity,Polyneuropathy,HP:0003401,Paresthesia,1987.0,France; European Union; Germany
1078524,CHEMBL1697760,MUZOLIMINE,Withdrawn,neurotoxicity,Polyneuropathy,HP:0003470,Paralysis,1987.0,France; European Union; Germany
1078524,CHEMBL1697760,MUZOLIMINE,Withdrawn,neurotoxicity,Polyneuropathy,EFO:0009562,polyneuropathy,1987.0,France; European Union; Germany
1078605,CHEMBL1697856,BUCETIN,Withdrawn,nephrotoxicity,Renal,EFO:0011056,nephrotoxicity,1986.0,Germany
545956,CHEMBL1698,BUPROPION HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
545956,CHEMBL1698,BUPROPION HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
547402,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
547402,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
547402,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
547576,CHEMBL1702,ATOMOXETINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
547576,CHEMBL1702,ATOMOXETINE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,Black Box Warning,metabolic toxicity,,,,,United States
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,Black Box Warning,,,,,,United States
549372,CHEMBL1709,SERTRALINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
282509,CHEMBL170988,PHENFORMIN,Withdrawn,metabolic toxicity,Lactic acidosis among diabetics receiving biguanides,EFO:1000036,lactic acidosis,1970.0,France; United States; Germany; Switzerland; Norway; Denmark; Canada; Turkey; Finland; Austria; Sweden; Cyprus; Ethiopia; Ireland; Yemen; United Kingdom; Saudia arabia
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,vascular toxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",EFO:0005251,hypotension,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,gastrointestinal toxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0002590,Paralytic ileus,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,neurotoxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0001250,Seizure,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,nephrotoxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0000016,Urinary retention,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,hepatotoxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",EFO:0004228,drug-induced liver injury,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,immune system toxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0001913,Granulocytopenia,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,immune system toxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0032310,Granulocytosis,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,hepatotoxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",EFO:0011052,hepatotoxicity,1970.0,United States
1093573,CHEMBL1712842,MEPAZINE ACETATE,Withdrawn,hepatotoxicity,"associated with granulocytopenia, granulocytosis, paralytic ileus, urinary retention, seizures, hypotension, and jaundice",HP:0000952,Jaundice,1970.0,United States
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
550857,CHEMBL1715,PIOGLITAZONE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
19569,CHEMBL17157,TERFENADINE,Withdrawn,,Fatal drug interactions with commonly use drugs,PATO:0001422,dead,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,Use of terfenadine products with certain other drugs or foods and in certain medical conditions is associated with the potential to result in rare and serious cardiac side effects primarily involving changes in heart rhythm,EFO:0004269,cardiac arrhythmia,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,cardiac arrhythmias,EFO:0004269,cardiac arrhythmia,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,Prolonged QT interval; ventricular tachycardia,HP:0001657,Prolonged QT interval,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,Prolonged QT interval; ventricular tachycardia,EFO:0005306,ventricular tachycardia,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,Risk of cardiac arrhythmia,EFO:0004269,cardiac arrhythmia,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,,Use of terfenadine products with certain other drugs or foods and in certain medical conditions is associated with the potential to result in rare and serious cardiac side effects primarily involving changes in heart rhythm,EFO:0009878,drug interaction,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,,"Fatal drug interactions with commonly use drugs; Rare but serious heart problems when taken with certain drugs, including antibiotics and antifungal drugs",EFO:0009878,drug interaction,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
19569,CHEMBL17157,TERFENADINE,Withdrawn,cardiotoxicity,serious cardiotoxic effects reported in conjunction with other drug,EFO:0009878,drug interaction,1997.0,Morocco; Singapore; France; Mauritius; Bhutan; Saudi Arabia; United States; Oman; Chile; Brazil; Argentina
551003,CHEMBL1717,TICLOPIDINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
554800,CHEMBL1725,IOPROMIDE,Black Box Warning,misuse,,,,,United States
557741,CHEMBL1729,CISAPRIDE,Black Box Warning,,,,,,United States
1121342,CHEMBL1742471,EBROTIDINE,Withdrawn,hepatotoxicity,reports of serious liver dysfunction particularly on long-term treatment and when the drug was administered with anti-inflammatory agents and corticosteroids,EFO:0004228,drug-induced liver injury,1998.0,Peru; Spain
1121342,CHEMBL1742471,EBROTIDINE,Withdrawn,hepatotoxicity,reports of serious liver dysfunction particularly on long-term treatment and when the drug was administered with anti-inflammatory agents and corticosteroids,EFO:0011052,hepatotoxicity,1998.0,Peru; Spain
1121342,CHEMBL1742471,EBROTIDINE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1998.0,Peru; Spain
1121342,CHEMBL1742471,EBROTIDINE,Withdrawn,,reports of serious liver dysfunction particularly on long-term treatment and when the drug was administered with anti-inflammatory agents and corticosteroids,EFO:0009878,drug interaction,1998.0,Peru; Spain
1121342,CHEMBL1742471,EBROTIDINE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1998.0,Peru; Spain
1121861,CHEMBL1742990,BELATACEPT,Black Box Warning,immune system toxicity,,,,,United States
1121861,CHEMBL1742990,BELATACEPT,Black Box Warning,carcinogenicity,,,,,United States
1121861,CHEMBL1742990,BELATACEPT,Black Box Warning,infectious disease,,,,,United States
1121863,CHEMBL1742992,BLINATUMOMAB,Black Box Warning,,,,,,United States
1121865,CHEMBL1742994,BRENTUXIMAB VEDOTIN,Black Box Warning,infectious disease,,,,,United States
1121867,CHEMBL1742996,BRODALUMAB,Black Box Warning,psychiatric toxicity,,,,,United States
1121914,CHEMBL1743043,MOXETUMOMAB PASUDOTOX,Black Box Warning,vascular toxicity,,,,,United States
1121914,CHEMBL1743043,MOXETUMOMAB PASUDOTOX,Black Box Warning,nephrotoxicity,,,,,United States
1121914,CHEMBL1743043,MOXETUMOMAB PASUDOTOX,Black Box Warning,metabolic toxicity,,,,,United States
1121918,CHEMBL1743047,NECITUMUMAB,Black Box Warning,cardiotoxicity,,,,,United States
1121918,CHEMBL1743047,NECITUMUMAB,Black Box Warning,metabolic toxicity,,,,,United States
1121919,CHEMBL1743048,OBINUTUZUMAB,Black Box Warning,infectious disease,,,,,United States
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,Black Box Warning,hepatotoxicity,,,,,United States
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,Black Box Warning,cardiotoxicity,,,,,United States
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,Black Box Warning,teratogenicity,,,,,United States
577488,CHEMBL1747,TOBRAMYCIN,Black Box Warning,nephrotoxicity,,,,,United States
577488,CHEMBL1747,TOBRAMYCIN,Black Box Warning,teratogenicity,,,,,United States
577488,CHEMBL1747,TOBRAMYCIN,Black Box Warning,neurotoxicity,,,,,United States
581843,CHEMBL1753,CLINDAMYCIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
581843,CHEMBL1753,CLINDAMYCIN,Black Box Warning,infectious disease,,,,,United States
581843,CHEMBL1753,CLINDAMYCIN,Black Box Warning,misuse,,,,,United States
333157,CHEMBL177,AMIKACIN,Black Box Warning,,,,,,United States
596044,CHEMBL1770,LEVAMISOLE HYDROCHLORIDE,Withdrawn,neurotoxicity,Adverse effects that cause encephalitis and mortality,NCIT:C26760,Encephalitis,2000.0,Vietnam; China
596044,CHEMBL1770,LEVAMISOLE HYDROCHLORIDE,Withdrawn,neurotoxicity,Adverse effects that cause encephalitis and mortality,PATO:0001422,dead,2000.0,Vietnam; China
598402,CHEMBL1771,CLOPIDOGREL,Black Box Warning,,,,,,United States
598447,CHEMBL1773,CAPECITABINE,Black Box Warning,,,,,,United States
1152049,CHEMBL1788385,TILBROQUINOL,Withdrawn,hepatotoxicity,Hepatoxicity,EFO:0004228,drug-induced liver injury,1999.0,France; Saudi Arabia
1152049,CHEMBL1788385,TILBROQUINOL,Withdrawn,hepatotoxicity,Hepatoxicity,EFO:0011052,hepatotoxicity,1999.0,France; Saudi Arabia
1152050,CHEMBL1788386,TETRAMETHRIN,Withdrawn,carcinogenicity,Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman
1152067,CHEMBL1788403,BIOALLETHRIN,Withdrawn,carcinogenicity,Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,Black Box Warning,infectious disease,,,,,United States
1158403,CHEMBL1795072,ZICONOTIDE ACETATE,Black Box Warning,psychiatric toxicity,,,,,United States
1158403,CHEMBL1795072,ZICONOTIDE ACETATE,Black Box Warning,neurotoxicity,,,,,United States
1160053,CHEMBL1796998,SULFUR HEXAFLUORIDE,Black Box Warning,,,,,,United States
1162878,CHEMBL1801800,METABROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:1000753,phototoxic dermatitis,1975.0,United States; Japan
1162878,CHEMBL1801800,METABROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0000701,skin disease,1975.0,United States; Japan
1162878,CHEMBL1801800,METABROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0020984,skin sensitization,1975.0,United States; Japan
1162878,CHEMBL1801800,METABROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:1000753,phototoxic dermatitis,1975.0,United States; Japan
1162878,CHEMBL1801800,METABROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:0020984,skin sensitization,1975.0,United States; Japan
365284,CHEMBL182,GANCICLOVIR,Black Box Warning,carcinogenicity,,,,,United States
365284,CHEMBL182,GANCICLOVIR,Black Box Warning,hematological toxicity,,,,,United States
365284,CHEMBL182,GANCICLOVIR,Black Box Warning,teratogenicity,,,,,United States
1204084,CHEMBL1863513,INGENOL MEBUTATE,Withdrawn,carcinogenicity,"Increased risk of skin cancer, particularly squamous cell carcinoma",EFO:0000707,squamous cell carcinoma,2020.0,European Union; Canada
1204084,CHEMBL1863513,INGENOL MEBUTATE,Withdrawn,carcinogenicity,"Increased risk of skin cancer, particularly squamous cell carcinoma",EFO:0004198,skin neoplasm,2020.0,European Union; Canada
1204084,CHEMBL1863513,INGENOL MEBUTATE,Withdrawn,carcinogenicity,Increased risk of non-melanoma skin cancer,EFO:0009260,non-melanoma skin carcinoma,2020.0,European Union; Canada
1215321,CHEMBL1874750,CINEPAZIDE,Withdrawn,hematological toxicity,Agranulocytosis,HP:0012234,Agranulocytosis,1987.0,Spain
316600,CHEMBL187709,TRIPARANOL,Withdrawn,dermatological toxicity,"Cataracts, Alopecia, lchthyosis",MONDO:0004907,alopecia,1962.0,France; United States
316600,CHEMBL187709,TRIPARANOL,Withdrawn,dermatological toxicity,"Cataracts, Alopecia, lchthyosis",MONDO:0019269,ichthyosis,1962.0,France; United States
316600,CHEMBL187709,TRIPARANOL,Withdrawn,occular toxicity,"Cataracts, Alopecia, lchthyosis",MONDO:0005129,cataract,1962.0,France; United States
1228462,CHEMBL1887891,DEXFENFLURAMINE HYDROCHLORIDE,Withdrawn,respiratory toxicity,"Rare, but potentially fatal pulmonary artery hypertension",EFO:0001361,pulmonary arterial hypertension,1997.0,Malaysia; India; European Union; United Kingdom; Saudi Arabia; United States; Canada; France; Brazil; Lithuania; Morocco
1228462,CHEMBL1887891,DEXFENFLURAMINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Cardiac valvular disease,EFO:0009551,heart valve disease,1997.0,Malaysia; India; European Union; United Kingdom; Saudi Arabia; United States; Canada; France; Brazil; Lithuania; Morocco
1228462,CHEMBL1887891,DEXFENFLURAMINE HYDROCHLORIDE,Withdrawn,,Reasons of safety,,,1997.0,Malaysia; India; European Union; United Kingdom; Saudi Arabia; United States; Canada; France; Brazil; Lithuania; Morocco
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",HP:0001250,Seizure,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,vascular toxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",EFO:0005251,hypotension,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",MONDO:0015346,Jeavons syndrome,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",EFO:0000612,myocardial infarction,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,risk of serious neurological and cardiac side effects in patients when buflomedil is used normally,EFO:0000612,myocardial infarction,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,risk of serious neurological and cardiac side effects in patients when buflomedil is used normally,HP:0001649,Tachycardia,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,"Low efficacy and with regards to a risk of serious side- effects linked to neurological and cardiac misuse (non- compliance with the indication, contraindications, dosage, and monitoring of renal function) and the therapeutic range is narrow; Severe and sometimes fatal cardiovascular and neurological risks related to drug overdose; Risks of severe cardiological and neurological adverse reactions",EFO:1001482,cardiotoxicity,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,"Low efficacy and with regards to a risk of serious side- effects linked to neurological and cardiac misuse (non- compliance with the indication, contraindications, dosage, and monitoring of renal function) and the therapeutic range is narrow; Severe and sometimes fatal cardiovascular and neurological risks related to drug overdose; Risks of severe cardiological and neurological adverse reactions",EFO:0011057,neurotoxicity,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,drug misuse,"Low efficacy and with regards to a risk of serious side- effects linked to neurological and cardiac misuse (non- compliance with the indication, contraindications, dosage, and monitoring of renal function) and the therapeutic range is narrow; Severe and sometimes fatal cardiovascular and neurological risks related to drug overdose; Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",EFO:0020911,overdose,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",EFO:0005306,ventricular tachycardia,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,risk of serious neurological and cardiac side effects in patients when buflomedil is used normally,HP:0001250,Seizure,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,risk of serious neurological and cardiac side effects in patients when buflomedil is used normally,EFO:0008526,status epilepticus,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,neurotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",EFO:0008526,status epilepticus,2011.0,France; European Union; Madagascar; Brazil
316539,CHEMBL188921,BUFLOMEDIL,Withdrawn,cardiotoxicity,"Serious nervous (convulsions, myoclonia and status epilepticus) and cardiac (tachycardia, hypotension, ventricular rhythm disorders and cardiac arrest) events especially in accidental overdose or voluntary overdose",HP:0001649,Tachycardia,2011.0,France; European Union; Madagascar; Brazil
314827,CHEMBL188952,PIRPROFEN,Withdrawn,hepatotoxicity,"Reports of serious adverse effects, in particular cases of liver toxicity, some of which were fatal",EFO:0004228,drug-induced liver injury,1990.0,Worldwide
314827,CHEMBL188952,PIRPROFEN,Withdrawn,hepatotoxicity,"Reports of serious adverse effects, in particular cases of liver toxicity, some of which were fatal",EFO:0011052,hepatotoxicity,1990.0,Worldwide
314827,CHEMBL188952,PIRPROFEN,Withdrawn,gastrointestinal toxicity,Gastrointestinal Toxicity; Hepatotoxicity,EFO:0011050,gastrointestinal toxicity,1990.0,Worldwide
314827,CHEMBL188952,PIRPROFEN,Withdrawn,hepatotoxicity,Gastrointestinal Toxicity; Hepatotoxicity,EFO:0011052,hepatotoxicity,1990.0,Worldwide
314827,CHEMBL188952,PIRPROFEN,Withdrawn,hepatotoxicity,Gastrointestinal Toxicity; Hepatotoxicity,EFO:0004228,drug-induced liver injury,1990.0,Worldwide
21459,CHEMBL19019,NALTREXONE,Black Box Warning,,,,,,United States
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,"adverse effects on survival, and that beneficial effects on the symptoms of heart failure did not last beyond the first 3 months of therapy; After the first 3 months of therapy, patients on the drug had a higher rate of hospitalization than patients taking a placebo",EFO:0020922,hospitalisation,1993.0,United States; United Kingdom
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,Increased mortality at higher doses; increased hospitalizations,PATO:0001422,dead,1993.0,United States; United Kingdom
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,Increased mortality at higher doses; increased hospitalizations,EFO:0020002,lack of efficacy,1993.0,United States; United Kingdom
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,Increased mortality at higher doses; increased hospitalizations,EFO:0020922,hospitalisation,1993.0,United States; United Kingdom
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,"adverse effects on survival, and that beneficial effects on the symptoms of heart failure did not last beyond the first 3 months of therapy; After the first 3 months of therapy, patients on the drug had a higher rate of hospitalization than patients taking a placebo",EFO:0020002,lack of efficacy,1993.0,United States; United Kingdom
1248678,CHEMBL1908307,FLOSEQUINAN,Withdrawn,,"adverse effects on survival, and that beneficial effects on the symptoms of heart failure did not last beyond the first 3 months of therapy; After the first 3 months of therapy, patients on the drug had a higher rate of hospitalization than patients taking a placebo",PATO:0001422,dead,1993.0,United States; United Kingdom
1248719,CHEMBL1908348,SPARTEINE SULFATE,Withdrawn,,unpredictable effects and was associated with tetanic uterine contractions and obstetrical complications,EFO:0009888,trauma complication,1979.0,United States
1248719,CHEMBL1908348,SPARTEINE SULFATE,Withdrawn,,unpredictable effects and was associated with tetanic uterine contractions and obstetrical complications,EFO:0020915,uterine hyperstimulation,1979.0,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,immune system toxicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,vascular toxicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,nephrotoxicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,carcinogenicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,infectious disease,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,neurotoxicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,musculoskeletal toxicity,,,,,United States
1248731,CHEMBL1908360,EVEROLIMUS,Black Box Warning,cardiotoxicity,,,,,United States
1248733,CHEMBL1908362,GADOFOSVESET TRISODIUM,Black Box Warning,,,,,,United States
1248996,CHEMBL1909072,PIPAMAZINE,Withdrawn,hepatotoxicity,associated with hepatic lesions,EFO:0011052,hepatotoxicity,1969.0,United States
1248996,CHEMBL1909072,PIPAMAZINE,Withdrawn,hepatotoxicity,associated with hepatic lesions,EFO:0020920,hepatic lesion,1969.0,United States
1248996,CHEMBL1909072,PIPAMAZINE,Withdrawn,hepatotoxicity,associated with hepatic lesions,EFO:0004228,drug-induced liver injury,1969.0,United States
1249052,CHEMBL1909282,FENCLOZIC ACID,Withdrawn,hepatotoxicity,Jaundice; Elevated Hepatic Enzymes,EFO:0004228,drug-induced liver injury,1970.0,United States; United Kingdom
1249052,CHEMBL1909282,FENCLOZIC ACID,Withdrawn,hepatotoxicity,Jaundice; Elevated Hepatic Enzymes,HP:0000952,Jaundice,1970.0,United States; United Kingdom
1249052,CHEMBL1909282,FENCLOZIC ACID,Withdrawn,hepatotoxicity,Jaundice; Elevated Hepatic Enzymes,EFO:0011052,hepatotoxicity,1970.0,United States; United Kingdom
1249052,CHEMBL1909282,FENCLOZIC ACID,Withdrawn,hepatotoxicity,Jaundice; Elevated Hepatic Enzymes,HP:0002910,Elevated circulating hepatic transaminase concentration,1970.0,United States; United Kingdom
1249053,CHEMBL1909283,MEBANAZINE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0004228,drug-induced liver injury,1975.0,United Kingdom
1249053,CHEMBL1909283,MEBANAZINE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0011052,hepatotoxicity,1975.0,United Kingdom
1249053,CHEMBL1909283,MEBANAZINE,Withdrawn,,Hepatotoxicity; Drug Interaction,EFO:0009878,drug interaction,1975.0,United Kingdom
1249055,CHEMBL1909285,NITREFAZOLE,Withdrawn,hematological toxicity,Hepatic and Hematologic Toxicity,EFO:0011051,hematological toxicity,1984.0,Germany; Austria
1249055,CHEMBL1909285,NITREFAZOLE,Withdrawn,hepatotoxicity,Hepatic and Hematologic Toxicity,EFO:0011052,hepatotoxicity,1984.0,Germany; Austria
1249055,CHEMBL1909285,NITREFAZOLE,Withdrawn,hepatotoxicity,"associated with hepatotoxic reactions, some of which were fatal",EFO:0004228,drug-induced liver injury,1984.0,Germany; Austria
1249055,CHEMBL1909285,NITREFAZOLE,Withdrawn,hepatotoxicity,"associated with hepatotoxic reactions, some of which were fatal",EFO:0011052,hepatotoxicity,1984.0,Germany; Austria
1249055,CHEMBL1909285,NITREFAZOLE,Withdrawn,hepatotoxicity,Hepatic and Hematologic Toxicity,EFO:0004228,drug-induced liver injury,1984.0,Germany; Austria
1249056,CHEMBL1909286,PHENOXYPROPAZINE,Withdrawn,,Hepatotoxicity; Drug Interaction,EFO:0009878,drug interaction,1966.0,United Kingdom
1249056,CHEMBL1909286,PHENOXYPROPAZINE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0011052,hepatotoxicity,1966.0,United Kingdom
1249056,CHEMBL1909286,PHENOXYPROPAZINE,Withdrawn,hepatotoxicity,Hepatotoxicity; Drug Interaction,EFO:0004228,drug-induced liver injury,1966.0,United Kingdom
1249058,CHEMBL1909288,TRIACETYLDIPHENOLISATIN,Withdrawn,hepatotoxicity,acute and chronic liver disease,EFO:0011052,hepatotoxicity,1971.0,Australia; Germany; Cyprus; Italy
1249058,CHEMBL1909288,TRIACETYLDIPHENOLISATIN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1971.0,Australia; Germany; Cyprus; Italy
1249058,CHEMBL1909288,TRIACETYLDIPHENOLISATIN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1971.0,Australia; Germany; Cyprus; Italy
1249058,CHEMBL1909288,TRIACETYLDIPHENOLISATIN,Withdrawn,immune system toxicity,risk of sensitization,EFO:1002003,hypersensitivity reaction disease,1971.0,Australia; Germany; Cyprus; Italy
1249058,CHEMBL1909288,TRIACETYLDIPHENOLISATIN,Withdrawn,hepatotoxicity,acute and chronic liver disease,EFO:0004228,drug-induced liver injury,1971.0,Australia; Germany; Cyprus; Italy
1249059,CHEMBL1909289,XENAZOIC ACID,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1965.0,France; Belgium
1249059,CHEMBL1909289,XENAZOIC ACID,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1965.0,France; Belgium
23198,CHEMBL19393,LEVAMFETAMINE,Withdrawn,drug misuse,evidence of abuse and high risk of dependence,MONDO:0002491,substance abuse,1973.0,United States
23198,CHEMBL19393,LEVAMFETAMINE,Withdrawn,drug misuse,evidence of abuse and high risk of dependence,MONDO:0004938,substance dependence,1973.0,United States
1277553,CHEMBL1946170,REGORAFENIB,Black Box Warning,hepatotoxicity,,,,,United States
23001,CHEMBL19490,ZOMEPIRAC,Withdrawn,immune system toxicity,"serious allergic reactions, including five deaths from anaphylaxis",EFO:0009482,drug allergy,1983.0,Worldwide
23001,CHEMBL19490,ZOMEPIRAC,Withdrawn,immune system toxicity,"serious allergic reactions, including five deaths from anaphylaxis",MONDO:0100053,anaphylaxis,1983.0,Worldwide
1279554,CHEMBL1950576,DIHYDROSTREPTOMYCIN,Withdrawn,ototoxicity,Severe vestibular damage,EFO:0009691,vestibular disease,1970.0,Philippines; Dominican Republic; United States
1279554,CHEMBL1950576,DIHYDROSTREPTOMYCIN,Withdrawn,ototoxicity,Can cause deafness,EFO:0001063,deafness,1970.0,Philippines; Dominican Republic; United States
1285395,CHEMBL1963684,PEGINESATIDE ACETATE,Black Box Warning,,,,,,United States
1285395,CHEMBL1963684,PEGINESATIDE ACETATE,Withdrawn,immune system toxicity,"serious hypersensitivity reactions, including anaphylaxis, which can be life-threatening or fatal.",EFO:1002003,hypersensitivity reaction disease,2019.0,United States
1285395,CHEMBL1963684,PEGINESATIDE ACETATE,Withdrawn,immune system toxicity,"serious hypersensitivity reactions, including anaphylaxis, which can be life-threatening or fatal.",MONDO:0100053,anaphylaxis,2019.0,United States
1285397,CHEMBL1964120,TALIGLUCERASE ALFA,Black Box Warning,infectious disease,,,,,United States
1285397,CHEMBL1964120,TALIGLUCERASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,nephrotoxicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,hematological toxicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,carcinogenicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,teratogenicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,hepatotoxicity,,,,,United States
1298870,CHEMBL1977579,STREPTOZOCIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
328601,CHEMBL198362,RIVAROXABAN,Black Box Warning,vascular toxicity,,,,,United States
1320257,CHEMBL1998966,PIFOXIME,Withdrawn,psychiatric toxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1976.0,France
1320257,CHEMBL1998966,PIFOXIME,Withdrawn,neurotoxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1976.0,France
1125,CHEMBL20,ACETAZOLAMIDE,Black Box Warning,dermatological toxicity,,,,,United States
1125,CHEMBL20,ACETAZOLAMIDE,Black Box Warning,hepatotoxicity,,,,,United States
1328912,CHEMBL2007641,PERTUZUMAB,Black Box Warning,teratogenicity,,,,,United States
1328912,CHEMBL2007641,PERTUZUMAB,Black Box Warning,cardiotoxicity,,,,,United States
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
1340277,CHEMBL2028019,CARIPRAZINE,Black Box Warning,,,,,,United States
341064,CHEMBL203321,BRINCIDOFOVIR,Black Box Warning,,,,,,United States
1355926,CHEMBL2062335,METOPROLOL TARTRATE,Black Box Warning,cardiotoxicity,,,,,United States
348726,CHEMBL207538,BREXANOLONE,Black Box Warning,cardiotoxicity,,,,,United States
1369640,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,Black Box Warning,,,,,,United States
1369640,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,Black Box Warning,misuse,,,,,United States
1376006,CHEMBL2103736,FENOPROFEN CALCIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
1376006,CHEMBL2103736,FENOPROFEN CALCIUM,Black Box Warning,neurotoxicity,,,,,United States
1376006,CHEMBL2103736,FENOPROFEN CALCIUM,Black Box Warning,cardiotoxicity,,,,,United States
1376006,CHEMBL2103736,FENOPROFEN CALCIUM,Black Box Warning,vascular toxicity,,,,,United States
1376008,CHEMBL2103738,LITHIUM CITRATE,Black Box Warning,misuse,,,,,United States
1376010,CHEMBL2103740,GADOXETATE DISODIUM,Black Box Warning,dermatological toxicity,,,,,United States
1376011,CHEMBL2103741,LEVOTHYROXINE SODIUM,Black Box Warning,,,,,,United States
1376013,CHEMBL2103743,TOFACITINIB CITRATE,Black Box Warning,carcinogenicity,,,,,United States
1376013,CHEMBL2103743,TOFACITINIB CITRATE,Black Box Warning,vascular toxicity,,,,,United States
1376013,CHEMBL2103743,TOFACITINIB CITRATE,Black Box Warning,infectious disease,,,,,United States
1376014,CHEMBL2103744,MORPHINE SULFATE,Black Box Warning,respiratory toxicity,,,,,United States
1376014,CHEMBL2103744,MORPHINE SULFATE,Black Box Warning,misuse,,,,,United States
1376065,CHEMBL2103795,AZILSARTAN KAMEDOXOMIL,Black Box Warning,teratogenicity,,,,,United States
1376097,CHEMBL2103827,DROXIDOPA,Black Box Warning,vascular toxicity,,,,,United States
1376137,CHEMBL2103867,PLECANATIDE,Black Box Warning,,,,,,United States
1376138,CHEMBL2103868,CABOZANTINIB S-MALATE,Black Box Warning,,,,,,United States
1376143,CHEMBL2103873,MACITENTAN,Black Box Warning,teratogenicity,,,,,United States
1376406,CHEMBL2104136,CLOMACRAN PHOSPHATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1982.0,United Kingdom
1376406,CHEMBL2104136,CLOMACRAN PHOSPHATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1982.0,United Kingdom
1376557,CHEMBL2104287,DIBENZEPIN HYDROCHLORIDE,Withdrawn,drug misuse,Unexpectedly high number of fatal suicidal attempts,EFO:0011049,drug misuse,1983.0,Sweden
1376759,CHEMBL2104489,ANAGESTONE ACETATE,Withdrawn,carcinogenicity,Animal Carcinogenicity,EFO:0011046,carcinogenicity,1969.0,Germany; Austria
1376807,CHEMBL2104537,AMOPROXAN,Withdrawn,dermatological toxicity,Dermatologic and Ophthalmic Toxicity,EFO:0011048,dermatological toxicity,1970.0,France
1376807,CHEMBL2104537,AMOPROXAN,Withdrawn,occular toxicity,Dermatologic and Ophthalmic Toxicity,EFO:0020928,occular toxicity,1970.0,France
1377063,CHEMBL2104793,PYROVALERONE HYDROCHLORIDE,Withdrawn,drug misuse,Misuse and abuse,MONDO:0002491,substance abuse,1979.0,France
1377180,CHEMBL2104910,SULFADICRAMIDE,Withdrawn,,benefit/risk ratio for these products is negative,,,1992.0,Germany
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,link between pholcodine use within the previous 12 months preceding general anaesthesia where neuromuscular blocking agents (NMBAs) are administered and a risk of anaphylactic reaction to NMBAs,EFO:0009878,drug interaction,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,Anaphylaxis to neuromuscular blocking agents (NMBAs) used in general anaesthesia,EFO:0009878,drug interaction,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,immune system toxicity,"use of pholcodine in the 12 months before general anaesthesia with neuromuscular blocking agents (NMBA) is a risk factor for developing an anaphylactic reaction (a sudden, severe and life-threatening allergic reaction) to NMBAs",MONDO:0100053,anaphylaxis,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,immune system toxicity,Anaphylaxis to neuromuscular blocking agents (NMBAs) used in general anaesthesia,MONDO:0100053,anaphylaxis,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,may predispose patients to anaphylaxis (a rare but life-threatening allergic reaction) during surgery. Patients who require surgery involving neuromuscular blocking agents (NMBAs) may be more likely to experience anaphylaxis,EFO:0009878,drug interaction,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,"risk of anaphylactic reactions (a sudden, severe and life-threatening allergic reaction) to medicines called neuromuscular blocking agents (NMBAs) which are used as muscle relaxants during general anaesthesia",EFO:0009878,drug interaction,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,"quality, safety or efficacy of the goods was unacceptable",,,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,immune system toxicity,may predispose patients to anaphylaxis (a rare but life-threatening allergic reaction) during surgery. Patients who require surgery involving neuromuscular blocking agents (NMBAs) may be more likely to experience anaphylaxis,MONDO:0100053,anaphylaxis,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,immune system toxicity,link between pholcodine use within the previous 12 months preceding general anaesthesia where neuromuscular blocking agents (NMBAs) are administered and a risk of anaphylactic reaction to NMBAs,MONDO:0100053,anaphylaxis,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,,"use of pholcodine in the 12 months before general anaesthesia with neuromuscular blocking agents (NMBA) is a risk factor for developing an anaphylactic reaction (a sudden, severe and life-threatening allergic reaction) to NMBAs",EFO:0009878,drug interaction,2022.0,New Zealand; European Union; Australia; United Kingdom
1377494,CHEMBL2105224,PHOLCODINE,Withdrawn,immune system toxicity,"risk of anaphylactic reactions (a sudden, severe and life-threatening allergic reaction) to medicines called neuromuscular blocking agents (NMBAs) which are used as muscle relaxants during general anaesthesia",MONDO:0100053,anaphylaxis,2022.0,New Zealand; European Union; Australia; United Kingdom
1377503,CHEMBL2105233,PROXIBARBAL,Withdrawn,immune system toxicity,Immunoallergic Thrombocytopenia,EFO:0007160,autoimmune thrombocytopenic purpura,1998.0,France; Turkey; Portugal; Italy; Spain
1377503,CHEMBL2105233,PROXIBARBAL,Withdrawn,hematological toxicity,Immunoallergic Thrombocytopenia,EFO:0007160,autoimmune thrombocytopenic purpura,1998.0,France; Turkey; Portugal; Italy; Spain
1377545,CHEMBL2105275,PROPYLHEXEDRINE,Withdrawn,,unfavourable benefit/risk balance,,,2000.0,Oman
1377615,CHEMBL2105345,PROPANIDID,Withdrawn,immune system toxicity,Allergy,EFO:0009482,drug allergy,1983.0,United Kingdom
1377615,CHEMBL2105345,PROPANIDID,Withdrawn,immune system toxicity,Allergy,EFO:1002003,hypersensitivity reaction disease,1983.0,United Kingdom
1377665,CHEMBL2105395,OSPEMIFENE,Black Box Warning,vascular toxicity,,,,,United States
1377665,CHEMBL2105395,OSPEMIFENE,Black Box Warning,cardiotoxicity,,,,,United States
1377665,CHEMBL2105395,OSPEMIFENE,Black Box Warning,neurotoxicity,,,,,United States
1377665,CHEMBL2105395,OSPEMIFENE,Black Box Warning,carcinogenicity,,,,,United States
1377728,CHEMBL2105458,THENALIDINE,Withdrawn,hematological toxicity,Agranulocytosis,HP:0012234,Agranulocytosis,1958.0,United States; United Kingdom; Sweden; Norway; Cyprus; Australia; Finland; France
1377728,CHEMBL2105458,THENALIDINE,Withdrawn,hematological toxicity,neutropenia,MONDO:0001475,neutropenia,1958.0,United States; United Kingdom; Sweden; Norway; Cyprus; Australia; Finland; France
1377767,CHEMBL2105497,ZIPEPROL,Withdrawn,,deaths,PATO:0001422,dead,1982.0,Brazil; Philippines
1377767,CHEMBL2105497,ZIPEPROL,Withdrawn,respiratory toxicity,respiratory arrest,EFO:0011060,Respiratory toxicity,1982.0,Brazil; Philippines
1377797,CHEMBL2105527,TETRAZEPAM,Withdrawn,dermatological toxicity,"low but increased risk of serious skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis and drug-rash-with-eosinophilia-and-systemic-symptoms (DRESS) syndrome)",EFO:0004276,Stevens-Johnson syndrome,2013.0,European Union
1377797,CHEMBL2105527,TETRAZEPAM,Withdrawn,dermatological toxicity,"low but increased risk of serious skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis and drug-rash-with-eosinophilia-and-systemic-symptoms (DRESS) syndrome)",EFO:0004775,toxic epidermal necrolysis,2013.0,European Union
1377797,CHEMBL2105527,TETRAZEPAM,Withdrawn,dermatological toxicity,"low but increased risk of serious skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis and drug-rash-with-eosinophilia-and-systemic-symptoms (DRESS) syndrome)",EFO:1002004,drug hypersensitivity syndrome,2013.0,European Union
1377836,CHEMBL2105566,FENPROPOREX,Withdrawn,,unfavourable benefit/risk balance,,,1999.0,Portugal; France; Oman
1377836,CHEMBL2105566,FENPROPOREX,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1999.0,Portugal; France; Oman
1377851,CHEMBL2105581,VERALIPRIDE,Withdrawn,psychiatric toxicity,depressive and anxiety states,MONDO:0002009,major depressive disorder,2005.0,European Union; Spain
1377851,CHEMBL2105581,VERALIPRIDE,Withdrawn,neurotoxicity,tardive dyskinesias,EFO:0004280,movement disorder,2005.0,European Union; Spain
1377851,CHEMBL2105581,VERALIPRIDE,Withdrawn,neurotoxicity,"Depression, anxiety, sleep disorders, tremor (shaking) and tardive dyskinesia",HP:0001337,Tremor,2005.0,European Union; Spain
1377851,CHEMBL2105581,VERALIPRIDE,Withdrawn,psychiatric toxicity,depressive and anxiety states,EFO:0005230,anxiety,2005.0,European Union; Spain
1377851,CHEMBL2105581,VERALIPRIDE,Withdrawn,psychiatric toxicity,"Depression, anxiety, sleep disorders, tremor (shaking) and tardive dyskinesia",EFO:0008568,Sleep Disorder,2005.0,European Union; Spain
1377883,CHEMBL2105613,DIVALPROEX SODIUM,Black Box Warning,hepatotoxicity,,,,,United States
1377883,CHEMBL2105613,DIVALPROEX SODIUM,Black Box Warning,teratogenicity,,,,,United States
1377883,CHEMBL2105613,DIVALPROEX SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
1377908,CHEMBL2105638,DELAFLOXACIN MEGLUMINE,Black Box Warning,neurotoxicity,,,,,United States
1377908,CHEMBL2105638,DELAFLOXACIN MEGLUMINE,Black Box Warning,musculoskeletal toxicity,,,,,United States
1377918,CHEMBL2105648,PALOVAROTENE,Black Box Warning,,,,,,United States
1377932,CHEMBL2105662,LOMITAPIDE MESYLATE,Black Box Warning,hepatotoxicity,,,,,United States
1377952,CHEMBL2105682,EDOXABAN TOSYLATE,Black Box Warning,,,,,,United States
1377970,CHEMBL2105700,BEDAQUILINE FUMARATE,Black Box Warning,cardiotoxicity,,,,,United States
1377978,CHEMBL2105708,PONATINIB HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
1377978,CHEMBL2105708,PONATINIB HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
1377978,CHEMBL2105708,PONATINIB HYDROCHLORIDE,Black Box Warning,neurotoxicity,,,,,United States
1377978,CHEMBL2105708,PONATINIB HYDROCHLORIDE,Black Box Warning,vascular toxicity,,,,,United States
1377979,CHEMBL2105709,QUIZARTINIB DIHYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
1377990,CHEMBL2105720,LESINURAD,Black Box Warning,,,,,,United States
1378002,CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
1378010,CHEMBL2105740,SITAXENTAN SODIUM,Withdrawn,hepatotoxicity,Liver toxicity,EFO:0004228,drug-induced liver injury,2010.0,Worldwide
1378010,CHEMBL2105740,SITAXENTAN SODIUM,Withdrawn,hepatotoxicity,Liver toxicity,EFO:0011052,hepatotoxicity,2010.0,Worldwide
1378010,CHEMBL2105740,SITAXENTAN SODIUM,Withdrawn,hepatotoxicity,Liver damage,EFO:0004228,drug-induced liver injury,2010.0,Worldwide
1378010,CHEMBL2105740,SITAXENTAN SODIUM,Withdrawn,hepatotoxicity,Liver damage,EFO:0011052,hepatotoxicity,2010.0,Worldwide
1378029,CHEMBL2105759,BARICITINIB,Black Box Warning,vascular toxicity,,,,,United States
1378029,CHEMBL2105759,BARICITINIB,Black Box Warning,carcinogenicity,,,,,United States
1378029,CHEMBL2105759,BARICITINIB,Black Box Warning,respiratory toxicity,,,,,United States
1378029,CHEMBL2105759,BARICITINIB,Black Box Warning,infectious disease,,,,,United States
1378030,CHEMBL2105760,BREXPIPRAZOLE,Black Box Warning,psychiatric toxicity,,,,,United States
1378097,CHEMBL2105827,"GLYCEROL, IODINATED",Withdrawn,carcinogenicity,Increased occurrence of cancer,EFO:0011046,carcinogenicity,1993.0,United States
1378211,CHEMBL2105941,AMOBARBITAL SODIUM,Withdrawn,drug misuse,Self-Poisonings,EFO:0008546,poisoning,1980.0,Norway; Sweden
1378425,CHEMBL2106155,ENCAINIDE HYDROCHLORIDE,Withdrawn,cardiotoxicity,associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack,PATO:0001422,dead,1991.0,United States; United Kingdom
1378487,CHEMBL2106217,FENFLURAMINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
1378487,CHEMBL2106217,FENFLURAMINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Valvulopathy,EFO:0009551,heart valve disease,1997.0,France; China; United States
1378826,CHEMBL2106556,CYCLOBARBITAL CALCIUM,Withdrawn,drug misuse,Self-poisonings,EFO:0008546,poisoning,1980.0,Norway
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,teratogenicity,,,,,United States
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,carcinogenicity,,,,,United States
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,immune system toxicity,,,,,United States
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,infectious disease,,,,,United States
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
1379064,CHEMBL2106794,NAFTAZONE,Withdrawn,,unfavourable risk-benefit profile,,,2002.0,Spain
1379099,CHEMBL2106829,METHAQUALONE HYDROCHLORIDE,Withdrawn,drug misuse,Overdose,EFO:0020911,overdose,1984.0,United States
1379177,CHEMBL2106907,METHIODAL SODIUM,Withdrawn,musculoskeletal toxicity,"induced muscle spasms in some patients subjected to myelography, presumably because of an irritant action on motor nerve roots .Registration was withdrawn when a safer X-ray contrast medium was introduced",NCIT:C50656,Muscle Spasm,1975.0,Sweden
1379185,CHEMBL2106915,METHOPHOLINE,Withdrawn,occular toxicity,associated with ophthalmic changes and corneal opacities in dogs,HP:0007957,Corneal opacity,1965.0,United States
1379185,CHEMBL2106915,METHOPHOLINE,Withdrawn,occular toxicity,associated with ophthalmic changes and corneal opacities in dogs,HP:0000505,Visual impairment,1965.0,United States
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,Black Box Warning,immune system toxicity,,,,,United States
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,Black Box Warning,neurotoxicity,,,,,United States
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,Black Box Warning,vascular toxicity,,,,,United States
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,Black Box Warning,respiratory toxicity,,,,,United States
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,Black Box Warning,cardiotoxicity,,,,,United States
1379509,CHEMBL2107239,IOXITALAMIC ACID,Withdrawn,vascular toxicity,"Severe adverse reactions including hypotension, arrhythmias, pulmonary oedema and renal disorders",EFO:0005251,hypotension,1998.0,Germany
1379509,CHEMBL2107239,IOXITALAMIC ACID,Withdrawn,nephrotoxicity,"Severe adverse reactions including hypotension, arrhythmias, pulmonary oedema and renal disorders",EFO:0003086,kidney disease,1998.0,Germany
1379509,CHEMBL2107239,IOXITALAMIC ACID,Withdrawn,cardiotoxicity,"Severe adverse reactions including hypotension, arrhythmias, pulmonary oedema and renal disorders",EFO:0004269,cardiac arrhythmia,1998.0,Germany
1379509,CHEMBL2107239,IOXITALAMIC ACID,Withdrawn,respiratory toxicity,"Severe adverse reactions including hypotension, arrhythmias, pulmonary oedema and renal disorders",EFO:1001134,pulmonary edema,1998.0,Germany
1379523,CHEMBL2107253,SULFADIMETHOXINE SODIUM,Withdrawn,,associated with Stevens-Johnson syndrome and fatalities,PATO:0001422,dead,1966.0,United States
1379523,CHEMBL2107253,SULFADIMETHOXINE SODIUM,Withdrawn,dermatological toxicity,associated with Stevens-Johnson syndrome and fatalities,EFO:0004276,Stevens-Johnson syndrome,1966.0,United States
1379530,CHEMBL2107260,SULFAMERAZINE SODIUM,Withdrawn,,benefit/risk ratio for these products is negative,,,1992.0,Germany
1379630,CHEMBL2107360,PALIPERIDONE PALMITATE,Black Box Warning,psychiatric toxicity,,,,,United States
1379630,CHEMBL2107360,PALIPERIDONE PALMITATE,Black Box Warning,,,,,,United States
1379656,CHEMBL2107386,VORAPAXAR SULFATE,Black Box Warning,vascular toxicity,,,,,United States
1379657,CHEMBL2107387,VORTIOXETINE HYDROBROMIDE,Black Box Warning,psychiatric toxicity,,,,,United States
1379701,CHEMBL2107431,LYNESTRENOL,Withdrawn,carcinogenicity,dose-related incidence of mammary tumours in the beagle bitch,EFO:0011046,carcinogenicity,1980.0,Australia
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hematological toxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",EFO:0005558,hemolytic anemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,metabolic toxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",HP:0001943,Hypoglycemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hematological toxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",EFO:0005558,hemolytic anemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",EFO:0004228,drug-induced liver injury,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",HP:0012115,Hepatitis,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hematological toxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",EFO:0005558,hemolytic anemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,metabolic toxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",HP:0001943,Hypoglycemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",EFO:0004228,drug-induced liver injury,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,nephrotoxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",EFO:1002048,kidney failure,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,nephrotoxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",EFO:1002048,kidney failure,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",EFO:0011052,hepatotoxicity,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,nephrotoxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",EFO:1002048,kidney failure,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,immune system toxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",MONDO:0100053,anaphylaxis,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,immune system toxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",MONDO:0100053,anaphylaxis,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",HP:0002910,Elevated circulating hepatic transaminase concentration,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",EFO:0011052,hepatotoxicity,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",EFO:0011052,hepatotoxicity,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,metabolic toxicity,"hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and anaphylactic reactions",HP:0001943,Hypoglycemia,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hepatotoxicity,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",EFO:0004228,drug-induced liver injury,1992.0,Worldwide
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,Withdrawn,hematological toxicity,"associated with hypoglycemia in elderly patients, as well as a constellation of multisystem organ involvement characterized by hemolytic anemia, frequently associated with renal failure, markedly abnormal liver tests, and coagulopathy",EFO:0009314,blood coagulation disease,1992.0,Worldwide
1379789,CHEMBL2107519,CHLORNAPHAZINE,Withdrawn,carcinogenicity,Carcinogenic especially in the bladder,EFO:0011046,carcinogenicity,1964.0,Denmark
1379824,CHEMBL2107554,SODIUM DIBUNATE,Withdrawn,neurotoxicity,central nervous system toxicity in experimental mice. Prolonged administration in humans results in reduction in granular leukocytes,EFO:0011057,neurotoxicity,1982.0,Philippines
1379824,CHEMBL2107554,SODIUM DIBUNATE,Withdrawn,hematological toxicity,central nervous system toxicity in experimental mice. Prolonged administration in humans results in reduction in granular leukocytes,EFO:0011051,hematological toxicity,1982.0,Philippines
1380104,CHEMBL2107834,RIOCIGUAT,Black Box Warning,teratogenicity,,,,,United States
1380106,CHEMBL2107840,PATIROMER CALCIUM,Black Box Warning,,,,,,United States
1380107,CHEMBL2107841,ALBIGLUTIDE,Black Box Warning,carcinogenicity,,,,,United States
1380123,CHEMBL2107857,METRELEPTIN,Black Box Warning,carcinogenicity,,,,,United States
1380123,CHEMBL2107857,METRELEPTIN,Black Box Warning,infectious disease,,,,,United States
1380123,CHEMBL2107857,METRELEPTIN,Black Box Warning,teratogenicity,,,,,United States
1380140,CHEMBL2107874,ROMOSOZUMAB,Black Box Warning,gastrointestinal toxicity,,,,,United States
1380140,CHEMBL2107874,ROMOSOZUMAB,Black Box Warning,neurotoxicity,,,,,United States
1380140,CHEMBL2107874,ROMOSOZUMAB,Black Box Warning,vascular toxicity,,,,,United States
1380140,CHEMBL2107874,ROMOSOZUMAB,Black Box Warning,cardiotoxicity,,,,,United States
1380150,CHEMBL2107884,RESLIZUMAB,Black Box Warning,immune system toxicity,,,,,United States
1380168,CHEMBL2107902,TECHNETIUM TC 99M FANOLESOMAB,Withdrawn,vascular toxicity,"Life-threatening adverse events , mortality (inc. included shortness of breath, low blood pressure, and cardiopulmonary arrest)",EFO:0005251,hypotension,2005.0,United States
1380168,CHEMBL2107902,TECHNETIUM TC 99M FANOLESOMAB,Withdrawn,cardiotoxicity,"Life-threatening adverse events , mortality (inc. included shortness of breath, low blood pressure, and cardiopulmonary arrest)",EFO:0009492,cardiac arrest,2005.0,United States
1380168,CHEMBL2107902,TECHNETIUM TC 99M FANOLESOMAB,Withdrawn,respiratory toxicity,"Life-threatening adverse events , mortality (inc. included shortness of breath, low blood pressure, and cardiopulmonary arrest)",EFO:0009444,hypoxia,2005.0,United States
1380168,CHEMBL2107902,TECHNETIUM TC 99M FANOLESOMAB,Withdrawn,respiratory toxicity,"Life-threatening adverse events , mortality (inc. included shortness of breath, low blood pressure, and cardiopulmonary arrest)",HP:0002094,Dyspnea,2005.0,United States
1380209,CHEMBL2107943,POLIDEXIDE SULFATE,Withdrawn,dermatological toxicity,evidence of oculo-mucocutaneous syndrome,EFO:0020917,oculomucocutaneous syndrome,1977.0,United Kingdom
1380293,CHEMBL2108027,DULAGLUTIDE,Black Box Warning,carcinogenicity,,,,,United States
1380301,CHEMBL2108035,INCOBOTULINUMTOXINA,Black Box Warning,,,,,,United States
1380344,CHEMBL2108078,PARATHYROID HORMONE,Black Box Warning,carcinogenicity,,,,,United States
1380405,CHEMBL2108139,POVIDONE,Withdrawn,dermatological toxicity,may cause storage disease with the formation of granulomas,HP:0032252,Granuloma,1978.0,United States
1380577,CHEMBL2108311,ASFOTASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
1380732,CHEMBL2108466,GINKGO,Withdrawn,immune system toxicity,"anaphylactic symptoms (shock, fever, leukocytosis, and cardiac arrhythmia), in some cases life-threatening",MONDO:0100053,anaphylaxis,1998.0,Germany
1380774,CHEMBL2108508,INTERFERON ALFA-2A,Black Box Warning,,,,,,United States
1380811,CHEMBL2108545,ORGOTEIN,Withdrawn,immune system toxicity,anaphylactic reactions,MONDO:0100053,anaphylaxis,1990.0,Switzerland
1380836,CHEMBL2108570,ABOBOTULINUMTOXINA,Black Box Warning,,,,,,United States
1380877,CHEMBL2108611,INOTUZUMAB OZOGAMICIN,Black Box Warning,hepatotoxicity,,,,,United States
1380904,CHEMBL2108638,RAXIBACUMAB,Black Box Warning,vascular toxicity,,,,,United States
1380933,CHEMBL2108667,YTTRIUM Y 90 IBRITUMOMAB TIUXETAN,Black Box Warning,,,,,,United States
1380942,CHEMBL2108676,ELOSULFASE ALFA,Black Box Warning,gastrointestinal toxicity,,,,,United States
1380942,CHEMBL2108676,ELOSULFASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
1380942,CHEMBL2108676,ELOSULFASE ALFA,Black Box Warning,cardiotoxicity,,,,,United States
1380942,CHEMBL2108676,ELOSULFASE ALFA,Black Box Warning,vascular toxicity,,,,,United States
1380942,CHEMBL2108676,ELOSULFASE ALFA,Black Box Warning,dermatological toxicity,,,,,United States
1380967,CHEMBL2108701,HYDROXYETHYL STARCH 130/0.4,Withdrawn,nephrotoxicity,serious risks (kidney injury and death) in certain patients (for example those who are very ill or have blood poisoning),PATO:0001422,dead,2022.0,European Union
1380967,CHEMBL2108701,HYDROXYETHYL STARCH 130/0.4,Withdrawn,nephrotoxicity,serious risks (kidney injury and death) in certain patients (for example those who are very ill or have blood poisoning),EFO:0011056,nephrotoxicity,2022.0,European Union
1380990,CHEMBL2108724,SEMAGLUTIDE,Black Box Warning,carcinogenicity,,,,,United States
1380996,CHEMBL2108730,SARILUMAB,Black Box Warning,infectious disease,,,,,United States
1381031,CHEMBL2108765,PUMACTANT,Withdrawn,,Higher mortality rate in neonates given pumactant,PATO:0001422,dead,2000.0,United Kingdom
1381041,CHEMBL2108775,PODOPHYLLUM RESIN,Withdrawn,teratogenicity,risk of teratogenicity,EFO:0009880,Teratogenicity,1970.0,Italy
1381154,CHEMBL2108888,AGALSIDASE BETA,Black Box Warning,immune system toxicity,,,,,United States
1381447,CHEMBL2109181,NEBACUMAB,Withdrawn,,no reduction in mortality in patients treated with nebacumab who had Gram-negative bacteraemia.,EFO:0020002,lack of efficacy,1993.0,Worldwide
1381447,CHEMBL2109181,NEBACUMAB,Withdrawn,,mortality was increased,PATO:0001422,dead,1993.0,Worldwide
1381454,CHEMBL2109188,FUSAFUNGINE,Withdrawn,immune system toxicity,Increased risk of allergic reactions with fatal outcome,EFO:0009482,drug allergy,2016.0,European Union; Armenia
1381454,CHEMBL2109188,FUSAFUNGINE,Withdrawn,immune system toxicity,Serious allergic reactions and limited evidence of benefit,EFO:1002003,hypersensitivity reaction disease,2016.0,European Union; Armenia
1381454,CHEMBL2109188,FUSAFUNGINE,Withdrawn,immune system toxicity,Risk of serious allergic reactions,EFO:1002018,BRONCHIAL DISEASE,2016.0,European Union; Armenia
1381454,CHEMBL2109188,FUSAFUNGINE,Withdrawn,immune system toxicity,Risk of serious allergic reactions,EFO:0009482,drug allergy,2016.0,European Union; Armenia
1381454,CHEMBL2109188,FUSAFUNGINE,Withdrawn,immune system toxicity,Risk of serious allergic reactions,EFO:1002003,hypersensitivity reaction disease,2016.0,European Union; Armenia
1383076,CHEMBL2110636,BUNAMIODYL,Withdrawn,nephrotoxicity,Renal failure,EFO:1002048,kidney failure,1964.0,Worldwide
1383076,CHEMBL2110636,BUNAMIODYL,Withdrawn,nephrotoxicity,"Oliguria, renal tubular necrosis, and death; the use of other cholecystographic agents within one week after bunamiodyl ingestion may be dangerous. It is contraindicated in patients with a history of renal disease. Evaluation of renal function should be performed before use of the drug",PATO:0001422,dead,1964.0,Worldwide
1383076,CHEMBL2110636,BUNAMIODYL,Withdrawn,nephrotoxicity,"Oliguria, renal tubular necrosis, and death; the use of other cholecystographic agents within one week after bunamiodyl ingestion may be dangerous. It is contraindicated in patients with a history of renal disease. Evaluation of renal function should be performed before use of the drug",EFO:1000794,acute kidney tubular necrosis,1964.0,Worldwide
1383076,CHEMBL2110636,BUNAMIODYL,Withdrawn,nephrotoxicity,"Oliguria, renal tubular necrosis, and death; the use of other cholecystographic agents within one week after bunamiodyl ingestion may be dangerous. It is contraindicated in patients with a history of renal disease. Evaluation of renal function should be performed before use of the drug",EFO:0009878,drug interaction,1964.0,Worldwide
1383402,CHEMBL2110962,MEFENOREX,Withdrawn,,unfavourable benefit/risk balance,,,1999.0,France; Oman
1383402,CHEMBL2110962,MEFENOREX,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1999.0,France; Oman
351701,CHEMBL211456,EPHEDRINE,Withdrawn,,Not safe for use in asthma,,,2005.0,Timor-Leste
1428762,CHEMBL2165326,APROCITENTAN,Black Box Warning,,,,,,United States
27104,CHEMBL21869,DIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0000701,skin disease,1975.0,Japan; United States
27104,CHEMBL21869,DIBROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:1000753,phototoxic dermatitis,1975.0,Japan; United States
27104,CHEMBL21869,DIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:1000753,phototoxic dermatitis,1975.0,Japan; United States
27104,CHEMBL21869,DIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0020984,skin sensitization,1975.0,Japan; United States
27104,CHEMBL21869,DIBROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:0020984,skin sensitization,1975.0,Japan; United States
1448219,CHEMBL2216870,IDELALISIB,Black Box Warning,gastrointestinal toxicity,,,,,United States
1448219,CHEMBL2216870,IDELALISIB,Black Box Warning,hepatotoxicity,,,,,United States
1448219,CHEMBL2216870,IDELALISIB,Black Box Warning,infectious disease,,,,,United States
1448219,CHEMBL2216870,IDELALISIB,Black Box Warning,respiratory toxicity,,,,,United States
1449133,CHEMBL2218860,GADOBUTROL,Black Box Warning,dermatological toxicity,,,,,United States
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,Withdrawn,hepatotoxicity,Severe cholestatic hepatitis and jaundice,HP:0000952,Jaundice,1982.0,Mauritius; Bangladesh; Sweden
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,Withdrawn,,Harmful,,,1982.0,Mauritius; Bangladesh; Sweden
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1982.0,Mauritius; Bangladesh; Sweden
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1982.0,Mauritius; Bangladesh; Sweden
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,Withdrawn,hepatotoxicity,Severe cholestatic hepatitis and jaundice,HP:0012115,Hepatitis,1982.0,Mauritius; Bangladesh; Sweden
1449186,CHEMBL2218913,CAPREOMYCIN SULFATE,Black Box Warning,,,,,,United States
1449219,CHEMBL2219415,GADOTERATE MEGLUMINE,Black Box Warning,dermatological toxicity,,,,,United States
1449229,CHEMBL2219425,ARIPIPRAZOLE LAUROXIL,Black Box Warning,,,,,,United States
27616,CHEMBL22242,REMOXIPRIDE,Withdrawn,hematological toxicity,Aplastic anemia,HP:0001915,Aplastic anemia,1993.0,Worldwide
27616,CHEMBL22242,REMOXIPRIDE,Withdrawn,hematological toxicity,aplastic anaemia,HP:0001915,Aplastic anemia,1993.0,Worldwide
372438,CHEMBL222559,TIPRANAVIR,Black Box Warning,hepatotoxicity,,,,,United States
372438,CHEMBL222559,TIPRANAVIR,Black Box Warning,neurotoxicity,,,,,United States
373973,CHEMBL223448,BROXYQUINOLINE,Withdrawn,neurotoxicity,Clioquinol might be one of the causes of subacute myelooptic neuropathy,EFO:0020919,subacute myelo-opticoneuropathy,1970.0,Japan
1503092,CHEMBL2303621,DACLATASVIR DIHYDROCHLORIDE,Black Box Warning,,,,,,United States
388819,CHEMBL231068,FLIBANSERIN,Black Box Warning,,,,,,United States
1510482,CHEMBL2311071,VINYL CHLORIDE,Withdrawn,neurotoxicity,"associated with acute toxicity manifested by dizziness, headache, disorientation, and unconsciousness",EFO:0009847,dizziness,1974.0,United States
1510482,CHEMBL2311071,VINYL CHLORIDE,Withdrawn,neurotoxicity,"associated with acute toxicity manifested by dizziness, headache, disorientation, and unconsciousness",EFO:0020914,disorientation,1974.0,United States
1510482,CHEMBL2311071,VINYL CHLORIDE,Withdrawn,neurotoxicity,"associated with acute toxicity manifested by dizziness, headache, disorientation, and unconsciousness",HP:0002315,Headache,1974.0,United States
1510482,CHEMBL2311071,VINYL CHLORIDE,Withdrawn,neurotoxicity,"associated with acute toxicity manifested by dizziness, headache, disorientation, and unconsciousness",HP:0007185,Loss of consciousness,1974.0,United States
397524,CHEMBL231779,APIXABAN,Black Box Warning,vascular toxicity,,,,,United States
394996,CHEMBL231813,TELAPREVIR,Black Box Warning,,,,,,United States
393440,CHEMBL231884,DIOSMIN,Withdrawn,,unfavourable risk-benefit profile,,,2002.0,Spain
395946,CHEMBL232201,BENZIODARONE,Withdrawn,hepatotoxicity,Jaundice,EFO:0011052,hepatotoxicity,1964.0,France; United Kingdom
395946,CHEMBL232201,BENZIODARONE,Withdrawn,hepatotoxicity,Jaundice,EFO:0004228,drug-induced liver injury,1964.0,France; United Kingdom
395946,CHEMBL232201,BENZIODARONE,Withdrawn,hepatotoxicity,Jaundice,HP:0000952,Jaundice,1964.0,France; United Kingdom
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,hepatotoxicity,"Guillan-Barre Syndrome, hepatotoxicity",EFO:0004228,drug-induced liver injury,1983.0,Worldwide
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,neurotoxicity,"Guillan-Barre Syndrome, hepatotoxicity",EFO:0007292,Guillain-Barre syndrome,1983.0,Worldwide
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,hepatotoxicity,"Guillan-Barre Syndrome, hepatotoxicity",EFO:0011052,hepatotoxicity,1983.0,Worldwide
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,neurotoxicity,associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome,EFO:0007292,Guillain-Barre syndrome,1983.0,Worldwide
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,immune system toxicity,associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome,EFO:1002003,hypersensitivity reaction disease,1983.0,Worldwide
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,Withdrawn,neurotoxicity,associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome,EFO:0000618,nervous system disease,1983.0,Worldwide
1532645,CHEMBL2355456,IBUTILIDE FUMARATE,Black Box Warning,cardiotoxicity,,,,,United States
1533286,CHEMBL2356097,METOPROLOL SUCCINATE,Black Box Warning,cardiotoxicity,,,,,United States
1537155,CHEMBL2359966,QUININE SULFATE,Black Box Warning,hematological toxicity,,,,,United States
1537155,CHEMBL2359966,QUININE SULFATE,Black Box Warning,,,,,,United States
1540495,CHEMBL2364623,PLAZOMICIN SULFATE,Black Box Warning,nephrotoxicity,,,,,United States
1540509,CHEMBL2364637,TENOFOVIR ALAFENAMIDE FUMARATE,Black Box Warning,hepatotoxicity,,,,,United States
1540521,CHEMBL2364649,MARGETUXIMAB,Black Box Warning,cardiotoxicity,,,,,United States
1540521,CHEMBL2364649,MARGETUXIMAB,Black Box Warning,teratogenicity,,,,,United States
1540521,CHEMBL2364649,MARGETUXIMAB,Black Box Warning,respiratory toxicity,,,,,United States
1540521,CHEMBL2364649,MARGETUXIMAB,Black Box Warning,hepatotoxicity,,,,,United States
1540521,CHEMBL2364649,MARGETUXIMAB,Black Box Warning,dermatological toxicity,,,,,United States
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,Black Box Warning,respiratory toxicity,,,,,United States
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,Black Box Warning,,,,,,United States
1279,CHEMBL24,ATENOLOL,Black Box Warning,cardiotoxicity,,,,,United States
404691,CHEMBL240597,CHENODIOL,Black Box Warning,hepatotoxicity,,,,,United States
31171,CHEMBL24072,PRENYLAMINE,Withdrawn,,Polymorphic Ventricular Tachycardia and Death,PATO:0001422,dead,1989.0,Worldwide
31171,CHEMBL24072,PRENYLAMINE,Withdrawn,cardiotoxicity,reports of polymorphic ventricular tachycardia,MONDO:0020575,polymorphic ventricular tachycardia,1989.0,Worldwide
31171,CHEMBL24072,PRENYLAMINE,Withdrawn,cardiotoxicity,Polymorphic Ventricular Tachycardia and Death,MONDO:0020575,polymorphic ventricular tachycardia,1989.0,Worldwide
1589794,CHEMBL2443262,OLICERIDINE,Black Box Warning,respiratory toxicity,,,,,United States
1589794,CHEMBL2443262,OLICERIDINE,Black Box Warning,misuse,,,,,United States
1590760,CHEMBL2448612,ERGOTAMINE TARTRATE,Black Box Warning,,,,,,United States
1590760,CHEMBL2448612,ERGOTAMINE TARTRATE,Withdrawn,vascular toxicity,"benefits from using this medicine no longer outweigh the risks of harm. Cafergot can cause serious effects on the heart and arteries, especially in older people",EFO:0011062,vascular toxicity,2019.0,New Zealand
1590760,CHEMBL2448612,ERGOTAMINE TARTRATE,Withdrawn,cardiotoxicity,"benefits from using this medicine no longer outweigh the risks of harm. Cafergot can cause serious effects on the heart and arteries, especially in older people",EFO:1001482,cardiotoxicity,2019.0,New Zealand
1590761,CHEMBL2448613,PIMAVANSERIN TARTRATE,Black Box Warning,,,,,,United States
408583,CHEMBL245807,OXYPHENISATINE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,EFO:0011052,hepatotoxicity,1973.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
408583,CHEMBL245807,OXYPHENISATINE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,EFO:0004228,drug-induced liver injury,1973.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
408583,CHEMBL245807,OXYPHENISATINE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,HP:0012115,Hepatitis,1973.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
408583,CHEMBL245807,OXYPHENISATINE,Withdrawn,hepatotoxicity,associated with hepatitis and jaundice,HP:0000952,Jaundice,1973.0,Germany; Italy; New Zealand; Belgium; Kuwait; Australia; Austria; Mauritius; Denmark; United Kingdom; Cuba; Spain; Netherlands; Cyprus; Norway; France; Japan; United States; Canada
33576,CHEMBL24828,VANDETANIB,Black Box Warning,cardiotoxicity,,,,,United States
421350,CHEMBL248702,DEXFENFLURAMINE,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1997.0,Malaysia; India; European Union; United Kingdom; Saudi Arabia; United States; Canada; France; Brazil; Lithuania; Morocco
421350,CHEMBL248702,DEXFENFLURAMINE,Withdrawn,cardiotoxicity,Heart valve disorders,EFO:0009551,heart valve disease,1997.0,Malaysia; India; European Union; United Kingdom; Saudi Arabia; United States; Canada; France; Brazil; Lithuania; Morocco
27105,CHEMBL24944,TRIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0020984,skin sensitization,1974.0,United States; Japan
27105,CHEMBL24944,TRIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:1000753,phototoxic dermatitis,1974.0,United States; Japan
27105,CHEMBL24944,TRIBROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:0020984,skin sensitization,1974.0,United States; Japan
27105,CHEMBL24944,TRIBROMSALAN,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:1000753,phototoxic dermatitis,1974.0,United States; Japan
27105,CHEMBL24944,TRIBROMSALAN,Withdrawn,dermatological toxicity,potent photosensitizer capable of causing disabling skin disorders,EFO:0000701,skin disease,1974.0,United States; Japan
418438,CHEMBL254857,FIPEXIDE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1990.0,France
418438,CHEMBL254857,FIPEXIDE,Withdrawn,respiratory toxicity,"associated with pneumopathy, neuropsychological disorders and rare cases of agranulocytosis",EFO:0003818,lung disease,1990.0,France
418438,CHEMBL254857,FIPEXIDE,Withdrawn,neurotoxicity,"associated with pneumopathy, neuropsychological disorders and rare cases of agranulocytosis",HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1990.0,France
418438,CHEMBL254857,FIPEXIDE,Withdrawn,psychiatric toxicity,"associated with pneumopathy, neuropsychological disorders and rare cases of agranulocytosis",HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1990.0,France
418438,CHEMBL254857,FIPEXIDE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1990.0,France
418438,CHEMBL254857,FIPEXIDE,Withdrawn,hematological toxicity,"associated with pneumopathy, neuropsychological disorders and rare cases of agranulocytosis",HP:0012234,Agranulocytosis,1990.0,France
418485,CHEMBL255044,FLUPIRTINE,Withdrawn,hepatotoxicity,Risk of serious liver injury,EFO:0011052,hepatotoxicity,2018.0,European Union
418485,CHEMBL255044,FLUPIRTINE,Withdrawn,hepatotoxicity,Risk of serious liver injury,EFO:0004228,drug-induced liver injury,2018.0,European Union
437583,CHEMBL256907,MARAVIROC,Black Box Warning,hepatotoxicity,,,,,United States
431376,CHEMBL260538,ULIPRISTAL ACETATE,Withdrawn,hepatotoxicity,Serious drug-induced liver injury,EFO:0011052,hepatotoxicity,2020.0,Canada
431376,CHEMBL260538,ULIPRISTAL ACETATE,Withdrawn,hepatotoxicity,Serious drug-induced liver injury,EFO:0004228,drug-induced liver injury,2020.0,Canada
70140,CHEMBL262777,VANCOMYCIN,Black Box Warning,teratogenicity,,,,,United States
8873,CHEMBL267345,AMPHOTERICIN B,Black Box Warning,,,,,,United States
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,Liver Toxicity and Death,EFO:0004228,drug-induced liver injury,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,Liver Toxicity and Death,EFO:0011052,hepatotoxicity,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,Liver Toxicity and Death,PATO:0001422,dead,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,deaths due to liver dysfunction,PATO:0001422,dead,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,deaths due to liver dysfunction,EFO:0004228,drug-induced liver injury,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,deaths due to liver dysfunction,EFO:0011052,hepatotoxicity,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,Liver Toxicity,EFO:0004228,drug-induced liver injury,1980.0,France; United States; United Kingdom; Germany; Philippines
2819,CHEMBL267744,TICRYNAFEN,Withdrawn,hepatotoxicity,Liver Toxicity,EFO:0011052,hepatotoxicity,1980.0,France; United States; United Kingdom; Germany; Philippines
2366,CHEMBL267894,AMOBARBITAL,Withdrawn,drug misuse,Self-Poisonings,EFO:0008546,poisoning,1980.0,Norway; Sweden
2366,CHEMBL267894,AMOBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1980.0,Norway; Sweden
2198,CHEMBL268164,CYCLOBARBITAL,Withdrawn,drug misuse,Self-poisonings,EFO:0008546,poisoning,1980.0,Norway
2516,CHEMBL268869,SULFAMETHOXYPYRIDAZINE,Withdrawn,,adverse reactions and low sales,EFO:0009658,adverse effect,1984.0,Sweden
9953,CHEMBL269644,ACETANILIDE,Withdrawn,hematological toxicity,Aplastic anaemia,HP:0001915,Aplastic anemia,1971.0,Japan
435293,CHEMBL270190,ALVIMOPAN,Black Box Warning,cardiotoxicity,,,,,United States
435293,CHEMBL270190,ALVIMOPAN,Black Box Warning,psychiatric toxicity,,,,,United States
37260,CHEMBL27193,DILEVALOL,Withdrawn,hepatotoxicity,Evidence of isolated cases of liver toxicity,EFO:0011052,hepatotoxicity,1990.0,Worldwide
37260,CHEMBL27193,DILEVALOL,Withdrawn,hepatotoxicity,Evidence of isolated cases of liver toxicity,EFO:0004228,drug-induced liver injury,1990.0,Worldwide
16580,CHEMBL276520,INDALPINE,Withdrawn,hematological toxicity,Agranulocytosis,HP:0012234,Agranulocytosis,1985.0,France
16580,CHEMBL276520,INDALPINE,Withdrawn,hematological toxicity,agranulocytosis and severe neutropenia,HP:0012234,Agranulocytosis,1985.0,France
16580,CHEMBL276520,INDALPINE,Withdrawn,hematological toxicity,agranulocytosis and severe neutropenia,MONDO:0001475,neutropenia,1985.0,France
33583,CHEMBL278819,MINAPRINE,Withdrawn,neurotoxicity,Convulsions,HP:0001250,Seizure,1996.0,France
22572,CHEMBL282052,METHAQUALONE,Withdrawn,drug misuse,Overdose,EFO:0020911,overdose,1984.0,United States
23417,CHEMBL282724,SITAXENTAN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,2010.0,Worldwide
23417,CHEMBL282724,SITAXENTAN,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,2010.0,Worldwide
23417,CHEMBL282724,SITAXENTAN,Withdrawn,hepatotoxicity,Risk of acute liver failure,EFO:0004228,drug-induced liver injury,2010.0,Worldwide
23417,CHEMBL282724,SITAXENTAN,Withdrawn,hepatotoxicity,Risk of acute liver failure,EFO:0011052,hepatotoxicity,2010.0,Worldwide
35538,CHEMBL28318,PROPYPHENAZONE,Withdrawn,,severe adverse reactions,EFO:0009658,adverse effect,1986.0,Turkey
49847,CHEMBL285674,ESTAZOLAM,Black Box Warning,,,,,,United States
60246,CHEMBL288470,AMINOPYRINE,Withdrawn,,Adverse effects,EFO:0009658,adverse effect,1965.0,France; United States; United Kingdom; Germany; Australia; Sweden; Philippines; Turkey; Kuwait; Denmark; Finland; Switzerland; India; Ethiopia; Venezuela; Chile; Republic of Korea; Japan; Rwanda; Mauritius
60246,CHEMBL288470,AMINOPYRINE,Withdrawn,hematological toxicity,Bone marrow depression and fatal agranulocytosis,HP:0012234,Agranulocytosis,1965.0,France; United States; United Kingdom; Germany; Australia; Sweden; Philippines; Turkey; Kuwait; Denmark; Finland; Switzerland; India; Ethiopia; Venezuela; Chile; Republic of Korea; Japan; Rwanda; Mauritius
60246,CHEMBL288470,AMINOPYRINE,Withdrawn,hematological toxicity,Agranulocytosis,HP:0012234,Agranulocytosis,1965.0,France; United States; United Kingdom; Germany; Australia; Sweden; Philippines; Turkey; Kuwait; Denmark; Finland; Switzerland; India; Ethiopia; Venezuela; Chile; Republic of Korea; Japan; Rwanda; Mauritius
60246,CHEMBL288470,AMINOPYRINE,Withdrawn,carcinogenicity,Potential to produce carcinogenic nitrosamines,EFO:0011046,carcinogenicity,1965.0,France; United States; United Kingdom; Germany; Australia; Sweden; Philippines; Turkey; Kuwait; Denmark; Finland; Switzerland; India; Ethiopia; Venezuela; Chile; Republic of Korea; Japan; Rwanda; Mauritius
60246,CHEMBL288470,AMINOPYRINE,Withdrawn,hematological toxicity,Serious side effects such as bone marrow depression and agranulocytosis,EFO:0007053,myelosuppression,1965.0,France; United States; United Kingdom; Germany; Australia; Sweden; Philippines; Turkey; Kuwait; Denmark; Finland; Switzerland; India; Ethiopia; Venezuela; Chile; Republic of Korea; Japan; Rwanda; Mauritius
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,shown to be a potent photosensitizer with the potential to cause serious skin disorders,EFO:1000753,phototoxic dermatitis,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,shown to be a potent photosensitizer with the potential to cause serious skin disorders,EFO:0000701,skin disease,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,shown to be a potent photosensitizer with the potential to cause serious skin disorders,EFO:0020984,skin sensitization,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,Dermatologic Toxicity,EFO:1000753,phototoxic dermatitis,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,Dermatologic Toxicity,EFO:0000701,skin disease,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:0020984,skin sensitization,1967.0,United States; Japan
46656,CHEMBL290106,BITHIONOL,Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:1000753,phototoxic dermatitis,1967.0,United States; Japan
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",Withdrawn,dermatological toxicity,potent photosensitizers and can cause disabling skin disorders,EFO:1000753,phototoxic dermatitis,1975.0,United States
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",Withdrawn,dermatological toxicity,potent photosensitizers and can cause disabling skin disorders,EFO:0020984,skin sensitization,1975.0,United States
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:1000753,phototoxic dermatitis,1976.0,Japan
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",Withdrawn,dermatological toxicity,Photosensitivity reactions,EFO:0020984,skin sensitization,1976.0,Japan
66831,CHEMBL295124,BERBERINE,Withdrawn,hepatotoxicity,"Jaundice, haemolytic anemia and kernicterus with brain damage in infants with glucose 6-phosphate dehydrogenase deficiency who were exposed either in utero or post-natally",HP:0000952,Jaundice,1978.0,Singapore
66831,CHEMBL295124,BERBERINE,Withdrawn,neurotoxicity,"Jaundice, haemolytic anemia and kernicterus with brain damage in infants with glucose 6-phosphate dehydrogenase deficiency who were exposed either in utero or post-natally",EFO:1001002,kernicterus,1978.0,Singapore
66831,CHEMBL295124,BERBERINE,Withdrawn,hematological toxicity,"Jaundice, haemolytic anemia and kernicterus with brain damage in infants with glucose 6-phosphate dehydrogenase deficiency who were exposed either in utero or post-natally",MONDO:0019535,drug-induced autoimmune hemolytic anemia,1978.0,Singapore
72036,CHEMBL295698,LEVOKETOCONAZOLE,Black Box Warning,cardiotoxicity,,,,,United States
72036,CHEMBL295698,LEVOKETOCONAZOLE,Black Box Warning,hepatotoxicity,,,,,United States
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,,"Increased risk of QT prolongation with concomitant administration of oral or parenteral formulations of azole antifungals, macrolide antibiotics except azithromycin, selective serotonin reuptake inhibitors and HIV protease inhibitors; Potential for serious drug interactions; Association with severe cardiac adverse events when used inappropriately with contraindicated drugs",EFO:0009878,drug interaction,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,Fatal arrhythmia; Drug Interaction,EFO:0004269,cardiac arrhythmia,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,Cardiotoxic effects,EFO:1001482,cardiotoxicity,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,,Fatal arrhythmia; Drug Interaction,EFO:0009878,drug interaction,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,"Rare but serious side-effects on heart, primary changes in heart rhythm",EFO:0004269,cardiac arrhythmia,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,Associated with adverse drug reactions including irregular heart rhythms and severe allergic reactions if taken at higher than recommended doses or in conjunction with some other drugs including antihypertensives and anti-asthmatics,EFO:0004269,cardiac arrhythmia,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,Serious adverse cardiovascular reactions,EFO:1001482,cardiotoxicity,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,,Several adverse reactions,EFO:0009658,adverse effect,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,"Prolongation of the QT-interval and ventricular arrhythmias; Increased risk of QT prolongation with concomitant administration of oral or parenteral formulations of azole antifungals, macrolide antibiotics except azithromycin, selective serotonin reuptake inhibitors and HIV protease inhibitors",HP:0001657,Prolonged QT interval,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,immune system toxicity,Associated with adverse drug reactions including irregular heart rhythms and severe allergic reactions if taken at higher than recommended doses or in conjunction with some other drugs including antihypertensives and anti-asthmatics,EFO:1002003,hypersensitivity reaction disease,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,cardiotoxicity,Prolongation of the QT-interval and ventricular arrhythmias,HP:0004308,Ventricular arrhythmia,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
65605,CHEMBL296419,ASTEMIZOLE,Withdrawn,immune system toxicity,Associated with adverse drug reactions including irregular heart rhythms and severe allergic reactions if taken at higher than recommended doses or in conjunction with some other drugs including antihypertensives and anti-asthmatics,EFO:0009878,drug interaction,1998.0,Malaysia; Singapore; Armenia; United Arab Emirates; Brunei; Mauritius; Bhutan; Tanzania; Spain; Chile; Argentina; Philippines; United States; South Africa; Brazil
76963,CHEMBL299400,BUTORPHANOL TARTRATE,Black Box Warning,misuse,,,,,United States
76963,CHEMBL299400,BUTORPHANOL TARTRATE,Black Box Warning,respiratory toxicity,,,,,United States
38588,CHEMBL30219,METHOHEXITAL SODIUM,Black Box Warning,,,,,,United States
1592355,CHEMBL3039537,SEBELIPASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
1592358,CHEMBL3039540,ADUCANUMAB,Black Box Warning,,,,,,United States
1592407,CHEMBL3039596,FOSINOPRIL SODIUM,Black Box Warning,teratogenicity,,,,,United States
1712,CHEMBL31,GATIFLOXACIN,Withdrawn,gastrointestinal toxicity,Increased risk of dysglycemia,HP:0001943,Hypoglycemia,2006.0,United States
1712,CHEMBL31,GATIFLOXACIN,Withdrawn,gastrointestinal toxicity,Increased risk of dysglycemia,HP:0003074,Hyperglycemia,2006.0,United States
128555,CHEMBL311498,CIANIDANOL,Withdrawn,hematological toxicity,Hemolytic Anemia,EFO:0005558,hemolytic anemia,1985.0,France; Spain; Germany; Switzerland
1626748,CHEMBL3137317,SONIDEGIB PHOSPHATE,Black Box Warning,teratogenicity,,,,,United States
1626757,CHEMBL3137326,DEUTETRABENAZINE,Black Box Warning,psychiatric toxicity,,,,,United States
1626776,CHEMBL3137342,DINUTUXIMAB,Black Box Warning,immune system toxicity,,,,,United States
1626776,CHEMBL3137342,DINUTUXIMAB,Black Box Warning,neurotoxicity,,,,,United States
1626792,CHEMBL3137358,SIMEPREVIR SODIUM,Black Box Warning,,,,,,United States
1631832,CHEMBL3142541,BUTAMBEN PICRATE,Withdrawn,psychiatric toxicity,Dermatologic Toxicity; Psychiatric Reaction,EFO:0011059,psychiatric toxicity,1964.0,United States
1631832,CHEMBL3142541,BUTAMBEN PICRATE,Withdrawn,dermatological toxicity,severe tissue slough and transverse myelitis,HP:0032156,Skin detachment,1964.0,United States
1631832,CHEMBL3142541,BUTAMBEN PICRATE,Withdrawn,dermatological toxicity,Dermatologic Toxicity; Psychiatric Reaction,EFO:0011048,dermatological toxicity,1964.0,United States
1631832,CHEMBL3142541,BUTAMBEN PICRATE,Withdrawn,neurotoxicity,severe tissue slough and transverse myelitis,MONDO:0021553,transverse myelitis,1964.0,United States
134695,CHEMBL316157,CEPHALORIDINE,Withdrawn,nephrotoxicity,Nephrotoxicity,EFO:0011056,nephrotoxicity,1989.0,Spain
153476,CHEMBL316561,PROGLUMIDE,Withdrawn,respiratory toxicity,Respiratory Reaction,,,1989.0,Germany
1671238,CHEMBL3181947,BROMFENAC SODIUM,Withdrawn,drug misuse,Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse,,,1998.0,United States; Saudi Arabia
1671238,CHEMBL3181947,BROMFENAC SODIUM,Withdrawn,hepatotoxicity,Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse,EFO:0004228,drug-induced liver injury,1998.0,United States; Saudi Arabia
1671238,CHEMBL3181947,BROMFENAC SODIUM,Withdrawn,hepatotoxicity,Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse,EFO:0011052,hepatotoxicity,1998.0,United States; Saudi Arabia
1671238,CHEMBL3181947,BROMFENAC SODIUM,Withdrawn,drug misuse,Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse,EFO:0011049,drug misuse,1998.0,United States; Saudi Arabia
1671238,CHEMBL3181947,BROMFENAC SODIUM,Withdrawn,hepatotoxicity,Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse,HP:0001399,Hepatic failure,1998.0,United States; Saudi Arabia
1671611,CHEMBL3182320,TROXERUTIN,Withdrawn,,unfavourable risk-benefit profile,,,2002.0,Spain
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hepatotoxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",EFO:0011052,hepatotoxicity,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hematological toxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",MONDO:0002280,anemia,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,dermatological toxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",EFO:0020927,skin reaction,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hematological toxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",HP:0001873,Thrombocytopenia,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hepatotoxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",HP:0001399,Hepatic failure,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,immune system toxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",MONDO:0001475,neutropenia,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hepatotoxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",EFO:0004228,drug-induced liver injury,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hepatotoxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",HP:0000952,Jaundice,2009.0,United States
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,Withdrawn,hematological toxicity,"Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",MONDO:0001475,neutropenia,2009.0,United States
1673803,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
1673803,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,Black Box Warning,infectious disease,,,,,United States
1674082,CHEMBL3184791,STREPTOMYCIN SULFATE,Black Box Warning,,,,,,United States
1676537,CHEMBL3187246,METHAPYRILENE FUMARATE,Withdrawn,carcinogenicity,was shown to be a potent carcinogen,EFO:0011046,carcinogenicity,1979.0,Germany; United States; United Kingdom; Italy; India; Philippines; Egypt; Dominican Republic; Chile; Canada; Australia
1676537,CHEMBL3187246,METHAPYRILENE FUMARATE,Withdrawn,carcinogenicity,Animal carcinogenicity (rodents),EFO:0011046,carcinogenicity,1979.0,Germany; United States; United Kingdom; Italy; India; Philippines; Egypt; Dominican Republic; Chile; Canada; Australia
1676656,CHEMBL3187365,ASENAPINE,Black Box Warning,,,,,,United States
1677867,CHEMBL3188576,DIHYDROSTREPTOMYCIN SULFATE,Withdrawn,psychiatric toxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1970.0,Philippines; Dominican Republic; United States
1677867,CHEMBL3188576,DIHYDROSTREPTOMYCIN SULFATE,Withdrawn,neurotoxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1970.0,Philippines; Dominican Republic; United States
1677867,CHEMBL3188576,DIHYDROSTREPTOMYCIN SULFATE,Withdrawn,ototoxicity,associated with ototoxicity,EFO:0006951,ototoxicity,1970.0,Philippines; Dominican Republic; United States
1678284,CHEMBL3188993,QUETIAPINE FUMARATE,Black Box Warning,psychiatric toxicity,,,,,United States
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,Black Box Warning,,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,respiratory toxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,carcinogenicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,hematological toxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,hepatotoxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,teratogenicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,infectious disease,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,nephrotoxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,vascular toxicity,,,,,United States
1737244,CHEMBL3244648,METHOTREXATE SODIUM,Black Box Warning,dermatological toxicity,,,,,United States
49226,CHEMBL32800,FENOTEROL,Withdrawn,respiratory toxicity,Asthma Mortality,MONDO:0004979,asthma,1990.0,New Zealand
163172,CHEMBL329522,EXIFONE,Withdrawn,hepatotoxicity,Acute hepatitis associated with the ingestion of exifone,HP:0200119,Acute hepatitis,1989.0,France
163172,CHEMBL329522,EXIFONE,Withdrawn,hepatotoxicity,Acute hepatitis associated with the ingestion of exifone,EFO:0004228,drug-induced liver injury,1989.0,France
163172,CHEMBL329522,EXIFONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1989.0,France
163172,CHEMBL329522,EXIFONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1989.0,France
163172,CHEMBL329522,EXIFONE,Withdrawn,hepatotoxicity,Acute hepatitis associated with the ingestion of exifone,EFO:0011052,hepatotoxicity,1989.0,France
1763536,CHEMBL3301574,TISAGENLECLEUCEL,Black Box Warning,infectious disease,,,,,United States
1763543,CHEMBL3301581,ABALOPARATIDE,Black Box Warning,carcinogenicity,,,,,United States
1763545,CHEMBL3301583,ANDEXANET ALFA,Black Box Warning,cardiotoxicity,,,,,United States
1763545,CHEMBL3301583,ANDEXANET ALFA,Black Box Warning,hematological toxicity,,,,,United States
1763545,CHEMBL3301583,ANDEXANET ALFA,Black Box Warning,gastrointestinal toxicity,,,,,United States
1763551,CHEMBL3301589,ENFORTUMAB VEDOTIN,Black Box Warning,dermatological toxicity,,,,,United States
1763551,CHEMBL3301589,ENFORTUMAB VEDOTIN,Black Box Warning,immune system toxicity,,,,,United States
1763565,CHEMBL3301603,GILTERITINIB FUMARATE,Black Box Warning,carcinogenicity,,,,,United States
1763589,CHEMBL3301627,TENAPANOR HYDROCHLORIDE,Black Box Warning,,,,,,United States
1763641,CHEMBL3301670,DIFEMERINE HYDROCHLORIDE,Withdrawn,,Multi-Organ Toxicities,EFO:1001373,Multiple Organ Failure,1986.0,Germany
1763641,CHEMBL3301670,DIFEMERINE HYDROCHLORIDE,Withdrawn,,exceptionally frequent adverse effects,EFO:0009658,adverse effect,1986.0,Germany
1763646,CHEMBL3301675,LINACLOTIDE,Black Box Warning,,,,,,United States
1763651,CHEMBL3301680,TELAVANCIN HYDROCHLORIDE,Black Box Warning,nephrotoxicity,,,,,United States
1763651,CHEMBL3301680,TELAVANCIN HYDROCHLORIDE,Black Box Warning,teratogenicity,,,,,United States
1768774,CHEMBL3306803,LUMATEPERONE,Black Box Warning,,,,,,United States
204090,CHEMBL338802,SULFAGUANIDINE,Withdrawn,,severe adverse reactions,EFO:0009658,adverse effect,1985.0,Turkey; Germany
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,nephrotoxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,EFO:1002048,kidney failure,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,gastrointestinal toxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0011050,gastrointestinal toxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hematological toxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0011051,hematological toxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,EFO:0004228,drug-induced liver injury,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,carcinogenicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,EFO:0011046,carcinogenicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,associated with fatal cholestatic jaundice among other serious adverse reactions,EFO:0004228,drug-induced liver injury,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0011052,hepatotoxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,EFO:0011052,hepatotoxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,EFO:0004228,drug-induced liver injury,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,carcinogenicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0011046,carcinogenicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0004228,drug-induced liver injury,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,HP:0001399,Hepatic failure,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,HP:0002605,Hepatic necrosis,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,dermatological toxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0011048,dermatological toxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,EFO:0011052,hepatotoxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,associated with fatal cholestatic jaundice among other serious adverse reactions,EFO:0011052,hepatotoxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,occular toxicity,"Serious toxic effects on various organ systems, particularly the gastrointestinal tract, the liver and bone marrow, in addition to previously known effects on the skin, eyes and nails. Subsequent to this decision, limited clinical trials were abandoned following demonstration of positive findings in carcinogenicity studies in mice.",EFO:0020928,occular toxicity,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,dermatological toxicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,EFO:0020984,skin sensitization,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,gastrointestinal toxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,HP:0002239,Gastrointestinal hemorrhage,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,gastrointestinal toxicity,Liver and kidney failure; Gastrointestinal bleeding; Ulcers,MPATH:579,ulcer,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,dermatological toxicity,Liver necrosis; Photosensitivity; Animal carcinogenicity,EFO:1000753,phototoxic dermatitis,1982.0,Worldwide
219327,CHEMBL340978,BENOXAPROFEN,Withdrawn,hepatotoxicity,associated with fatal cholestatic jaundice among other serious adverse reactions,EFO:1001068,obstructive jaundice,1982.0,Worldwide
228897,CHEMBL341812,IBUFENAC,Withdrawn,hepatotoxicity,Hepatotoxicity; Jaundice,EFO:0011052,hepatotoxicity,1968.0,United Kingdom
228897,CHEMBL341812,IBUFENAC,Withdrawn,hepatotoxicity,Hepatotoxicity; Jaundice,HP:0000952,Jaundice,1968.0,United Kingdom
228897,CHEMBL341812,IBUFENAC,Withdrawn,hepatotoxicity,Hepatotoxicity; Jaundice,EFO:0004228,drug-induced liver injury,1968.0,United Kingdom
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,respiratory toxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,hepatotoxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,hematological toxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,carcinogenicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,nephrotoxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,teratogenicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,infectious disease,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,vascular toxicity,,,,,United States
49931,CHEMBL34259,METHOTREXATE,Black Box Warning,dermatological toxicity,,,,,United States
227437,CHEMBL344159,TOLVAPTAN,Black Box Warning,hepatotoxicity,,,,,United States
254983,CHEMBL345524,ANTRAFENINE,Withdrawn,,Unspecific experimental toxicity,,,1984.0,France
255981,CHEMBL346235,DIAMTHAZOLE DIHYDROCHLORIDE,Withdrawn,psychiatric toxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1972.0,France; United States
255981,CHEMBL346235,DIAMTHAZOLE DIHYDROCHLORIDE,Withdrawn,neurotoxicity,Neuropsychiatric Reaction,HP:0011446,ABNORMALITY OF MENTAL FUNCTION,1972.0,France; United States
255981,CHEMBL346235,DIAMTHAZOLE DIHYDROCHLORIDE,Withdrawn,neurotoxicity,associated with neurotoxicity,EFO:0011057,neurotoxicity,1972.0,France; United States
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,hepatotoxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",EFO:0011052,hepatotoxicity,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,hepatotoxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",HP:0000952,Jaundice,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,,Unfavourable risk-benefit ratio,,,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,hepatotoxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",HP:0012115,Hepatitis,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,gastrointestinal toxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",EFO:0009454,gastric ulcer,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,hepatotoxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",EFO:0004228,drug-induced liver injury,1991.0,Germany; Italy
252029,CHEMBL348000,CINCHOPHEN,Withdrawn,hepatotoxicity,"Hepatic toxicity, including jaundice, hepatitis and cirrhosis and a greater incidence of gastric ulceration than is associated with other nonsteroidal antiinflammatory agents",EFO:0001422,cirrhosis of liver,1991.0,Germany; Italy
2046,CHEMBL35,FUROSEMIDE,Black Box Warning,,,,,,United States
1926775,CHEMBL3544926,OBILTOXAXIMAB,Black Box Warning,immune system toxicity,,,,,United States
1926820,CHEMBL3544971,DEXTROAMPHETAMINE SULFATE,Black Box Warning,misuse,,,,,United States
1926823,CHEMBL3544974,ASENAPINE MALEATE,Black Box Warning,,,,,,United States
1926837,CHEMBL3544988,DAPRODUSTAT,Black Box Warning,,,,,,United States
1926908,CHEMBL3545059,ALISKIREN FUMARATE,Black Box Warning,teratogenicity,,,,,United States
1926981,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,Black Box Warning,,,,,,United States
1927032,CHEMBL3545183,ETELCALCETIDE HYDROCHLORIDE,Black Box Warning,,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,immune system toxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,hepatotoxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,hematological toxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,respiratory toxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,dermatological toxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,gastrointestinal toxicity,,,,,United States
1927101,CHEMBL3545252,DOCETAXEL,Black Box Warning,vascular toxicity,,,,,United States
1927111,CHEMBL3545262,SACITUZUMAB GOVITECAN,Black Box Warning,gastrointestinal toxicity,,,,,United States
1927111,CHEMBL3545262,SACITUZUMAB GOVITECAN,Black Box Warning,hematological toxicity,,,,,United States
1927217,CHEMBL3545368,PANOBINOSTAT LACTATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
1927217,CHEMBL3545368,PANOBINOSTAT LACTATE,Black Box Warning,cardiotoxicity,,,,,United States
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,Black Box Warning,carcinogenicity,,,,,United States
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,Black Box Warning,hepatotoxicity,,,,,United States
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
301194,CHEMBL360328,LORCASERIN,Withdrawn,carcinogenicity,Carcinogenicity,EFO:0011046,carcinogenicity,2020.0,United States
1959536,CHEMBL3608680,FEZOLINETANT,Black Box Warning,hepatotoxicity,,,,,United States
1959536,CHEMBL3608680,FEZOLINETANT,Black Box Warning,cardiotoxicity,,,,,United States
1959536,CHEMBL3608680,FEZOLINETANT,Black Box Warning,teratogenicity,,,,,United States
1959536,CHEMBL3608680,FEZOLINETANT,Black Box Warning,immune system toxicity,,,,,United States
308699,CHEMBL363295,TERODILINE,Withdrawn,cardiotoxicity,"cardiac adverse reactions, including ventricular tachycardia, heart block and bradycardia",HP:0001662,Bradycardia,1991.0,Worldwide
308699,CHEMBL363295,TERODILINE,Withdrawn,cardiotoxicity,"cardiac adverse reactions, including ventricular tachycardia, heart block and bradycardia",EFO:0005306,ventricular tachycardia,1991.0,Worldwide
308699,CHEMBL363295,TERODILINE,Withdrawn,cardiotoxicity,"cardiac adverse reactions, including ventricular tachycardia, heart block and bradycardia",MP:0010559,heart block,1991.0,Worldwide
1978977,CHEMBL3646221,VADADUSTAT,Black Box Warning,,,,,,United States
1978977,CHEMBL3646221,VADADUSTAT,Black Box Warning,cardiotoxicity,,,,,United States
1987927,CHEMBL3655081,ABROCITINIB,Black Box Warning,carcinogenicity,,,,,United States
1987927,CHEMBL3655081,ABROCITINIB,Black Box Warning,infectious disease,,,,,United States
1987927,CHEMBL3655081,ABROCITINIB,Black Box Warning,musculoskeletal toxicity,,,,,United States
1987927,CHEMBL3655081,ABROCITINIB,Black Box Warning,cardiotoxicity,,,,,United States
2039153,CHEMBL3707183,QUINIDINE SULFATE,Black Box Warning,cardiotoxicity,,,,,United States
2039219,CHEMBL3707248,VALBENAZINE TOSYLATE,Black Box Warning,psychiatric toxicity,,,,,United States
2039219,CHEMBL3707248,VALBENAZINE TOSYLATE,Black Box Warning,,,,,,United States
2039329,CHEMBL3707358,OLIPUDASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
2039353,CHEMBL3707382,VESTRONIDASE ALFA,Black Box Warning,,,,,,United States
366271,CHEMBL374731,TELBIVUDINE,Black Box Warning,,,,,,United States
373970,CHEMBL376140,TIGECYCLINE,Black Box Warning,,,,,,United States
2208,CHEMBL38,TRETINOIN,Black Box Warning,hematological toxicity,,,,,United States
2208,CHEMBL38,TRETINOIN,Black Box Warning,teratogenicity,,,,,United States
2208,CHEMBL38,TRETINOIN,Black Box Warning,carcinogenicity,,,,,United States
2096372,CHEMBL3833321,LECANEMAB,Black Box Warning,carcinogenicity,,,,,United States
2096404,CHEMBL3833353,PRAMLINTIDE ACETATE,Black Box Warning,,,,,,United States
2096444,CHEMBL3833393,EMICIZUMAB,Black Box Warning,,,,,,United States
364520,CHEMBL386630,TESTOSTERONE,Black Box Warning,,,,,,United States
374182,CHEMBL388590,BENZBROMARONE,Withdrawn,hepatotoxicity,Serious liver damage,EFO:0004228,drug-induced liver injury,2003.0,France; Portugal
374182,CHEMBL388590,BENZBROMARONE,Withdrawn,hepatotoxicity,Serious liver damage,EFO:0011052,hepatotoxicity,2003.0,France; Portugal
374182,CHEMBL388590,BENZBROMARONE,Withdrawn,,Unfavourable benefit-risk evaluation,,,2003.0,France; Portugal
2158101,CHEMBL3948730,UMBRALISIB,Withdrawn,,possible increased risk of death,PATO:0001422,dead,2022.0,United States
392195,CHEMBL395429,OXYTOCIN,Black Box Warning,,,,,,United States
56090,CHEMBL39736,BUFORMIN,Withdrawn,metabolic toxicity,Lactic acidosis,EFO:1000036,lactic acidosis,1978.0,Germany; Belgium; Ireland; Austria
416772,CHEMBL398435,TICAGRELOR,Black Box Warning,vascular toxicity,,,,,United States
2196851,CHEMBL3988900,ZINC OXIDE,Black Box Warning,cardiotoxicity,,,,,United States
2196851,CHEMBL3988900,ZINC OXIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2197274,CHEMBL3989403,ZOMEPIRAC SODIUM,Withdrawn,immune system toxicity,Anaphylactic reactions and non_fatal allergic reactions,MONDO:0100053,anaphylaxis,1983.0,Worldwide
2197274,CHEMBL3989403,ZOMEPIRAC SODIUM,Withdrawn,immune system toxicity,Anaphylactic reactions and non_fatal allergic reactions,EFO:0009482,drug allergy,1983.0,Worldwide
2197277,CHEMBL3989406,ENALAPRILAT,Black Box Warning,teratogenicity,,,,,United States
2197380,CHEMBL3989509,PENTAZOCINE LACTATE,Black Box Warning,,,,,,United States
2197385,CHEMBL3989514,IRINOTECAN HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2197385,CHEMBL3989514,IRINOTECAN HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
2197386,CHEMBL3989515,PENICILLIN G BENZATHINE,Black Box Warning,misuse,,,,,United States
2197391,CHEMBL3989520,HISTAMINE PHOSPHATE,Black Box Warning,metabolic toxicity,,,,,United States
2197393,CHEMBL3989522,EDETATE CALCIUM DISODIUM MONOHYDRATE,Black Box Warning,,,,,,United States
2197422,CHEMBL3989551,LINCOMYCIN HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2197422,CHEMBL3989551,LINCOMYCIN HYDROCHLORIDE,Black Box Warning,infectious disease,,,,,United States
2197427,CHEMBL3989556,REMOXIPRIDE HYDROCHLORIDE,Withdrawn,hematological toxicity,Aplastic anemia,HP:0001915,Aplastic anemia,1993.0,Worldwide
2197435,CHEMBL3989564,TOBRAMYCIN SULFATE,Black Box Warning,neurotoxicity,,,,,United States
2197435,CHEMBL3989564,TOBRAMYCIN SULFATE,Black Box Warning,nephrotoxicity,,,,,United States
2197435,CHEMBL3989564,TOBRAMYCIN SULFATE,Black Box Warning,teratogenicity,,,,,United States
2197547,CHEMBL3989676,OXYPHENBUTAZONE,Withdrawn,hematological toxicity,Blood Dyscrasis; Steven Johnson Syndrome,EFO:0005803,hematologic disease,1984.0,France; United States; United Kingdom; Germany; Sweden; Bangladesh; Ethiopia; Cyprus
2197547,CHEMBL3989676,OXYPHENBUTAZONE,Withdrawn,dermatological toxicity,Blood Dyscrasis; Steven Johnson Syndrome,EFO:0004276,Stevens-Johnson syndrome,1984.0,France; United States; United Kingdom; Germany; Sweden; Bangladesh; Ethiopia; Cyprus
2197548,CHEMBL3989677,HYDROCODONE BITARTRATE,Black Box Warning,respiratory toxicity,,,,,United States
2197548,CHEMBL3989677,HYDROCODONE BITARTRATE,Black Box Warning,misuse,,,,,United States
2197548,CHEMBL3989677,HYDROCODONE BITARTRATE,Black Box Warning,,,,,,United States
2197562,CHEMBL3989691,ELTROMBOPAG OLAMINE,Black Box Warning,hepatotoxicity,,,,,United States
2197565,CHEMBL3989694,OLANZAPINE PAMOATE,Black Box Warning,,,,,,United States
2197569,CHEMBL3989698,TRANYLCYPROMINE SULFATE,Black Box Warning,psychiatric toxicity,,,,,United States
2197569,CHEMBL3989698,TRANYLCYPROMINE SULFATE,Black Box Warning,vascular toxicity,,,,,United States
2197569,CHEMBL3989698,TRANYLCYPROMINE SULFATE,Black Box Warning,cardiotoxicity,,,,,United States
2197587,CHEMBL3989716,PROPOXYPHENE NAPSYLATE,Black Box Warning,,,,,,United States
2197587,CHEMBL3989716,PROPOXYPHENE NAPSYLATE,Withdrawn,cardiotoxicity,"when propoxyphene was taken at therapeutic doses, there were significant changes to the electrical activity of the heart which can increase the risk for serious abnormal heart rhythms",EFO:0004269,cardiac arrhythmia,2009.0,European Union; New Zealand; Canada; Iraq; United States
2197595,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,Black Box Warning,,,,,,United States
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,Black Box Warning,,,,,,United States
2197639,CHEMBL3989768,LEVORPHANOL TARTRATE,Black Box Warning,misuse,,,,,United States
2197639,CHEMBL3989768,LEVORPHANOL TARTRATE,Black Box Warning,respiratory toxicity,,,,,United States
2197639,CHEMBL3989768,LEVORPHANOL TARTRATE,Black Box Warning,cardiotoxicity,,,,,United States
2197640,CHEMBL3989769,NEOMYCIN SULFATE,Black Box Warning,neurotoxicity,,,,,United States
2197640,CHEMBL3989769,NEOMYCIN SULFATE,Black Box Warning,nephrotoxicity,,,,,United States
2197640,CHEMBL3989769,NEOMYCIN SULFATE,Black Box Warning,,,,,,United States
2197640,CHEMBL3989769,NEOMYCIN SULFATE,Withdrawn,metabolic toxicity,shown to cause malabsorption in children and to be of little or no therapeutic value.,EFO:0009554,malabsorption syndrome,1982.0,Bangladesh
2197674,CHEMBL3989803,DIPYRONE,Withdrawn,immune system toxicity,Agranulocytosis; Anaphylactic Reaction,MONDO:0100053,anaphylaxis,1975.0,Malaysia; Morocco; Ireland; Timor-Leste; Greece; Yemen; United Arab Emirates; Nigeria; Singapore; Denmark; United Kingdom; Saudi Arabia; Armenia; Sweden; Norway; France; Syrian Arab Republic; Nepal; Zimbabwe; United States; Ghana; Pakistan; Sri Lanka; Bahrain
2197674,CHEMBL3989803,DIPYRONE,Withdrawn,hematological toxicity,associated with potentially fatal agranulocytosis,HP:0012234,Agranulocytosis,1975.0,Malaysia; Morocco; Ireland; Timor-Leste; Greece; Yemen; United Arab Emirates; Nigeria; Singapore; Denmark; United Kingdom; Saudi Arabia; Armenia; Sweden; Norway; France; Syrian Arab Republic; Nepal; Zimbabwe; United States; Ghana; Pakistan; Sri Lanka; Bahrain
2197674,CHEMBL3989803,DIPYRONE,Withdrawn,hematological toxicity,Agranulocytosis; Anaphylactic Reaction,HP:0012234,Agranulocytosis,1975.0,Malaysia; Morocco; Ireland; Timor-Leste; Greece; Yemen; United Arab Emirates; Nigeria; Singapore; Denmark; United Kingdom; Saudi Arabia; Armenia; Sweden; Norway; France; Syrian Arab Republic; Nepal; Zimbabwe; United States; Ghana; Pakistan; Sri Lanka; Bahrain
2197674,CHEMBL3989803,DIPYRONE,Withdrawn,,Adverse reaction,EFO:0009658,adverse effect,1975.0,Malaysia; Morocco; Ireland; Timor-Leste; Greece; Yemen; United Arab Emirates; Nigeria; Singapore; Denmark; United Kingdom; Saudi Arabia; Armenia; Sweden; Norway; France; Syrian Arab Republic; Nepal; Zimbabwe; United States; Ghana; Pakistan; Sri Lanka; Bahrain
2197691,CHEMBL3989820,ZOLPIDEM TARTRATE,Black Box Warning,misuse,,,,,United States
2197691,CHEMBL3989820,ZOLPIDEM TARTRATE,Black Box Warning,vascular toxicity,,,,,United States
2197691,CHEMBL3989820,ZOLPIDEM TARTRATE,Black Box Warning,,,,,,United States
2197695,CHEMBL3989824,THIOTHIXENE HYDROCHLORIDE,Black Box Warning,,,,,,United States
2197701,CHEMBL3989830,SIBUTRAMINE HYDROCHLORIDE,Withdrawn,neurotoxicity,"cardiovascular events, such as heart attack, stroke and cardiac arrest",EFO:0000712,stroke,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
2197701,CHEMBL3989830,SIBUTRAMINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,"cardiovascular events, such as heart attack, stroke and cardiac arrest",EFO:0009492,cardiac arrest,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
2197701,CHEMBL3989830,SIBUTRAMINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,"cardiovascular events, such as heart attack, stroke and cardiac arrest",EFO:0000612,myocardial infarction,2010.0,India; European Union; Hong Kong; United States; New Zealand; Canada; Indonesia; Egypt; Guatemala; Australia
2197704,CHEMBL3989833,ZIPRASIDONE MESYLATE,Black Box Warning,,,,,,United States
2197716,CHEMBL3989845,IMIPRAMINE PAMOATE,Black Box Warning,psychiatric toxicity,,,,,United States
2197732,CHEMBL3989861,DESVENLAFAXINE FUMARATE,Black Box Warning,,,,,,United States
2197758,CHEMBL3989887,TACROLIMUS,Black Box Warning,carcinogenicity,,,,,United States
2197758,CHEMBL3989887,TACROLIMUS,Black Box Warning,immune system toxicity,,,,,United States
2197758,CHEMBL3989887,TACROLIMUS,Black Box Warning,infectious disease,,,,,United States
2197802,CHEMBL3989931,ENASIDENIB MESYLATE,Black Box Warning,carcinogenicity,,,,,United States
2197829,CHEMBL3989958,IVOSIDENIB,Black Box Warning,carcinogenicity,,,,,United States
2197844,CHEMBL3989973,PEXIDARTINIB HYDROCHLORIDE,Black Box Warning,,,,,,United States
2197857,CHEMBL3989986,RAVULIZUMAB,Black Box Warning,infectious disease,,,,,United States
2197860,CHEMBL3989989,AXICABTAGENE CILOLEUCEL,Black Box Warning,carcinogenicity,,,,,United States
146,CHEMBL4,OFLOXACIN,Black Box Warning,neurotoxicity,,,,,United States
146,CHEMBL4,OFLOXACIN,Black Box Warning,musculoskeletal toxicity,,,,,United States
2217,CHEMBL40,PHENOBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1985.0,Sweden
418415,CHEMBL400599,BENFLUOREX,Withdrawn,respiratory toxicity,heart valve diseases and pulmonary arterial hypertension,EFO:0001361,pulmonary arterial hypertension,2009.0,European Union
418415,CHEMBL400599,BENFLUOREX,Withdrawn,cardiotoxicity,heart valve diseases and pulmonary arterial hypertension,EFO:0009551,heart valve disease,2009.0,European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,Liver injury,EFO:0011052,hepatotoxicity,2007.0,Canada; Australia; European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,Serious liver-related adverse events,EFO:0004228,drug-induced liver injury,2007.0,Canada; Australia; European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,serious liver side effects,EFO:0011052,hepatotoxicity,2007.0,Canada; Australia; European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,Liver injury,EFO:0004228,drug-induced liver injury,2007.0,Canada; Australia; European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,Serious liver-related adverse events,EFO:0011052,hepatotoxicity,2007.0,Canada; Australia; European Union
424824,CHEMBL404108,LUMIRACOXIB,Withdrawn,hepatotoxicity,serious liver side effects,EFO:0004228,drug-induced liver injury,2007.0,Canada; Australia; European Union
418491,CHEMBL404849,SULOCTIDIL,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1985.0,Worldwide
418491,CHEMBL404849,SULOCTIDIL,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1985.0,Worldwide
418491,CHEMBL404849,SULOCTIDIL,Withdrawn,hepatotoxicity,hepatitis,EFO:0004228,drug-induced liver injury,1985.0,Worldwide
418491,CHEMBL404849,SULOCTIDIL,Withdrawn,hepatotoxicity,hepatitis,HP:0012115,Hepatitis,1985.0,Worldwide
543,CHEMBL405,AMPHETAMINE,Black Box Warning,misuse,,,,,United States
2205527,CHEMBL4065616,REMDESIVIR,Black Box Warning,,,,,,United States
2206847,CHEMBL4066936,VERICIGUAT,Black Box Warning,teratogenicity,,,,,United States
635,CHEMBL407,FLUMAZENIL,Black Box Warning,neurotoxicity,,,,,United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,"hepatic necrosis and failure, with a mean time to onset of 3 months.",EFO:0004228,drug-induced liver injury,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,"hepatic necrosis and failure, with a mean time to onset of 3 months.",HP:0002605,Hepatic necrosis,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0011052,hepatotoxicity,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,Severe hepatic adverse effects,EFO:0011052,hepatotoxicity,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,"hepatic necrosis and failure, with a mean time to onset of 3 months.",HP:0001399,Hepatic failure,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,Severe hepatic adverse effects,EFO:0004228,drug-induced liver injury,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,Hepatotoxicity,EFO:0004228,drug-induced liver injury,1997.0,Peru; United Kingdom; United States
666,CHEMBL408,TROGLITAZONE,Withdrawn,hepatotoxicity,"hepatic necrosis and failure, with a mean time to onset of 3 months.",EFO:0011052,hepatotoxicity,1997.0,Peru; United Kingdom; United States
2224030,CHEMBL4084119,LIRAGLUTIDE,Black Box Warning,carcinogenicity,,,,,United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,,higher occurrence of vaso-occlusive crises (VOC) during treatment. Higher number of deaths,PATO:0001422,dead,2024.0,United Kingdom; European Union; United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,,higher rate of vaso-occlusive crisis (severe pain caused by sickled red blood cells blocking blood flow and oxygen delivery to tissues) in patients with sickle cell disease receiving Oxbryta compared to placebo. There were also more deaths,PATO:0001422,dead,2024.0,United Kingdom; European Union; United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,vascular toxicity,higher occurrence of vaso-occlusive crises (VOC) during treatment. Higher number of deaths,EFO:0011062,vascular toxicity,2024.0,United Kingdom; European Union; United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,,unfavourable imbalance in the number of vaso-occlusive crises and fatal events,PATO:0001422,dead,2024.0,United Kingdom; European Union; United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,vascular toxicity,higher rate of vaso-occlusive crisis (severe pain caused by sickled red blood cells blocking blood flow and oxygen delivery to tissues) in patients with sickle cell disease receiving Oxbryta compared to placebo. There were also more deaths,EFO:0011062,vascular toxicity,2024.0,United Kingdom; European Union; United States
2241718,CHEMBL4101807,VOXELOTOR,Withdrawn,vascular toxicity,unfavourable imbalance in the number of vaso-occlusive crises and fatal events,EFO:0011062,vascular toxicity,2024.0,United Kingdom; European Union; United States
2245541,CHEMBL4105630,ZURANOLONE,Black Box Warning,,,,,,United States
923,CHEMBL413,SIROLIMUS,Black Box Warning,carcinogenicity,,,,,United States
923,CHEMBL413,SIROLIMUS,Black Box Warning,immune system toxicity,,,,,United States
923,CHEMBL413,SIROLIMUS,Black Box Warning,infectious disease,,,,,United States
923,CHEMBL413,SIROLIMUS,Black Box Warning,cardiotoxicity,,,,,United States
61945,CHEMBL41355,EZOGABINE,Black Box Warning,,,,,,United States
390990,CHEMBL414357,EXENATIDE,Black Box Warning,carcinogenicity,,,,,United States
243124,CHEMBL414804,OXALIPLATIN,Black Box Warning,immune system toxicity,,,,,United States
1063,CHEMBL416,METHOXSALEN,Black Box Warning,carcinogenicity,,,,,United States
176014,CHEMBL418995,AMINEPTINE,Withdrawn,dermatological toxicity,Abuse; Dependence; Severe Acne,EFO:0003894,acne,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Potential for abuse and risk of dependence; Follows the decision taken by France to suspend amineptine on the basis of abuse and dependency potential,MONDO:0002491,substance abuse,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Potential for abuse and risk of dependence,MONDO:0004938,substance dependence,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Abuse; Dependence; Severe Acne,MONDO:0002491,substance abuse,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Potential for abuse and risk of dependence,MONDO:0002491,substance abuse,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Potential for abuse and risk of dependence; Follows the decision taken by France to suspend amineptine on the basis of abuse and dependency potential,MONDO:0004938,substance dependence,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
176014,CHEMBL418995,AMINEPTINE,Withdrawn,drug misuse,Abuse; Dependence; Severe Acne,MONDO:0004938,substance dependence,1999.0,France; Thailand; United Arab Emirates; Vietnam; Morocco
189204,CHEMBL419213,LISINOPRIL,Black Box Warning,teratogenicity,,,,,United States
189204,CHEMBL419213,LISINOPRIL,Black Box Warning,cardiotoxicity,,,,,United States
2261,CHEMBL42,CLOZAPINE,Black Box Warning,hematological toxicity,,,,,United States
2261,CHEMBL42,CLOZAPINE,Black Box Warning,cardiotoxicity,,,,,United States
2261,CHEMBL42,CLOZAPINE,Black Box Warning,vascular toxicity,,,,,United States
2261,CHEMBL42,CLOZAPINE,Black Box Warning,neurotoxicity,,,,,United States
2261,CHEMBL42,CLOZAPINE,Black Box Warning,infectious disease,,,,,United States
2287105,CHEMBL4208954,AMIKACIN SULFATE,Black Box Warning,nephrotoxicity,,,,,United States
2287105,CHEMBL4208954,AMIKACIN SULFATE,Black Box Warning,neurotoxicity,,,,,United States
2287105,CHEMBL4208954,AMIKACIN SULFATE,Black Box Warning,respiratory toxicity,,,,,United States
128275,CHEMBL421701,DITHIAZANINE IODIDE,Withdrawn,vascular toxicity,fatal cases of severe acidosis and shock,HP:0031273,Shock,1964.0,France; Italy; Cuba; Chad
128275,CHEMBL421701,DITHIAZANINE IODIDE,Withdrawn,metabolic toxicity,fatal cases of severe acidosis and shock,EFO:1000014,acidosis,1964.0,France; Italy; Cuba; Chad
367314,CHEMBL426559,LAROPIPRANT,Withdrawn,,Higher frequency of non-fatal but serious side effects,EFO:0009658,adverse effect,2013.0,European Union
8062,CHEMBL428647,PACLITAXEL,Black Box Warning,immune system toxicity,,,,,United States
8062,CHEMBL428647,PACLITAXEL,Black Box Warning,hematological toxicity,,,,,United States
8062,CHEMBL428647,PACLITAXEL,Black Box Warning,dermatological toxicity,,,,,United States
8062,CHEMBL428647,PACLITAXEL,Black Box Warning,vascular toxicity,,,,,United States
2335035,CHEMBL4297064,MILNACIPRAN HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
2335059,CHEMBL4297088,CHLORHEXIDINE GLUCONATE,Withdrawn,dermatological toxicity,associated with chemical and thermal burns,EFO:0009503,caustic injury,1984.0,United States
2335059,CHEMBL4297088,CHLORHEXIDINE GLUCONATE,Withdrawn,dermatological toxicity,associated with chemical and thermal burns,EFO:0020910,thermal burn,1984.0,United States
2335062,CHEMBL4297091,CODEINE SULFATE,Black Box Warning,respiratory toxicity,,,,,United States
2335062,CHEMBL4297091,CODEINE SULFATE,Black Box Warning,misuse,,,,,United States
2335118,CHEMBL4297147,HALOPERIDOL LACTATE,Black Box Warning,psychiatric toxicity,,,,,United States
2335118,CHEMBL4297147,HALOPERIDOL LACTATE,Black Box Warning,,,,,,United States
2335187,CHEMBL4297216,FEDRATINIB HYDROCHLORIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2335200,CHEMBL4297229,PRABOTULINUMTOXIN A,Black Box Warning,,,,,,United States
2335488,CHEMBL4297517,MAVACAMTEN,Black Box Warning,cardiotoxicity,,,,,United States
2335505,CHEMBL4297534,GLASDEGIB MALEATE,Black Box Warning,,,,,,United States
2335505,CHEMBL4297534,GLASDEGIB MALEATE,Black Box Warning,teratogenicity,,,,,United States
2335508,CHEMBL4297537,INOTERSEN SODIUM,Black Box Warning,,,,,,United States
2335544,CHEMBL4297573,TAGRAXOFUSP,Black Box Warning,nephrotoxicity,,,,,United States
2335581,CHEMBL4297610,OLUTASIDENIB,Black Box Warning,cardiotoxicity,,,,,United States
2335581,CHEMBL4297610,OLUTASIDENIB,Black Box Warning,carcinogenicity,,,,,United States
2335605,CHEMBL4297634,GADOPICLENOL,Black Box Warning,dermatological toxicity,,,,,United States
2335705,CHEMBL4297734,CRIZANLIZUMAB,Withdrawn,,higher rate of severe and serious treatment-related side effects for Adakveo compared with placebo,EFO:0009658,adverse effect,2023.0,United Kingdom; European Union
2335705,CHEMBL4297734,CRIZANLIZUMAB,Withdrawn,,"benefit-risk balance of Adakveo is no longer considered favourable (No new safety concerns were identified. However, there were higher rates of grade 3 treatment related adverse events as well as of serious related adverse events for crizanlizumab compared to placebo.)",EFO:0009658,adverse effect,2023.0,United Kingdom; European Union
2335759,CHEMBL4297788,MOSUNETUZUMAB,Black Box Warning,immune system toxicity,,,,,United States
2335772,CHEMBL4297801,PEGUNIGALSIDASE ALFA,Black Box Warning,immune system toxicity,,,,,United States
2335772,CHEMBL4297801,PEGUNIGALSIDASE ALFA,Black Box Warning,neurotoxicity,,,,,United States
2335773,CHEMBL4297802,PEGVALIASE,Black Box Warning,,,,,,United States
2335780,CHEMBL4297809,ELRANATAMAB,Black Box Warning,,,,,,United States
2335810,CHEMBL4297839,TIRZEPATIDE,Black Box Warning,carcinogenicity,,,,,United States
2335812,CHEMBL4297841,TISOTUMAB VEDOTIN,Black Box Warning,nephrotoxicity,,,,,United States
2335815,CHEMBL4297844,TRASTUZUMAB DERUXTECAN,Black Box Warning,gastrointestinal toxicity,,,,,United States
2335815,CHEMBL4297844,TRASTUZUMAB DERUXTECAN,Black Box Warning,teratogenicity,,,,,United States
2335833,CHEMBL4297862,BOTULINUM TOXIN TYPE A,Black Box Warning,hepatotoxicity,,,,,United States
2335833,CHEMBL4297862,BOTULINUM TOXIN TYPE A,Black Box Warning,,,,,,United States
2335955,CHEMBL4297984,NAXITAMAB,Black Box Warning,vascular toxicity,,,,,United States
2335961,CHEMBL4297990,TEBENTAFUSP,Black Box Warning,,,,,,United States
2336057,CHEMBL4298086,POZELIMAB,Black Box Warning,infectious disease,,,,,United States
2336057,CHEMBL4298086,POZELIMAB,Black Box Warning,neurotoxicity,,,,,United States
2336063,CHEMBL4298092,GLOFITAMAB,Black Box Warning,immune system toxicity,,,,,United States
2336139,CHEMBL4298168,IBREXAFUNGERP CITRATE,Black Box Warning,teratogenicity,,,,,United States
2336151,CHEMBL4298180,DARVADSTROCEL,Withdrawn,,clinical benefit of Alofisel is no longer demonstrated and therefore it would not outweigh the risks associated with its use,EFO:0020002,lack of efficacy,2024.0,European Union
2336170,CHEMBL4298199,IDECABTAGENE VICLEUCEL,Black Box Warning,musculoskeletal toxicity,,,,,United States
2336170,CHEMBL4298199,IDECABTAGENE VICLEUCEL,Black Box Warning,hepatotoxicity,,,,,United States
2336170,CHEMBL4298199,IDECABTAGENE VICLEUCEL,Black Box Warning,hematological toxicity,,,,,United States
2336171,CHEMBL4298200,LIFILEUCEL,Black Box Warning,,,,,,United States
2336180,CHEMBL4298209,BELANTAMAB MAFODOTIN,Black Box Warning,,,,,,United States
2336180,CHEMBL4298209,BELANTAMAB MAFODOTIN,Withdrawn,,negative benefit risk balance,,,2024.0,United Kingdom
2336182,CHEMBL4298211,PEGCETACOPLAN,Black Box Warning,infectious disease,,,,,United States
2341011,CHEMBL4303060,MELPHALAN FLUFENAMIDE,Withdrawn,,increased risk of death,PATO:0001422,dead,2024.0,United States
2341159,CHEMBL4303288,ABACAVIR SULFATE,Black Box Warning,hepatotoxicity,,,,,United States
2341159,CHEMBL4303288,ABACAVIR SULFATE,Black Box Warning,metabolic toxicity,,,,,United States
2341159,CHEMBL4303288,ABACAVIR SULFATE,Black Box Warning,immune system toxicity,,,,,United States
58232,CHEMBL43128,PRIMAQUINE PHOSPHATE,Black Box Warning,,,,,,United States
1991,CHEMBL433,VALPROATE SODIUM,Black Box Warning,hepatotoxicity,,,,,United States
1991,CHEMBL433,VALPROATE SODIUM,Black Box Warning,teratogenicity,,,,,United States
1991,CHEMBL433,VALPROATE SODIUM,Black Box Warning,gastrointestinal toxicity,,,,,United States
63100,CHEMBL43452,POMALIDOMIDE,Black Box Warning,vascular toxicity,,,,,United States
63100,CHEMBL43452,POMALIDOMIDE,Black Box Warning,teratogenicity,,,,,United States
2084,CHEMBL436,TOLRESTAT,Withdrawn,hepatotoxicity,Hepatic necrosis,EFO:0004228,drug-induced liver injury,1996.0,Worldwide
2084,CHEMBL436,TOLRESTAT,Withdrawn,hepatotoxicity,Hepatic necrosis,EFO:0011052,hepatotoxicity,1996.0,Worldwide
2084,CHEMBL436,TOLRESTAT,Withdrawn,hepatotoxicity,Hepatic necrosis,HP:0002605,Hepatic necrosis,1996.0,Worldwide
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,nephrotoxicity,"renal complications, rash, fever, blood dyscrasias, and liver damage",HP:0000112,Nephropathy,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,hepatotoxicity,"renal complications, rash, fever, blood dyscrasias, and liver damage",EFO:0004228,drug-induced liver injury,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,dermatological toxicity,"renal complications, rash, fever, blood dyscrasias, and liver damage",EFO:1000697,exanthem,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,,crystalluria,,,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,,serious side effects,EFO:0009658,adverse effect,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,hematological toxicity,"renal complications, rash, fever, blood dyscrasias, and liver damage",EFO:0005803,hematologic disease,1970.0,United States; Philippines; Dominican Republic
2095,CHEMBL437,SULFATHIAZOLE,Withdrawn,hepatotoxicity,"renal complications, rash, fever, blood dyscrasias, and liver damage",EFO:0011052,hepatotoxicity,1970.0,United States; Philippines; Dominican Republic
61682,CHEMBL44354,CEFTAZIDIME,Black Box Warning,,,,,,United States
2265,CHEMBL446,SULFAMETHAZINE,Withdrawn,,benefit/risk ratio for these products is negative,,,1992.0,Germany
67839,CHEMBL44618,CHLOROFORM,Withdrawn,carcinogenicity,Carcinogenicity in rats,EFO:0011046,carcinogenicity,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,hepatotoxicity,Carcinogenic effects of chloroform on animals and possible hepatotoxic and nephrotoxic effects after prolonged use by humans,EFO:0011052,hepatotoxicity,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,carcinogenicity,carcinogenic in mice and rats,EFO:0011046,carcinogenicity,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,,Toxicity,,,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,cardiotoxicity,"Toxic to the liver and the heart, and to be carcinogenic",EFO:1001482,cardiotoxicity,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,nephrotoxicity,Carcinogenic effects of chloroform on animals and possible hepatotoxic and nephrotoxic effects after prolonged use by humans,EFO:0011056,nephrotoxicity,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,hepatotoxicity,Carcinogenic effects of chloroform on animals and possible hepatotoxic and nephrotoxic effects after prolonged use by humans,EFO:0004228,drug-induced liver injury,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
67839,CHEMBL44618,CHLOROFORM,Withdrawn,,Adverse effects and toxicity,EFO:0009658,adverse effect,1976.0,United States; Turkey; Japan; Italy; Canada; Philippines; Ethiopia; Dominican Republic; Nigeria; Ireland; Bangladesh; Oman
68607,CHEMBL44657,ETOPOSIDE,Black Box Warning,hematological toxicity,,,,,United States
68607,CHEMBL44657,ETOPOSIDE,Black Box Warning,nephrotoxicity,,,,,United States
68607,CHEMBL44657,ETOPOSIDE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2327,CHEMBL448,PENTOBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1980.0,Sweden; Norway
2327,CHEMBL448,PENTOBARBITAL,Withdrawn,drug misuse,Self-Poisonings,EFO:0008546,poisoning,1980.0,Sweden; Norway
2465,CHEMBL452,CLONAZEPAM,Black Box Warning,,,,,,United States
2465,CHEMBL452,CLONAZEPAM,Black Box Warning,misuse,,,,,United States
453046,CHEMBL452231,TENIPOSIDE,Black Box Warning,immune system toxicity,,,,,United States
453046,CHEMBL452231,TENIPOSIDE,Black Box Warning,hematological toxicity,,,,,United States
452239,CHEMBL455186,TREOSULFAN,Black Box Warning,hematological toxicity,,,,,United States
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,cardiotoxicity,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0004269,cardiac arrhythmia,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,musculoskeletal toxicity,Safety concerns in relation to potential for serious drug interactions.; Reports of life-threatening interactions of the drug: extremely low heart rates and a risk of muscle injury; Following reports of serious adverse effects caused by the interaction with other medicines,EFO:0011055,Musculoskeletal toxicity,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,,Safety concerns in relation to potential for serious drug interactions.; Reports of life-threatening interactions of the drug: extremely low heart rates and a risk of muscle injury; Following reports of serious adverse effects caused by the interaction with other medicines,EFO:0009878,drug interaction,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,musculoskeletal toxicity,reports of life- threatening interactions of the drug: extremely low heart rates and a risk of muscle injury,EFO:0011055,Musculoskeletal toxicity,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,cardiotoxicity,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0005307,torsades de pointes,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,,potential to induce cardiac arrhythmias (including torsades de pointes) especially when taken concomitantly with other medications,EFO:0009878,drug interaction,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,cardiotoxicity,Safety concerns in relation to potential for serious drug interactions.; Reports of life-threatening interactions of the drug: extremely low heart rates and a risk of muscle injury; Following reports of serious adverse effects caused by the interaction with other medicines,HP:0001662,Bradycardia,1998.0,Worldwide
72035,CHEMBL45816,MIBEFRADIL,Withdrawn,cardiotoxicity,reports of life- threatening interactions of the drug: extremely low heart rates and a risk of muscle injury,HP:0001662,Bradycardia,1998.0,Worldwide
2456099,CHEMBL4585668,BELZUTIFAN,Black Box Warning,cardiotoxicity,,,,,United States
2456099,CHEMBL4585668,BELZUTIFAN,Black Box Warning,teratogenicity,,,,,United States
2464648,CHEMBL4594217,CANAGLIFLOZIN,Black Box Warning,,,,,,United States
2464673,CHEMBL4594242,CALCITONIN,Withdrawn,carcinogenicity,Increased risk of malignancy,EFO:0011046,carcinogenicity,2013.0,Oman
2464732,CHEMBL4594301,REMIMAZOLAM BESYLATE,Black Box Warning,,,,,,United States
2464751,CHEMBL4594320,AVALGLUCOSIDASE ALFA,Black Box Warning,respiratory toxicity,,,,,United States
2464751,CHEMBL4594320,AVALGLUCOSIDASE ALFA,Black Box Warning,vascular toxicity,,,,,United States
2464760,CHEMBL4594329,CIPAGLUCOSIDASE ALFA,Black Box Warning,dermatological toxicity,,,,,United States
2464760,CHEMBL4594329,CIPAGLUCOSIDASE ALFA,Black Box Warning,respiratory toxicity,,,,,United States
2464760,CHEMBL4594329,CIPAGLUCOSIDASE ALFA,Black Box Warning,neurotoxicity,,,,,United States
2464764,CHEMBL4594333,ELIVALDOGENE AUTOTEMCEL,Black Box Warning,dermatological toxicity,,,,,United States
2464776,CHEMBL4594345,PEGULICIANINE ACETATE,Black Box Warning,,,,,,United States
2464813,CHEMBL4594382,DEURUXOLITINIB PHOSPHATE,Black Box Warning,,,,,,United States
2464934,CHEMBL4594503,TALQUETAMAB,Black Box Warning,immune system toxicity,,,,,United States
2464936,CHEMBL4594505,TECLISTAMAB,Black Box Warning,nephrotoxicity,,,,,United States
2464936,CHEMBL4594505,TECLISTAMAB,Black Box Warning,respiratory toxicity,,,,,United States
2464936,CHEMBL4594505,TECLISTAMAB,Black Box Warning,neurotoxicity,,,,,United States
2465049,CHEMBL4594618,BREXUCABTAGENE AUTOLEUCEL,Black Box Warning,,,,,,United States
452538,CHEMBL462547,URETHANE,Withdrawn,carcinogenicity,reported to have both a carcinogenic and mutagenic potential,EFO:0011046,carcinogenicity,1963.0,Germany; Denmark; Brazil; Egypt; Italy; Cuba; United States; Japan
452538,CHEMBL462547,URETHANE,Withdrawn,carcinogenicity,carcinogenic nature,EFO:0011046,carcinogenicity,1963.0,Germany; Denmark; Brazil; Egypt; Italy; Cuba; United States; Japan
4193,CHEMBL464,ETRETINATE,Withdrawn,teratogenicity,Risk for birth defects,EFO:0009880,Teratogenicity,1989.0,France; United States; Brazil
4193,CHEMBL464,ETRETINATE,Withdrawn,musculoskeletal toxicity,"Dangerous side effects, mainly myopathy",EFO:0004145,myopathy,1989.0,France; United States; Brazil
2486529,CHEMBL4650269,LOVOTIBEGLOGENE AUTOTEMCEL,Black Box Warning,,,,,,United States
2486653,CHEMBL4650393,EPCORITAMAB,Black Box Warning,immune system toxicity,,,,,United States
4730,CHEMBL467,HYDROXYUREA,Black Box Warning,carcinogenicity,,,,,United States
4730,CHEMBL467,HYDROXYUREA,Black Box Warning,hematological toxicity,,,,,United States
4730,CHEMBL467,HYDROXYUREA,Black Box Warning,infectious disease,,,,,United States
5028,CHEMBL468,THALIDOMIDE,Black Box Warning,teratogenicity,,,,,United States
5028,CHEMBL468,THALIDOMIDE,Black Box Warning,vascular toxicity,,,,,United States
5028,CHEMBL468,THALIDOMIDE,Withdrawn,teratogenicity,teratogenic effects,EFO:0009880,Teratogenicity,1963.0,Finland
488074,CHEMBL468837,HEPTABARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1984.0,Sweden
5080,CHEMBL469,KETOROLAC,Withdrawn,nephrotoxicity,"severe adverse reactions including renal failure, some of which were fatal.",EFO:1002048,kidney failure,1993.0,Germany; France
5080,CHEMBL469,KETOROLAC,Withdrawn,,high frequency and seriousness of adverse drug reactions,EFO:0009658,adverse effect,1993.0,Germany; France
66028,CHEMBL46917,CARBARIL,Withdrawn,carcinogenicity,Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman
5638,CHEMBL473,DOFETILIDE,Black Box Warning,cardiotoxicity,,,,,United States
460092,CHEMBL473417,VISMODEGIB,Black Box Warning,teratogenicity,,,,,United States
5772,CHEMBL476,DACARBAZINE,Black Box Warning,teratogenicity,,,,,United States
5772,CHEMBL476,DACARBAZINE,Black Box Warning,carcinogenicity,,,,,United States
5772,CHEMBL476,DACARBAZINE,Black Box Warning,hepatotoxicity,,,,,United States
5772,CHEMBL476,DACARBAZINE,Black Box Warning,hematological toxicity,,,,,United States
5772,CHEMBL476,DACARBAZINE,Black Box Warning,nephrotoxicity,,,,,United States
5970,CHEMBL479,THIORIDAZINE,Black Box Warning,,,,,,United States
5970,CHEMBL479,THIORIDAZINE,Withdrawn,cardiotoxicity,Cardiac arrythmias,EFO:0004269,cardiac arrhythmia,2005.0,Worldwide
2537490,CHEMBL4802239,MOBOCERTINIB SUCCINATE,Black Box Warning,,,,,,United States
2537490,CHEMBL4802239,MOBOCERTINIB SUCCINATE,Black Box Warning,cardiotoxicity,,,,,United States
2537505,CHEMBL4802254,AFAMITRESGENE AUTOLEUCEL,Black Box Warning,,,,,,United States
2537514,CHEMBL4802263,CILTACABTAGENE AUTOLEUCEL,Black Box Warning,musculoskeletal toxicity,,,,,United States
2537514,CHEMBL4802263,CILTACABTAGENE AUTOLEUCEL,Black Box Warning,hematological toxicity,,,,,United States
2537514,CHEMBL4802263,CILTACABTAGENE AUTOLEUCEL,Black Box Warning,hepatotoxicity,,,,,United States
6167,CHEMBL485,CODEINE,Withdrawn,drug misuse,misuse and abuse,MONDO:0002491,substance abuse,1985.0,Malaysia; Bangladesh
6167,CHEMBL485,CODEINE,Withdrawn,drug misuse,Liability for addiction and misuse,MONDO:0002491,substance abuse,1985.0,Malaysia; Bangladesh
6167,CHEMBL485,CODEINE,Withdrawn,drug misuse,Liability for addiction and misuse,MONDO:0004938,substance dependence,1985.0,Malaysia; Bangladesh
516056,CHEMBL485696,SULFISOMIDINE,Withdrawn,,benefit/risk ratio for these products is negative,,,1992.0,Germany
453831,CHEMBL488093,PYRITINOL,Withdrawn,drug misuse,evidence of insufficient therapeutic value and risk of misuse,MONDO:0002491,substance abuse,1982.0,Bangladesh
453831,CHEMBL488093,PYRITINOL,Withdrawn,drug misuse,evidence of insufficient therapeutic value and risk of misuse,EFO:0020002,lack of efficacy,1982.0,Bangladesh
8130,CHEMBL495,ALPROSTADIL,Black Box Warning,,,,,,United States
8130,CHEMBL495,ALPROSTADIL,Black Box Warning,teratogenicity,,,,,United States
8167,CHEMBL496,HEXACHLOROPHENE,Withdrawn,dermatological toxicity,"teratogenicity, embryotoxicity, neurotoxicity, photosensitizing and allergic potential",EFO:0020984,skin sensitization,1988.0,Union of Soviet Socialist Republics
8167,CHEMBL496,HEXACHLOROPHENE,Withdrawn,teratogenicity,"teratogenicity, embryotoxicity, neurotoxicity, photosensitizing and allergic potential",EFO:0009880,Teratogenicity,1988.0,Union of Soviet Socialist Republics
8167,CHEMBL496,HEXACHLOROPHENE,Withdrawn,dermatological toxicity,"teratogenicity, embryotoxicity, neurotoxicity, photosensitizing and allergic potential",EFO:1000753,phototoxic dermatitis,1988.0,Union of Soviet Socialist Republics
8167,CHEMBL496,HEXACHLOROPHENE,Withdrawn,neurotoxicity,"teratogenicity, embryotoxicity, neurotoxicity, photosensitizing and allergic potential",EFO:0011057,neurotoxicity,1988.0,Union of Soviet Socialist Republics
8167,CHEMBL496,HEXACHLOROPHENE,Withdrawn,immune system toxicity,"teratogenicity, embryotoxicity, neurotoxicity, photosensitizing and allergic potential",EFO:0009482,drug allergy,1988.0,Union of Soviet Socialist Republics
8193,CHEMBL497,CLIOQUINOL,Withdrawn,neurotoxicity,Implication in subacute myelo- optic neuropathy.,EFO:0020919,subacute myelo-opticoneuropathy,1973.0,France; Germany; United Kingdom; Japan; United States; Zimbabwe; Bangladesh; Philippines; Saudi Arabia; Ethiopia; Honduras
8193,CHEMBL497,CLIOQUINOL,Withdrawn,neurotoxicity,Neurotoxicity,EFO:0011057,neurotoxicity,1973.0,France; Germany; United Kingdom; Japan; United States; Zimbabwe; Bangladesh; Philippines; Saudi Arabia; Ethiopia; Honduras
8193,CHEMBL497,CLIOQUINOL,Withdrawn,neurotoxicity,Propensity to cause neurological disorders,EFO:0011057,neurotoxicity,1973.0,France; Germany; United Kingdom; Japan; United States; Zimbabwe; Bangladesh; Philippines; Saudi Arabia; Ethiopia; Honduras
8838,CHEMBL501,AMPHETAMINE SULFATE,Black Box Warning,cardiotoxicity,,,,,United States
8838,CHEMBL501,AMPHETAMINE SULFATE,Black Box Warning,misuse,,,,,United States
8838,CHEMBL501,AMPHETAMINE SULFATE,Black Box Warning,neurotoxicity,,,,,United States
490427,CHEMBL501867,VINCRISTINE SULFATE,Black Box Warning,misuse,,,,,United States
456123,CHEMBL502097,MIPOMERSEN SODIUM,Black Box Warning,,,,,,United States
487855,CHEMBL503565,VINBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1984.0,Sweden
77129,CHEMBL50588,EMETINE,Withdrawn,,Harmful,,,1982.0,Mauritius
2739482,CHEMBL5095051,VENLAFAXINE BESYLATE,Black Box Warning,,,,,,United States
2739832,CHEMBL5095401,IPTACOPAN HYDROCHLORIDE,Black Box Warning,,,,,,United States
2739871,CHEMBL5095440,OBECABTAGENE AUTOLEUCEL,Black Box Warning,,,,,,United States
446784,CHEMBL511142,BUPRENORPHINE,Black Box Warning,misuse,,,,,United States
446784,CHEMBL511142,BUPRENORPHINE,Black Box Warning,respiratory toxicity,,,,,United States
459679,CHEMBL512351,BETRIXABAN,Black Box Warning,vascular toxicity,,,,,United States
10898,CHEMBL514,LOMUSTINE,Black Box Warning,hematological toxicity,,,,,United States
11002,CHEMBL515,CHLORAMBUCIL,Black Box Warning,carcinogenicity,,,,,United States
11002,CHEMBL515,CHLORAMBUCIL,Black Box Warning,teratogenicity,,,,,United States
11002,CHEMBL515,CHLORAMBUCIL,Black Box Warning,hematological toxicity,,,,,United States
453649,CHEMBL515914,AZARIBINE,Withdrawn,vascular toxicity,Thromboembolism,HP:0001907,Thromboembolism,1976.0,United States; Mauritius; Saudi Arabia
453649,CHEMBL515914,AZARIBINE,Withdrawn,,Adverse effect,EFO:0009658,adverse effect,1976.0,United States; Mauritius; Saudi Arabia
11674,CHEMBL521,IBUPROFEN,Black Box Warning,gastrointestinal toxicity,,,,,United States
11674,CHEMBL521,IBUPROFEN,Black Box Warning,neurotoxicity,,,,,United States
11674,CHEMBL521,IBUPROFEN,Black Box Warning,cardiotoxicity,,,,,United States
11674,CHEMBL521,IBUPROFEN,Black Box Warning,vascular toxicity,,,,,United States
461225,CHEMBL521606,NADOLOL,Black Box Warning,cardiotoxicity,,,,,United States
478003,CHEMBL522038,XIMELAGATRAN,Withdrawn,hepatotoxicity,severe liver injury during longer-term (more than 11 days) treatment,EFO:0004228,drug-induced liver injury,2006.0,Worldwide
478003,CHEMBL522038,XIMELAGATRAN,Withdrawn,hepatotoxicity,severe liver injury during longer-term (more than 11 days) treatment,EFO:0011052,hepatotoxicity,2006.0,Worldwide
478003,CHEMBL522038,XIMELAGATRAN,Withdrawn,hepatotoxicity,serious liver injury,EFO:0011052,hepatotoxicity,2006.0,Worldwide
478003,CHEMBL522038,XIMELAGATRAN,Withdrawn,hepatotoxicity,serious liver injury,EFO:0004228,drug-induced liver injury,2006.0,Worldwide
500007,CHEMBL525610,TERIPARATIDE,Black Box Warning,carcinogenicity,,,,,United States
11968,CHEMBL527,PIROXICAM,Black Box Warning,cardiotoxicity,,,,,United States
11968,CHEMBL527,PIROXICAM,Black Box Warning,neurotoxicity,,,,,United States
11968,CHEMBL527,PIROXICAM,Black Box Warning,gastrointestinal toxicity,,,,,United States
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
12494,CHEMBL531,PERGOLIDE,Withdrawn,cardiotoxicity,Valvulopathy,EFO:0009551,heart valve disease,2007.0,United States; Canada
2832006,CHEMBL5314355,POLYMYXIN B SULFATE,Black Box Warning,neurotoxicity,,,,,United States
2832006,CHEMBL5314355,POLYMYXIN B SULFATE,Black Box Warning,,,,,,United States
2832013,CHEMBL5314362,ENTECAVIR,Black Box Warning,metabolic toxicity,,,,,United States
2832013,CHEMBL5314362,ENTECAVIR,Black Box Warning,hepatotoxicity,,,,,United States
2832013,CHEMBL5314362,ENTECAVIR,Black Box Warning,immune system toxicity,,,,,United States
2832026,CHEMBL5314375,CIDOFOVIR,Black Box Warning,hematological toxicity,,,,,United States
2832026,CHEMBL5314375,CIDOFOVIR,Black Box Warning,teratogenicity,,,,,United States
2832026,CHEMBL5314375,CIDOFOVIR,Black Box Warning,carcinogenicity,,,,,United States
2832026,CHEMBL5314375,CIDOFOVIR,Black Box Warning,nephrotoxicity,,,,,United States
2832030,CHEMBL5314379,VOCLOSPORIN,Black Box Warning,infectious disease,,,,,United States
2832030,CHEMBL5314379,VOCLOSPORIN,Black Box Warning,carcinogenicity,,,,,United States
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,Black Box Warning,vascular toxicity,,,,,United States
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,Black Box Warning,infectious disease,,,,,United States
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,Black Box Warning,cardiotoxicity,,,,,United States
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,Black Box Warning,carcinogenicity,,,,,United States
2832699,CHEMBL5315048,ZILUCOPLAN SODIUM,Black Box Warning,,,,,,United States
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,Black Box Warning,vascular toxicity,,,,,United States
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,Black Box Warning,carcinogenicity,,,,,United States
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,Black Box Warning,gastrointestinal toxicity,,,,,United States
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,Black Box Warning,neurotoxicity,,,,,United States
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,Black Box Warning,respiratory toxicity,,,,,United States
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,Black Box Warning,infectious disease,,,,,United States
78364,CHEMBL53292,ISOXICAM,Withdrawn,dermatological toxicity,Stevens Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0004775,toxic epidermal necrolysis,1983.0,Worldwide
78364,CHEMBL53292,ISOXICAM,Withdrawn,dermatological toxicity,Stevens Johnson Syndrome; Toxic Epidermal Necrolysis,EFO:0004276,Stevens-Johnson syndrome,1983.0,Worldwide
78364,CHEMBL53292,ISOXICAM,Withdrawn,dermatological toxicity,"severe skin reactions, some of which were fatal",EFO:0020927,skin reaction,1983.0,Worldwide
82895,CHEMBL53418,DANTHRON,Withdrawn,carcinogenicity,Carcinogenicity,EFO:0011046,carcinogenicity,1988.0,United States; Canada; Singapore
82895,CHEMBL53418,DANTHRON,Withdrawn,carcinogenicity,Potential carcinogenicity,EFO:0011046,carcinogenicity,1988.0,United States; Canada; Singapore
82895,CHEMBL53418,DANTHRON,Withdrawn,carcinogenicity,May have a carcinogenic potential,EFO:0011046,carcinogenicity,1988.0,United States; Canada; Singapore
543171,CHEMBL535650,MEFLOQUINE HYDROCHLORIDE,Black Box Warning,psychiatric toxicity,,,,,United States
564219,CHEMBL538943,VINORELBINE TARTRATE,Black Box Warning,hematological toxicity,,,,,United States
564219,CHEMBL538943,VINORELBINE TARTRATE,Black Box Warning,infectious disease,,,,,United States
298316,CHEMBL539423,SPARSENTAN,Black Box Warning,teratogenicity,,,,,United States
298316,CHEMBL539423,SPARSENTAN,Black Box Warning,hepatotoxicity,,,,,United States
551160,CHEMBL539770,TERODILINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Ventricular Tachycardia and Arrhythmia,EFO:0005306,ventricular tachycardia,1991.0,Worldwide
551160,CHEMBL539770,TERODILINE HYDROCHLORIDE,Withdrawn,cardiotoxicity,Ventricular Tachycardia and Arrhythmia,HP:0004308,Ventricular arrhythmia,1991.0,Worldwide
3859,CHEMBL54,HALOPERIDOL,Black Box Warning,psychiatric toxicity,,,,,United States
3859,CHEMBL54,HALOPERIDOL,Black Box Warning,,,,,,United States
3859,CHEMBL54,HALOPERIDOL,Black Box Warning,respiratory toxicity,,,,,United States
83245,CHEMBL54349,ALPIDEM,Withdrawn,hepatotoxicity,Hepatitis,EFO:0004228,drug-induced liver injury,1993.0,France
83245,CHEMBL54349,ALPIDEM,Withdrawn,hepatotoxicity,Hepatitis,HP:0012115,Hepatitis,1993.0,France
83245,CHEMBL54349,ALPIDEM,Withdrawn,hepatotoxicity,Hepatitis,EFO:0011052,hepatotoxicity,1993.0,France
13928,CHEMBL547,ISOTRETINOIN,Black Box Warning,teratogenicity,,,,,United States
2882636,CHEMBL5483015,ARSENIC TRIOXIDE,Black Box Warning,carcinogenicity,,,,,United States
2882636,CHEMBL5483015,ARSENIC TRIOXIDE,Black Box Warning,cardiotoxicity,,,,,United States
84633,CHEMBL54976,TRYPTOPHAN,Withdrawn,musculoskeletal toxicity,eosinophilia-myalgia syndrome,EFO:1001316,Eosinophilia-Myalgia Syndrome,1989.0,Germany; United Kingdom; Japan; Oman
84633,CHEMBL54976,TRYPTOPHAN,Withdrawn,hematological toxicity,eosinophilia-myalgia syndrome,EFO:1001316,Eosinophilia-Myalgia Syndrome,1989.0,Germany; United Kingdom; Japan; Oman
84633,CHEMBL54976,TRYPTOPHAN,Withdrawn,hematological toxicity,Eosinophilic Myalgia Syndrome,EFO:1001316,Eosinophilia-Myalgia Syndrome,1989.0,Germany; United Kingdom; Japan; Oman
84633,CHEMBL54976,TRYPTOPHAN,Withdrawn,musculoskeletal toxicity,Eosinophilic Myalgia Syndrome,EFO:1001316,Eosinophilia-Myalgia Syndrome,1989.0,Germany; United Kingdom; Japan; Oman
564990,CHEMBL550348,DEFERASIROX,Black Box Warning,gastrointestinal toxicity,,,,,United States
564990,CHEMBL550348,DEFERASIROX,Black Box Warning,nephrotoxicity,,,,,United States
564990,CHEMBL550348,DEFERASIROX,Black Box Warning,hepatotoxicity,,,,,United States
564990,CHEMBL550348,DEFERASIROX,Black Box Warning,vascular toxicity,,,,,United States
564990,CHEMBL550348,DEFERASIROX,Black Box Warning,metabolic toxicity,,,,,United States
563451,CHEMBL550495,METHYLENE BLUE,Black Box Warning,,,,,,United States
16308,CHEMBL563,FLURBIPROFEN,Black Box Warning,cardiotoxicity,,,,,United States
16308,CHEMBL563,FLURBIPROFEN,Black Box Warning,gastrointestinal toxicity,,,,,United States
16308,CHEMBL563,FLURBIPROFEN,Black Box Warning,neurotoxicity,,,,,United States
85553,CHEMBL56367,NIMESULIDE,Withdrawn,,Adverse health effects,EFO:0009658,adverse effect,2005.0,Nigeria; Bhutan; Ireland
85553,CHEMBL56367,NIMESULIDE,Withdrawn,hepatotoxicity,Hepatoxicity and neonatal renal failure,EFO:0004228,drug-induced liver injury,2005.0,Nigeria; Bhutan; Ireland
85553,CHEMBL56367,NIMESULIDE,Withdrawn,hepatotoxicity,Hepatoxicity and neonatal renal failure,EFO:0011052,hepatotoxicity,2005.0,Nigeria; Bhutan; Ireland
85553,CHEMBL56367,NIMESULIDE,Withdrawn,hepatotoxicity,Liver damage,EFO:0004228,drug-induced liver injury,2005.0,Nigeria; Bhutan; Ireland
85553,CHEMBL56367,NIMESULIDE,Withdrawn,nephrotoxicity,Hepatoxicity and neonatal renal failure,EFO:1002048,kidney failure,2005.0,Nigeria; Bhutan; Ireland
85553,CHEMBL56367,NIMESULIDE,Withdrawn,hepatotoxicity,Liver damage,EFO:0011052,hepatotoxicity,2005.0,Nigeria; Bhutan; Ireland
16415,CHEMBL565,CLOFIBRATE,Withdrawn,vascular toxicity,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",HP:0001907,Thromboembolism,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,carcinogenicity,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",EFO:0011046,carcinogenicity,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",MONDO:0002155,cholecystitis,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,,Increased mortality associated with use,PATO:0001422,dead,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,cardiotoxicity,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",EFO:0004269,cardiac arrhythmia,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",EFO:0004210,gallstones,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,cardiotoxicity,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",NCIT:C51221,Angina,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",NCIT:C50495,Claudication,1979.0,Israel; Norway; Bangladesh
16415,CHEMBL565,CLOFIBRATE,Withdrawn,,"Increases the incidence of gallstones and cholecystitis, drug-induced cardiac arrhythmias, cardiomegaly, angina, claudication and thromboembolic phenomena. It also enhances the effects and toxicity of other acidic drugs and it is implicated in the incidence of various tumours",EFO:0009878,drug interaction,1979.0,Israel; Norway; Bangladesh
574221,CHEMBL566315,OBETICHOLIC ACID,Black Box Warning,,,,,,United States
574221,CHEMBL566315,OBETICHOLIC ACID,Withdrawn,,benefits are no longer considered to outweigh its risks,,,2024.0,European Union
16505,CHEMBL567,PERPHENAZINE,Black Box Warning,psychiatric toxicity,,,,,United States
16505,CHEMBL567,PERPHENAZINE,Black Box Warning,,,,,,United States
16506,CHEMBL568,OXAZEPAM,Black Box Warning,,,,,,United States
16506,CHEMBL568,OXAZEPAM,Black Box Warning,misuse,,,,,United States
4345,CHEMBL57,NEVIRAPINE,Black Box Warning,immune system toxicity,,,,,United States
4345,CHEMBL57,NEVIRAPINE,Black Box Warning,hepatotoxicity,,,,,United States
4345,CHEMBL57,NEVIRAPINE,Black Box Warning,dermatological toxicity,,,,,United States
16591,CHEMBL571,KETOPROFEN,Black Box Warning,cardiotoxicity,,,,,United States
16591,CHEMBL571,KETOPROFEN,Black Box Warning,gastrointestinal toxicity,,,,,United States
16591,CHEMBL571,KETOPROFEN,Black Box Warning,neurotoxicity,,,,,United States
581798,CHEMBL576127,FENSPIRIDE,Withdrawn,cardiotoxicity,Heart rhythm problems. This included cases of QT prolongation and torsades de pointes (abnormalities of the hearts electrical activity that may lead to heart rhythm disturbances).,EFO:0005307,torsades de pointes,2019.0,European Union
581798,CHEMBL576127,FENSPIRIDE,Withdrawn,cardiotoxicity,Heart rhythm problems. This included cases of QT prolongation and torsades de pointes (abnormalities of the hearts electrical activity that may lead to heart rhythm disturbances).,HP:0001657,Prolonged QT interval,2019.0,European Union
574539,CHEMBL578767,FLUMEXADOL,Withdrawn,,benefit/risk ratio for these products is negative,,,1992.0,Germany
16959,CHEMBL580,LORAZEPAM,Black Box Warning,,,,,,United States
16959,CHEMBL580,LORAZEPAM,Black Box Warning,misuse,,,,,United States
17411,CHEMBL585,TRIAMTERENE,Black Box Warning,metabolic toxicity,,,,,United States
19915,CHEMBL596,FENTANYL,Black Box Warning,respiratory toxicity,,,,,United States
19915,CHEMBL596,FENTANYL,Black Box Warning,misuse,,,,,United States
20496,CHEMBL599,MELOXICAM,Black Box Warning,gastrointestinal toxicity,,,,,United States
20496,CHEMBL599,MELOXICAM,Black Box Warning,cardiotoxicity,,,,,United States
20496,CHEMBL599,MELOXICAM,Black Box Warning,neurotoxicity,,,,,United States
173,CHEMBL6,INDOMETHACIN,Black Box Warning,neurotoxicity,,,,,United States
173,CHEMBL6,INDOMETHACIN,Black Box Warning,gastrointestinal toxicity,,,,,United States
173,CHEMBL6,INDOMETHACIN,Black Box Warning,cardiotoxicity,,,,,United States
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,Black Box Warning,cardiotoxicity,,,,,United States
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,Black Box Warning,hematological toxicity,,,,,United States
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,Black Box Warning,dermatological toxicity,,,,,United States
22391,CHEMBL606,MISOPROSTOL,Black Box Warning,teratogenicity,,,,,United States
22391,CHEMBL606,MISOPROSTOL,Black Box Warning,cardiotoxicity,,,,,United States
22391,CHEMBL606,MISOPROSTOL,Black Box Warning,hematological toxicity,,,,,United States
3283075,CHEMBL6067484,GENTAMICIN SULFATE,Black Box Warning,neurotoxicity,,,,,United States
3283075,CHEMBL6067484,GENTAMICIN SULFATE,Black Box Warning,nephrotoxicity,,,,,United States
3283075,CHEMBL6067484,GENTAMICIN SULFATE,Black Box Warning,teratogenicity,,,,,United States
3283075,CHEMBL6067484,GENTAMICIN SULFATE,Black Box Warning,,,,,,United States
3283084,CHEMBL6067493,BLEOMYCIN SULFATE,Black Box Warning,respiratory toxicity,,,,,United States
3283819,CHEMBL6068328,ELTROMBOPAG CHOLINE,Black Box Warning,,,,,,United States
3283886,CHEMBL6068395,REVUMENIB CITRATE,Black Box Warning,,,,,,United States
22641,CHEMBL608,PROBUCOL,Withdrawn,metabolic toxicity,Reduction in serum HDL-C levels and partly because of possible QT interval prolongation or ventricular arrhythmias,EFO:0004612,high density lipoprotein cholesterol measurement,1995.0,United States
22641,CHEMBL608,PROBUCOL,Withdrawn,cardiotoxicity,Reduction in serum HDL-C levels and partly because of possible QT interval prolongation or ventricular arrhythmias,HP:0001657,Prolonged QT interval,1995.0,United States
22641,CHEMBL608,PROBUCOL,Withdrawn,cardiotoxicity,Reduction in serum HDL-C levels and partly because of possible QT interval prolongation or ventricular arrhythmias,HP:0004308,Ventricular arrhythmia,1995.0,United States
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,risk of serious haemorrhagic strokes,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,Haemorrhagic stroke. Severe high blood pressure.,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,vascular toxicity,Haemorrhagic stroke. Severe high blood pressure.,EFO:0000537,hypertension,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,cardiotoxicity,Associated with strokes.,EFO:0000712,stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,Associated with strokes.,EFO:0000712,stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,Risk of hemorrhagic stroke,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,vascular toxicity,"hypertensive episodes in susceptible individuals, particularly when taken together with coffee, alcohol, antihistamines or neuroleptics",EFO:0000537,hypertension,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,Risk of haemorrhagic stroke,EFO:0020921,hemorrhagic stroke,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,neurotoxicity,potential of these products to induce several adverse reactions including cerebral haemorrhage,ZP:0000527,"brain hemorrhagic, abnormal",1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
94091,CHEMBL61006,PHENYLPROPANOLAMINE,Withdrawn,vascular toxicity,"hypertensive episodes in susceptible individuals, particularly when taken together with coffee, alcohol, antihistamines or neuroleptics",EFO:0009878,drug interaction,1987.0,Australia; Bhutan; Timor-Leste; South Korea; United States; Canada; Singapore; Malaysia; Brazil; Germany
23199,CHEMBL612,DEXTROAMPHETAMINE,Black Box Warning,neurotoxicity,,,,,United States
23199,CHEMBL612,DEXTROAMPHETAMINE,Black Box Warning,misuse,,,,,United States
93930,CHEMBL62193,SULFADIMETHOXINE,Withdrawn,dermatological toxicity,Stevens-Johnson syndrome and fatalities,EFO:0004276,Stevens-Johnson syndrome,1966.0,United States
93930,CHEMBL62193,SULFADIMETHOXINE,Withdrawn,,Stevens-Johnson syndrome and fatalities,PATO:0001422,dead,1966.0,United States
26431,CHEMBL622,ETODOLAC,Black Box Warning,cardiotoxicity,,,,,United States
26431,CHEMBL622,ETODOLAC,Black Box Warning,gastrointestinal toxicity,,,,,United States
26431,CHEMBL622,ETODOLAC,Black Box Warning,neurotoxicity,,,,,United States
26465,CHEMBL623,NEFAZODONE,Withdrawn,hepatotoxicity,acute hepatic failure,EFO:0004228,drug-induced liver injury,2003.0,Canada; Spain; Turkey
26465,CHEMBL623,NEFAZODONE,Withdrawn,hepatotoxicity,life-threatening hepatotoxicity,EFO:0011052,hepatotoxicity,2003.0,Canada; Spain; Turkey
26465,CHEMBL623,NEFAZODONE,Withdrawn,hepatotoxicity,acute hepatic failure,HP:0001399,Hepatic failure,2003.0,Canada; Spain; Turkey
27278,CHEMBL637,VENLAFAXINE,Black Box Warning,psychiatric toxicity,,,,,United States
104250,CHEMBL63857,PHENOLPHTHALEIN,Withdrawn,carcinogenicity,May cause cancer,EFO:0011046,carcinogenicity,1997.0,Oman; Canada; Saudi Arabia
104250,CHEMBL63857,PHENOLPHTHALEIN,Withdrawn,carcinogenicity,May cause cancer; Potential risk of carcinogenicity,EFO:0011046,carcinogenicity,1997.0,Oman; Canada; Saudi Arabia
4941,CHEMBL64,ISONIAZID,Black Box Warning,hepatotoxicity,,,,,United States
4941,CHEMBL64,ISONIAZID,Black Box Warning,gastrointestinal toxicity,,,,,United States
573,CHEMBL6437,MIANSERIN,Withdrawn,,adverse effects,EFO:0009658,adverse effect,1986.0,Oman
97867,CHEMBL64391,ITRACONAZOLE,Black Box Warning,cardiotoxicity,,,,,United States
27419,CHEMBL646,TRIAZOLAM,Black Box Warning,,,,,,United States
27419,CHEMBL646,TRIAZOLAM,Black Box Warning,misuse,,,,,United States
27419,CHEMBL646,TRIAZOLAM,Withdrawn,neurotoxicity,Psychiatric reaction and amnesia,EFO:1001454,amnesia,1982.0,France; United Kingdom; Argentina; Finland; Netherlands
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,Psychiatric reaction and amnesia,MONDO:0002009,major depressive disorder,1982.0,France; United Kingdom; Argentina; Finland; Netherlands
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,"serious psychiatric adverse effects, including memory disturbances, anxiety, depression and agressivity",EFO:0003015,aggressive behavior,1982.0,Norway
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,"serious psychiatric adverse effects, including memory disturbances, anxiety, depression and agressivity",MONDO:0002009,major depressive disorder,1982.0,Norway
27419,CHEMBL646,TRIAZOLAM,Withdrawn,neurotoxicity,"psychiatric adverse effects, particularly loss of memory and depression",EFO:1001454,amnesia,1982.0,France; United Kingdom; Argentina; Finland; Netherlands
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,"serious psychiatric adverse effects, including memory disturbances, anxiety, depression and agressivity",EFO:0001072,memory impairment,1982.0,Norway
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,"psychiatric adverse effects, particularly loss of memory and depression",MONDO:0002009,major depressive disorder,1982.0,France; United Kingdom; Argentina; Finland; Netherlands
27419,CHEMBL646,TRIAZOLAM,Withdrawn,,harmful,,,1982.0,Mauritius
27419,CHEMBL646,TRIAZOLAM,Withdrawn,psychiatric toxicity,"serious psychiatric adverse effects, including memory disturbances, anxiety, depression and agressivity",EFO:0005230,anxiety,1982.0,Norway
1256,CHEMBL6466,COUMARIN,Withdrawn,hepatotoxicity,Hepatic adverse effects,EFO:0004228,drug-induced liver injury,1996.0,France
1256,CHEMBL6466,COUMARIN,Withdrawn,hepatotoxicity,Hepatic adverse effects,EFO:0011052,hepatotoxicity,1996.0,France
98346,CHEMBL64894,GENTIAN VIOLET,Withdrawn,gastrointestinal toxicity,"Reports of adverse reactions and toxicity such as buccal ulceration, stomatitis, kerato-conjunctivitis. Studies have shown methylrosanilinium chloride to be a carcinogen in mice and it has been labelled as a mutagen, a mitotic poison and a clastogen",EFO:0009688,stomatitis,1998.0,Malaysia
98346,CHEMBL64894,GENTIAN VIOLET,Withdrawn,carcinogenicity,"Reports of adverse reactions and toxicity such as buccal ulceration, stomatitis, kerato-conjunctivitis. Studies have shown methylrosanilinium chloride to be a carcinogen in mice and it has been labelled as a mutagen, a mitotic poison and a clastogen",EFO:0011046,carcinogenicity,1998.0,Malaysia
98346,CHEMBL64894,GENTIAN VIOLET,Withdrawn,gastrointestinal toxicity,"Reports of adverse reactions and toxicity such as buccal ulceration, stomatitis, kerato-conjunctivitis. Studies have shown methylrosanilinium chloride to be a carcinogen in mice and it has been labelled as a mutagen, a mitotic poison and a clastogen",HP:0000155,Oral ulcer,1998.0,Malaysia
98346,CHEMBL64894,GENTIAN VIOLET,Withdrawn,occular toxicity,"Reports of adverse reactions and toxicity such as buccal ulceration, stomatitis, kerato-conjunctivitis. Studies have shown methylrosanilinium chloride to be a carcinogen in mice and it has been labelled as a mutagen, a mitotic poison and a clastogen",MONDO:0004768,Keratoconjunctivitis,1998.0,Malaysia
27610,CHEMBL654,MIRTAZAPINE,Black Box Warning,psychiatric toxicity,,,,,United States
27611,CHEMBL655,MIDAZOLAM,Black Box Warning,,,,,,United States
27624,CHEMBL656,OXYCODONE,Black Box Warning,respiratory toxicity,,,,,United States
27624,CHEMBL656,OXYCODONE,Black Box Warning,misuse,,,,,United States
27648,CHEMBL661,ALPRAZOLAM,Black Box Warning,,,,,,United States
27648,CHEMBL661,ALPRAZOLAM,Black Box Warning,misuse,,,,,United States
28310,CHEMBL671,THIOTEPA,Black Box Warning,hematological toxicity,,,,,United States
28310,CHEMBL671,THIOTEPA,Black Box Warning,carcinogenicity,,,,,United States
28310,CHEMBL671,THIOTEPA,Black Box Warning,teratogenicity,,,,,United States
29989,CHEMBL686,MEFENAMIC ACID,Black Box Warning,neurotoxicity,,,,,United States
29989,CHEMBL686,MEFENAMIC ACID,Black Box Warning,gastrointestinal toxicity,,,,,United States
29989,CHEMBL686,MEFENAMIC ACID,Black Box Warning,cardiotoxicity,,,,,United States
30072,CHEMBL688,FENTANYL CITRATE,Black Box Warning,respiratory toxicity,,,,,United States
30072,CHEMBL688,FENTANYL CITRATE,Black Box Warning,misuse,,,,,United States
1380,CHEMBL6995,PRACTOLOL,Withdrawn,ototoxicity,harmful effects on hearing and on the eyes and skin,EFO:0006951,ototoxicity,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,,health risks associated with use and/or questionable therapeutic value,EFO:0020002,lack of efficacy,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,occular toxicity,harmful effects on hearing and on the eyes and skin,EFO:0020928,occular toxicity,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,,health risks associated with use and/or questionable therapeutic value,EFO:0009658,adverse effect,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,dermatological toxicity,harmful effects on hearing and on the eyes and skin,EFO:0011048,dermatological toxicity,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,immune system toxicity,"serious hypersensitivity reactions, some of which were fatal",EFO:1002004,drug hypersensitivity syndrome,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,immune system toxicity,"serious hypersensitivity reactions, some of which were fatal",EFO:0009482,drug allergy,1975.0,India; Mauritius; Turkey; Germany
1380,CHEMBL6995,PRACTOLOL,Withdrawn,,"serious hypersensitivity reactions, some of which were fatal",PATO:0001422,dead,1975.0,India; Mauritius; Turkey; Germany
110103,CHEMBL70046,SORIVUDINE,Withdrawn,,Drug Interaction with 5-FU and Deaths,PATO:0001422,dead,1993.0,Japan
110103,CHEMBL70046,SORIVUDINE,Withdrawn,,Drug Interaction with 5-FU and Deaths,EFO:0009878,drug interaction,1993.0,Japan
32869,CHEMBL701,BACLOFEN,Black Box Warning,musculoskeletal toxicity,,,,,United States
32869,CHEMBL701,BACLOFEN,Black Box Warning,psychiatric toxicity,,,,,United States
32869,CHEMBL701,BACLOFEN,Black Box Warning,neurotoxicity,,,,,United States
111390,CHEMBL70418,CLOBAZAM,Black Box Warning,,,,,,United States
111390,CHEMBL70418,CLOBAZAM,Black Box Warning,misuse,,,,,United States
112090,CHEMBL70927,DEFERIPRONE,Black Box Warning,hematological toxicity,,,,,United States
34094,CHEMBL714,ALBUTEROL,Black Box Warning,,,,,,United States
34197,CHEMBL715,OLANZAPINE,Black Box Warning,,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,neurotoxicity,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,vascular toxicity,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,cardiotoxicity,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,musculoskeletal toxicity,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,carcinogenicity,,,,,United States
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,Black Box Warning,respiratory toxicity,,,,,United States
37266,CHEMBL728,PROCHLORPERAZINE,Black Box Warning,,,,,,United States
37493,CHEMBL730,NITROGLYCERIN,Black Box Warning,,,,,,United States
38727,CHEMBL741,LAMOTRIGINE,Black Box Warning,dermatological toxicity,,,,,United States
40940,CHEMBL752,ADENOSINE PHOSPHATE,Withdrawn,,"Not safe or effective for intended use as vasodilator, anti-inflammatory",EFO:0009658,adverse effect,1973.0,United States
40940,CHEMBL752,ADENOSINE PHOSPHATE,Withdrawn,,"Not safe or effective for intended use as vasodilator, anti-inflammatory",EFO:0020002,lack of efficacy,1973.0,United States
41644,CHEMBL754,FOSCARNET SODIUM,Black Box Warning,nephrotoxicity,,,,,United States
41644,CHEMBL754,FOSCARNET SODIUM,Black Box Warning,neurotoxicity,,,,,United States
41644,CHEMBL754,FOSCARNET SODIUM,Black Box Warning,vascular toxicity,,,,,United States
41644,CHEMBL754,FOSCARNET SODIUM,Black Box Warning,dermatological toxicity,,,,,United States
2355,CHEMBL7568,QUINACRINE,Withdrawn,,questions about the safety of the drug,,,1998.0,India
122247,CHEMBL76370,TEGASEROD,Withdrawn,cardiotoxicity,Cardiovascular ischaemic events,EFO:1001375,Myocardial Ischemia,2007.0,United States; Australia; Canada
43952,CHEMBL772,RESERPINE,Withdrawn,,associated with a greater frequency and severity of adverse effects in strengths greater than 1 mg,EFO:0009658,adverse effect,1977.0,United States
2367,CHEMBL7728,HEXOBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1984.0,Sweden
44647,CHEMBL776,METAPROTERENOL,Withdrawn,cardiotoxicity,"Low bronchodilating efficacy (compared to salbutamol) and high incidence of cardiac side effects, mainly palpitations and tachycardia due to its nonselectivity.",HP:0001649,Tachycardia,2009.0,United Kingdom
44647,CHEMBL776,METAPROTERENOL,Withdrawn,cardiotoxicity,"Low bronchodilating efficacy (compared to salbutamol) and high incidence of cardiac side effects, mainly palpitations and tachycardia due to its nonselectivity.",HP:0001962,Palpitations,2009.0,United Kingdom
47340,CHEMBL786,TAMOXIFEN CITRATE,Black Box Warning,carcinogenicity,,,,,United States
47340,CHEMBL786,TAMOXIFEN CITRATE,Black Box Warning,vascular toxicity,,,,,United States
47340,CHEMBL786,TAMOXIFEN CITRATE,Black Box Warning,neurotoxicity,,,,,United States
47340,CHEMBL786,TAMOXIFEN CITRATE,Black Box Warning,respiratory toxicity,,,,,United States
47340,CHEMBL786,TAMOXIFEN CITRATE,Black Box Warning,immune system toxicity,,,,,United States
2407,CHEMBL7863,APROBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,MONDO:0002491,substance abuse,1985.0,Sweden
2407,CHEMBL7863,APROBARBITAL,Withdrawn,drug misuse,Fatal intoxications and abuse,EFO:0008546,poisoning,1985.0,Sweden
47447,CHEMBL787,MONTELUKAST,Black Box Warning,,,,,,United States
47447,CHEMBL787,MONTELUKAST,Black Box Warning,neurotoxicity,,,,,United States
49842,CHEMBL796,METHYLPHENIDATE,Black Box Warning,misuse,,,,,United States
49842,CHEMBL796,METHYLPHENIDATE,Black Box Warning,neurotoxicity,,,,,United States
50440,CHEMBL799,CILOSTAZOL,Black Box Warning,,,,,,United States
241,CHEMBL8,CIPROFLOXACIN,Black Box Warning,neurotoxicity,,,,,United States
241,CHEMBL8,CIPROFLOXACIN,Black Box Warning,musculoskeletal toxicity,,,,,United States
51042,CHEMBL802,MINOXIDIL,Black Box Warning,cardiotoxicity,,,,,United States
51182,CHEMBL803,CYTARABINE,Black Box Warning,hematological toxicity,,,,,United States
51182,CHEMBL803,CYTARABINE,Black Box Warning,gastrointestinal toxicity,,,,,United States
51182,CHEMBL803,CYTARABINE,Black Box Warning,hepatotoxicity,,,,,United States
52087,CHEMBL806,FLUTAMIDE,Black Box Warning,hepatotoxicity,,,,,United States
52087,CHEMBL806,FLUTAMIDE,Black Box Warning,vascular toxicity,,,,,United States
52087,CHEMBL806,FLUTAMIDE,Black Box Warning,dermatological toxicity,,,,,United States
52087,CHEMBL806,FLUTAMIDE,Black Box Warning,immune system toxicity,,,,,United States
52087,CHEMBL806,FLUTAMIDE,Black Box Warning,nephrotoxicity,,,,,United States
53686,CHEMBL810,TEMOZOLOMIDE,Black Box Warning,,,,,,United States
54149,CHEMBL812,PYRIDOSTIGMINE BROMIDE,Black Box Warning,,,,,,United States
56644,CHEMBL820,BUSULFAN,Black Box Warning,hematological toxicity,,,,,United States
56644,CHEMBL820,BUSULFAN,Black Box Warning,carcinogenicity,,,,,United States
59519,CHEMBL831,LOXAPINE,Black Box Warning,respiratory toxicity,,,,,United States
62701,CHEMBL843,ROSIGLITAZONE MALEATE,Black Box Warning,cardiotoxicity,,,,,United States
62701,CHEMBL843,ROSIGLITAZONE MALEATE,Withdrawn,cardiotoxicity,Increased risk of ischaemic heart disease,EFO:0003144,heart failure,2010.0,Armenia; Guatemala; Egypt; New Zealand; Madagascar; European Union
62701,CHEMBL843,ROSIGLITAZONE MALEATE,Withdrawn,cardiotoxicity,Increased risk of ischaemic heart disease,EFO:0009373,edema,2010.0,Armenia; Guatemala; Egypt; New Zealand; Madagascar; European Union
63649,CHEMBL848,LENALIDOMIDE,Black Box Warning,hematological toxicity,,,,,United States
63649,CHEMBL848,LENALIDOMIDE,Black Box Warning,vascular toxicity,,,,,United States
63649,CHEMBL848,LENALIDOMIDE,Black Box Warning,teratogenicity,,,,,United States
63649,CHEMBL848,LENALIDOMIDE,Black Box Warning,respiratory toxicity,,,,,United States
63649,CHEMBL848,LENALIDOMIDE,Black Box Warning,musculoskeletal toxicity,,,,,United States
7714,CHEMBL85,RISPERIDONE,Black Box Warning,,,,,,United States
65415,CHEMBL852,MELPHALAN,Black Box Warning,hematological toxicity,,,,,United States
65415,CHEMBL852,MELPHALAN,Black Box Warning,teratogenicity,,,,,United States
139173,CHEMBL85231,MEDIFOXAMINE,Withdrawn,hepatotoxicity,Evidence of hepatic injury,EFO:0011052,hepatotoxicity,1999.0,France; Morocco
139173,CHEMBL85231,MEDIFOXAMINE,Withdrawn,hepatotoxicity,Evidence of hepatic injury,EFO:0004228,drug-induced liver injury,1999.0,France; Morocco
65494,CHEMBL853,ZALCITABINE,Black Box Warning,,,,,,United States
66273,CHEMBL864,CARBINOXAMINE,Withdrawn,,High incidence of adverse drug reactions (ADRs) at therapeutic levels,EFO:0009658,adverse effect,2008.0,Iraq
67010,CHEMBL865,VALDECOXIB,Black Box Warning,,,,,,United States
67010,CHEMBL865,VALDECOXIB,Withdrawn,dermatological toxicity,"associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compared to other nonsteroidal anti-inflammatory drugs",EFO:1000694,erythema multiforme,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,"Cardiovascular risk, (heart attack or stroke)",EFO:0000712,stroke,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,"Cardiovascular risk, (heart attack or stroke)",EFO:0000612,myocardial infarction,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,Increased risk of heart attack,EFO:0000612,myocardial infarction,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,Risk for heart attack and stroke,EFO:0000612,myocardial infarction,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,dermatological toxicity,"associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compared to other nonsteroidal anti-inflammatory drugs",EFO:0004276,Stevens-Johnson syndrome,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,"associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compared to other nonsteroidal anti-inflammatory drugs",EFO:1001482,cardiotoxicity,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,dermatological toxicity,Serious skin reactions and cardiovascular problems,EFO:0020927,skin reaction,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,dermatological toxicity,"associated with increased risk of serious cardiovascular events and an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compared to other nonsteroidal anti-inflammatory drugs",EFO:0004775,toxic epidermal necrolysis,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,neurotoxicity,"Cardiovascular risk, (heart attack or stroke)",EFO:0000712,stroke,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,Serious skin reactions and cardiovascular problems,EFO:1001482,cardiotoxicity,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,cardiotoxicity,Risk for heart attack and stroke,EFO:0000712,stroke,2005.0,United States; New Zealand; Bhutan; Canada
67010,CHEMBL865,VALDECOXIB,Withdrawn,neurotoxicity,Risk for heart attack and stroke,EFO:0000712,stroke,2005.0,United States; New Zealand; Bhutan; Canada
68396,CHEMBL866,MYCOPHENOLIC ACID,Black Box Warning,carcinogenicity,,,,,United States
68396,CHEMBL866,MYCOPHENOLIC ACID,Black Box Warning,immune system toxicity,,,,,United States
68396,CHEMBL866,MYCOPHENOLIC ACID,Black Box Warning,teratogenicity,,,,,United States
68396,CHEMBL866,MYCOPHENOLIC ACID,Black Box Warning,infectious disease,,,,,United States
70239,CHEMBL869,NITROFURAZONE,Withdrawn,,superseded by safer and more effective preparations,,,1977.0,United States; Japan
70239,CHEMBL869,NITROFURAZONE,Withdrawn,carcinogenicity,mammary tumors in rats and ovarian tumors in mice,EFO:0011046,carcinogenicity,1977.0,United States; Japan
139434,CHEMBL87493,FENFLURAMINE,Withdrawn,respiratory toxicity,heart valve damage and pulmonary arterial hypertension,EFO:0001361,pulmonary arterial hypertension,1997.0,France; China; United States
139434,CHEMBL87493,FENFLURAMINE,Withdrawn,respiratory toxicity,arterial pulmonary hypertension,EFO:0001361,pulmonary arterial hypertension,1997.0,France; China; United States
139434,CHEMBL87493,FENFLURAMINE,Withdrawn,cardiotoxicity,heart valve damage and pulmonary arterial hypertension,EFO:0009551,heart valve disease,1997.0,France; China; United States
73548,CHEMBL878,METOLAZONE,Black Box Warning,,,,,,United States
74911,CHEMBL885,EMTRICITABINE,Black Box Warning,hepatotoxicity,,,,,United States
141484,CHEMBL89598,VIGABATRIN,Black Box Warning,,,,,,United States
77652,CHEMBL898,DIFLUNISAL,Black Box Warning,cardiotoxicity,,,,,United States
77652,CHEMBL898,DIFLUNISAL,Black Box Warning,neurotoxicity,,,,,United States
77652,CHEMBL898,DIFLUNISAL,Black Box Warning,gastrointestinal toxicity,,,,,United States
246,CHEMBL9,NORFLOXACIN,Black Box Warning,,,,,,United States
78902,CHEMBL904,DEXMETHYLPHENIDATE HYDROCHLORIDE,Black Box Warning,misuse,,,,,United States
149457,CHEMBL90593,PRASTERONE,Withdrawn,,lack of information on efficacy and safety of long-term use,,,1985.0,United States
82983,CHEMBL917,FLOXURIDINE,Black Box Warning,,,,,,United States
83044,CHEMBL919,FOSPHENYTOIN SODIUM,Black Box Warning,cardiotoxicity,,,,,United States
83044,CHEMBL919,FOSPHENYTOIN SODIUM,Black Box Warning,vascular toxicity,,,,,United States
83044,CHEMBL919,FOSPHENYTOIN SODIUM,Black Box Warning,misuse,,,,,United States
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,Black Box Warning,metabolic toxicity,,,,,United States
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,Black Box Warning,hepatotoxicity,,,,,United States
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,Black Box Warning,nephrotoxicity,,,,,United States
5622,CHEMBL9225,HEXESTROL,Withdrawn,carcinogenicity,suspected carcinogenicity in newborns following prenatal exposure.,EFO:0011046,carcinogenicity,1979.0,Italy
84644,CHEMBL928,DANTROLENE SODIUM,Black Box Warning,hepatotoxicity,,,,,United States
150941,CHEMBL93268,SODIUM NITRITE,Black Box Warning,hematological toxicity,,,,,United States
150941,CHEMBL93268,SODIUM NITRITE,Black Box Warning,vascular toxicity,,,,,United States
150722,CHEMBL94081,ALCLOFENAC,Withdrawn,vascular toxicity,Vasculitis; Rash,EFO:0006803,vasculitis,1977.0,United Kingdom; Cyprus; Egypt; Ireland; Italy
150722,CHEMBL94081,ALCLOFENAC,Withdrawn,dermatological toxicity,Vasculitis; Rash,EFO:1000697,exanthem,1977.0,United Kingdom; Cyprus; Egypt; Ireland; Italy
150722,CHEMBL94081,ALCLOFENAC,Withdrawn,dermatological toxicity,Vasculitis; Rash,EFO:0006803,vasculitis,1977.0,United Kingdom; Cyprus; Egypt; Ireland; Italy
150722,CHEMBL94081,ALCLOFENAC,Withdrawn,carcinogenicity,Epoxide urinary metabolite has mutagenic activity,EFO:0011046,carcinogenicity,1977.0,United Kingdom; Cyprus; Egypt; Ireland; Italy
150722,CHEMBL94081,ALCLOFENAC,Withdrawn,vascular toxicity,Vasculitis; Rash,EFO:1000697,exanthem,1977.0,United Kingdom; Cyprus; Egypt; Ireland; Italy
153408,CHEMBL94394,BUFEXAMAC,Withdrawn,dermatological toxicity,"risks of serious skin reactions from bufexamac outweigh any possible benefits when used for the treatment of insect bites, stings and itches, and minor burns and sunburn",EFO:0006346,severe cutaneous adverse reaction,2010.0,European Union; Madagascar; New Zealand
153408,CHEMBL94394,BUFEXAMAC,Withdrawn,immune system toxicity,Contact allergies,EFO:0005319,contact dermatitis,2010.0,European Union; Madagascar; New Zealand
153408,CHEMBL94394,BUFEXAMAC,Withdrawn,immune system toxicity,High risk of sometimes serious contact allergy,EFO:0005319,contact dermatitis,2010.0,European Union; Madagascar; New Zealand
93117,CHEMBL956,SUPROFEN,Withdrawn,nephrotoxicity,"Flank pain, decreased kidney function",HP:0030157,Flank pain,1987.0,United States; United Kingdom; Spain
93117,CHEMBL956,SUPROFEN,Withdrawn,musculoskeletal toxicity,"Flank pain, decreased kidney function",HP:0030157,Flank pain,1987.0,United States; United Kingdom; Spain
93117,CHEMBL956,SUPROFEN,Withdrawn,nephrotoxicity,"Flank pain, decreased kidney function",EFO:0020912,decreased kidney function,1987.0,United States; United Kingdom; Spain
93117,CHEMBL956,SUPROFEN,Withdrawn,musculoskeletal toxicity,"Flank pain, decreased kidney function",EFO:0020912,decreased kidney function,1987.0,United States; United Kingdom; Spain
93617,CHEMBL957,BOSENTAN,Black Box Warning,teratogenicity,,,,,United States
93617,CHEMBL957,BOSENTAN,Black Box Warning,hepatotoxicity,,,,,United States
93895,CHEMBL960,LEFLUNOMIDE,Black Box Warning,teratogenicity,,,,,United States
93895,CHEMBL960,LEFLUNOMIDE,Black Box Warning,hepatotoxicity,,,,,United States
94571,CHEMBL964,DISULFIRAM,Black Box Warning,,,,,,United States
95909,CHEMBL967,TEMAZEPAM,Black Box Warning,,,,,,United States
95978,CHEMBL971,PENTOBARBITAL SODIUM,Withdrawn,drug misuse,Self-Poisonings,EFO:0008546,poisoning,1980.0,Sweden; Norway
96021,CHEMBL972,SELEGILINE,Black Box Warning,psychiatric toxicity,,,,,United States
96107,CHEMBL973,TERIFLUNOMIDE,Black Box Warning,hepatotoxicity,,,,,United States
96107,CHEMBL973,TERIFLUNOMIDE,Black Box Warning,teratogenicity,,,,,United States
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Risk of overdose, abuse and misuse (serious side effects including overdose, loss of consciousness, abuse, addiction and severe symptoms on stopping treatment abruptly)",MONDO:0004938,substance dependence,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Risk of overdose, abuse and misuse (serious side effects including overdose, loss of consciousness, abuse, addiction and severe symptoms on stopping treatment abruptly)",EFO:0020911,overdose,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Serious side effects seen with these medicines. These included confusion and loss of consciousness, particularly in elderly people, and the risk of addiction to the medicine when used for prolonged periods, with severe withdrawal symptoms on stopping treatment abruptly. The French medicines agency was also concerned by reports of these medicines being taken for longer than recommended and cases of overdose (sometimes in combination with other medicines) leading to coma or death.",EFO:0020911,overdose,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Serious side effects seen with these medicines. These included confusion and loss of consciousness, particularly in elderly people, and the risk of addiction to the medicine when used for prolonged periods, with severe withdrawal symptoms on stopping treatment abruptly. The French medicines agency was also concerned by reports of these medicines being taken for longer than recommended and cases of overdose (sometimes in combination with other medicines) leading to coma or death.",MONDO:0004938,substance dependence,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Risk of overdose, abuse and misuse (serious side effects including overdose, loss of consciousness, abuse, addiction and severe symptoms on stopping treatment abruptly)",MONDO:0002491,substance abuse,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,neurotoxicity,"Serious side effects seen with these medicines. These included confusion and loss of consciousness, particularly in elderly people, and the risk of addiction to the medicine when used for prolonged periods, with severe withdrawal symptoms on stopping treatment abruptly. The French medicines agency was also concerned by reports of these medicines being taken for longer than recommended and cases of overdose (sometimes in combination with other medicines) leading to coma or death.",HP:0001259,Coma,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Dependence, withdrawal, abuse, and other undesirable effects",MONDO:0004938,substance dependence,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,neurotoxicity,"Serious side effects seen with these medicines. These included confusion and loss of consciousness, particularly in elderly people, and the risk of addiction to the medicine when used for prolonged periods, with severe withdrawal symptoms on stopping treatment abruptly. The French medicines agency was also concerned by reports of these medicines being taken for longer than recommended and cases of overdose (sometimes in combination with other medicines) leading to coma or death.",HP:0001289,Confusion,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"Dependence, withdrawal, abuse, and other undesirable effects",MONDO:0002491,substance abuse,1981.0,European Union; United Kingdom; Canada; Sweden
99389,CHEMBL979,MEPROBAMATE,Withdrawn,drug misuse,"lack of evidence of their value in long-term management of obesity, they have the potential for abuse and despite warnings they are frequently used over unacceptably prolonged periods.",MONDO:0002491,substance abuse,1981.0,European Union; United Kingdom; Canada; Sweden
101810,CHEMBL983,SUCCINYLCHOLINE CHLORIDE,Black Box Warning,,,,,,United States
101810,CHEMBL983,SUCCINYLCHOLINE CHLORIDE,Black Box Warning,misuse,,,,,United States
107119,CHEMBL991,STAVUDINE,Black Box Warning,metabolic toxicity,,,,,United States
107119,CHEMBL991,STAVUDINE,Black Box Warning,hepatotoxicity,,,,,United States
109797,CHEMBL995,LOSARTAN POTASSIUM,Black Box Warning,teratogenicity,,,,,United States
